TWI622598B - Polymerizable compound, polymerizable composition, and optical anisotropy - Google Patents

Polymerizable compound, polymerizable composition, and optical anisotropy Download PDF

Info

Publication number
TWI622598B
TWI622598B TW101109357A TW101109357A TWI622598B TW I622598 B TWI622598 B TW I622598B TW 101109357 A TW101109357 A TW 101109357A TW 101109357 A TW101109357 A TW 101109357A TW I622598 B TWI622598 B TW I622598B
Authority
TW
Taiwan
Prior art keywords
oco
coo
formula
group
carbon atoms
Prior art date
Application number
TW101109357A
Other languages
Chinese (zh)
Other versions
TW201307407A (en
Inventor
Masahiro Horiguchi
Masanao Hayashi
Yutaka Kadomoto
Masayuki Iwakubo
Yoshio Aoki
Yoshitaka Saitou
Tetsuo Kusumoto
Original Assignee
Dainippon Ink & Chemicals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Ink & Chemicals filed Critical Dainippon Ink & Chemicals
Publication of TW201307407A publication Critical patent/TW201307407A/en
Application granted granted Critical
Publication of TWI622598B publication Critical patent/TWI622598B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/612Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety
    • C07C69/616Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety polycyclic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C13/00Cyclic hydrocarbons containing rings other than, or in addition to, six-membered aromatic rings
    • C07C13/28Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof
    • C07C13/32Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof with condensed rings
    • C07C13/47Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof with condensed rings with a bicyclo ring system containing ten carbon atoms
    • C07C13/48Completely or partially hydrogenated naphthalenes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/02Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
    • C07C69/12Acetic acid esters
    • C07C69/14Acetic acid esters of monohydroxylic compounds
    • C07C69/145Acetic acid esters of monohydroxylic compounds of unsaturated alcohols
    • C07C69/157Acetic acid esters of monohydroxylic compounds of unsaturated alcohols containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/10Esters
    • C08F220/20Esters of polyhydric alcohols or phenols, e.g. 2-hydroxyethyl (meth)acrylate or glycerol mono-(meth)acrylate
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/32Non-steroidal liquid crystal compounds containing condensed ring systems, i.e. fused, bridged or spiro ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Liquid Crystal Substances (AREA)
  • Polyethers (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)

Abstract

本發明之課題在於提供一種具有大的折射率各向異性且構成聚合性液晶組成物時具有高保存穩定性和高配向性的聚合性化合物,及含有該聚合性化合物的聚合性液晶組成物。進而,提供藉由使該聚合性液晶組成物進行聚合而得到的聚合物及使用該聚合物的光學各向異性體。本課題的解決方法在於,提供通式(I)所表示的聚合性化合物,並提供以該化合物為構成構件的聚合性液晶組成物,進而提供藉由使該聚合性液晶組成物進行聚合而得到的聚合物及使用該聚合物的光學各向異性體。 An object of the present invention is to provide a polymerizable compound having a large refractive index anisotropy and having high storage stability and high orientation when constituting a polymerizable liquid crystal composition, and a polymerizable liquid crystal composition containing the polymerizable compound. Furthermore, a polymer obtained by polymerizing the polymerizable liquid crystal composition and an optically anisotropic body using the polymer are provided. The solution to this problem is to provide a polymerizable compound represented by the general formula (I), a polymerizable liquid crystal composition using the compound as a constituent member, and further providing a polymerizable liquid crystal composition obtained by polymerizing the polymerizable liquid crystal composition. Polymer and optical anisotropy using the polymer.

Description

聚合性化合物、聚合性組成物及光學各向異性體 Polymerizable compound, polymerizable composition, and optical anisotropy

本發明係關於聚合性化合物、含有該化合物的聚合性液晶組成物及使用該聚合性組成物的光學各向異性體。 The present invention relates to a polymerizable compound, a polymerizable liquid crystal composition containing the compound, and an optically anisotropic body using the polymerizable composition.

聚合性化合物用於各種膜。例如,可藉由使聚合性化合物以液晶狀態進行排列後,將其進行聚合來製作具有均勻的配向的膜。這樣製作的膜可用於液晶顯示器所需要的偏光板、相位差板等。另外,聚合性化合物還可用於製作具有膽甾醇結構的膜。多數情況下,為了滿足所要求的光學特性、聚合速度、溶解性、熔點、玻璃化溫度、膜的透明性、機械強度、表面硬度、耐熱性及耐光性,可使用包含2種以上的聚合性化合物的組成物。此時,對於使用的聚合性化合物,要求對其他特性不造成不良影響而對組成物帶來良好的物性。特別是以製作具有膽甾醇結構的膜為目的時,需要可在較寬的溫度範圍內作為向列相或膽甾醇相存在,而且具有高的向列相或膽甾醇相液晶配向性的聚合性化合物。另外,為了調製具有大的折射率各向異性的組成物,要求具有大的折射率各向異性的聚合性化合物。進而由於在處理組成物時,特定的成分從組成物析出時組成比會變化,因此需要保存穩定性高的聚合性化合物。 The polymerizable compound is used in various films. For example, a film having a uniform orientation can be produced by arranging polymerizable compounds in a liquid crystal state and polymerizing them. The thus-produced film can be used for a polarizing plate, a retardation plate, and the like required for a liquid crystal display. The polymerizable compound can also be used to produce a film having a cholesteric structure. In many cases, in order to satisfy the required optical characteristics, polymerization speed, solubility, melting point, glass transition temperature, film transparency, mechanical strength, surface hardness, heat resistance, and light resistance, two or more kinds of polymerizability can be used. Composition of compounds. At this time, the polymerizable compound used is required to bring good physical properties to the composition without adversely affecting other characteristics. Especially for the purpose of producing a film having a cholesteric structure, it is necessary to have a polymerizable property that it can exist as a nematic phase or a cholesteric phase in a wide temperature range and has high nematic or cholesteric liquid crystal alignment properties. Compound. In addition, in order to prepare a composition having a large refractive index anisotropy, a polymerizable compound having a large refractive index anisotropy is required. Furthermore, since the composition ratio changes when a specific component is precipitated from the composition during processing of the composition, a polymerizable compound having high storage stability is required.

將該具有膽甾醇結構的膜作為顯示器等的亮度提高膜使用時,要求具有霧度值小、沒有斑點的均勻的膽甾醇結構。因此,期望開發除了上述特性以外,配向性也高的聚合性化合物。然而,迄今為止所開發的聚合性化合物(專利文獻1~專利文獻3)雖然折射率各向異性大,但存在保存穩定性低、配向性低這樣的問題。因此,將含有此等聚合性化合物的組成物塗佈於PET上並進行乾燥所得到的光學各向異性體的霧度值變大,或者產生斑點,因此難以製成具有均勻配向的膜。另一方面,在專利文獻4及專利文獻5中,記載了藉由導入二苯乙炔(tolan)骨架而增大折射率各向異 性的聚合性化合物,但該文獻中沒有關於保存穩定性、配向性的記載。另外,在專利文獻6及專利文獻7中,雖然有關於具有萘結構的聚合性化合物的記載,但關於保存穩定性及霧度值並未詳細記載。 When this film having a cholesteric structure is used as a brightness-improving film such as a display, a uniform cholesteric structure having a small haze value and no spots is required. Therefore, it is desired to develop a polymerizable compound having high alignment properties in addition to the above characteristics. However, the polymerizable compounds (Patent Documents 1 to 3) developed so far have large refractive index anisotropy, but have problems of low storage stability and low alignment. Therefore, the haze value of the optically anisotropic body obtained by coating a composition containing such a polymerizable compound on PET and drying it becomes large, or spots are generated, and it is difficult to produce a film having a uniform alignment. On the other hand, in Patent Documents 4 and 5, it is described that the refractive index anisotropy is increased by introducing a diphenylacetylene (tolan) skeleton. Polymerizable compounds, but there is no description about storage stability and orientation in this document. Moreover, although patent document 6 and patent document 7 have description about the polymerizable compound which has a naphthalene structure, storage stability and a haze value are not described in detail.

[先前技術文獻] [Prior technical literature] [專利文獻] [Patent Literature]

專利文獻1:日本特開2008-88291號公報 Patent Document 1: Japanese Patent Application Laid-Open No. 2008-88291

專利文獻2:日本特開2008-195762號公報 Patent Document 2: Japanese Patent Application Laid-Open No. 2008-195762

專利文獻3:日本特開平2-238087號公報 Patent Document 3: Japanese Patent Application Laid-Open No. 2-238087

專利文獻4:日本特開2002-265421號公報 Patent Document 4: Japanese Patent Application Laid-Open No. 2002-265421

專利文獻5:EP1786887B1號公報 Patent Document 5: EP1786887B1

專利文獻6:日本特開2008-179654號公報 Patent Document 6: Japanese Patent Application Laid-Open No. 2008-179654

專利文獻7:日本特開2007-119415號公報 Patent Document 7: Japanese Patent Application Laid-Open No. 2007-119415

本發明欲解決的課題為提供具有大的折射率各向異性、且構成聚合性液晶組成物時具有高保存穩定性和高配向性的聚合性化合物及含有該聚合性化合物的聚合性液晶組成物。進而,提供藉由使該聚合性液晶組成物進行聚合所得到的聚合物及使用該聚合物的光學各向異性體。 The problem to be solved by the present invention is to provide a polymerizable compound having a large refractive index anisotropy and a high storage stability and a high orientation when constituting a polymerizable liquid crystal composition, and a polymerizable liquid crystal composition containing the polymerizable compound. . Further, a polymer obtained by polymerizing the polymerizable liquid crystal composition and an optically anisotropic body using the polymer are provided.

本案發明人等進行了聚合性化合物的各種取代基的研究,結果發現具有特定結構的聚合性化合物可解決上述課題,從而完成了本發明。 The present inventors have studied various substituents of a polymerizable compound, and as a result, found that a polymerizable compound having a specific structure can solve the above problems, and completed the present invention.

本發明提供通式(I)表示的聚合性化合物及使用該化合物的聚合性液晶組成物。 The present invention provides a polymerizable compound represented by the general formula (I) and a polymerizable liquid crystal composition using the compound.

(式中,P表示選自下述式(P-1)~式(P-15)表示的聚合性基團的取代基; (In the formula, P represents a substituent selected from a polymerizable group represented by the following formula (P-1) to formula (P-15);

S1表示1個-CH2-或不相鄰的2個以上的-CH2-可分別獨立地經-O-、-S-、-CO-、-COO-、-OCO-、-CO-S-、-S-CO-、-O-CO-O-、-CO-NH-、-NH-CO-取代的碳原子數1~20的伸烷基或單鍵;X1分別獨立地表示-O-、-S-、-OCH2-、-CH2O-、-CO-、-COO-、-OCO-、-CO-S-、-S-CO-、-O-CO-O-、-CO-NH-、-NH-CO-、-SCH2-、-CH2S-、-CF2O-、-OCF2-、-CF2S-、-SCF2-、-CH2CH2-、-CH2CF2-、-CF2CH2-、-CF2CF2-、-CH=CH-COO-、-CH=CH-OCO-、-COO-CH=CH-、-OCO-CH=CH-、-COO-CH2CH2-、-OCO-CH2CH2-、-CH2CH2-COO-、-CH2CH2-OCO-、-COO-CH2-、-OCO-CH2-、-CH2-COO-、-CH2-OCO-、-CY1=CY2-、-C≡C-或單鍵(式中,Y1及Y2分別獨立地表示氫原子、碳原子數1~12的烷基、氟原子、氯原子或氰基。);L1~L6分別獨立地表示氫原子、氟原子、氯原子、氰基、硝基、碳原子數1~7的烷基、碳原子數1~7的烷氧基或碳原子數1~7的烷醯基,存在於該烷基、烷氧基或烷醯基中的1個以上的氫原子可取代為氟原子或氯原子;M1~M4分別獨立地表示氫原子、氟原子、氯原子、氰基、硝基、碳原子數1~7的烷基、碳原子數1~7的烷氧基、碳原子數1~7的烷醯基或-X2-S2-P(式中,X2、S2及P 分別表示與上述X1、S1及P相同含意,各自可為相同的基團也可為不同的基團。),存在於該烷基、烷氧基或烷醯基中的1個以上的氫原子可以被氟原子或氯原子取代,不存在M1~M4全部同樣地為氫原子的情況;A1、A2及A3分別獨立地表示1,4-伸苯基、萘-2,6-二基、1,4-伸環己基、1,4-伸環己烯基、1,4-雙環[2.2.2]伸辛基、十氫萘-2,6-二基、1,2,3,4-四氫萘-2,6-二基、吡啶-2,6-二基、嘧啶-2,5-二基或1,3-二烷-2,5-二基,此等基團可未經取代,也可以經氟原子、氯原子、氰基、硝基、碳原子數1~7的烷基、碳原子數1~7的烷氧基或碳原子數1~7的烷醯基取代,此等烷基、烷氧基或烷醯基的1個以上的氫原子可以取代為氟原子或氯原子,A1及/或A2存在多個時此等可相同也可不同;Z1、Z2及Z4分別獨立地表示-OCH2-、-CH2O-、-COO-、-OCO-、-CO-S-、-S-CO-、-CO-NH-、-NH-CO-、-SCH2-、-CH2S-、-CF2O-、-OCF2-、-CF2S-、-SCF2-、-CH2CH2-、-CH2CF2-、-CF2CH2-、-CF2CF2-、-CH=CH-COO-、-CH=CH-OCO-、-COO-CH=CH-、-OCO-CH=CH-、-COO-CH2CH2-、-OCO-CH2CH2-、-CH2CH2-COO-、-CH2CH2-OCO-、-COO-CH2-、-OCO-CH2-、-CH2-COO-、-CH2-OCO-、-CY3=CY4-、-C≡C-或單鍵(式中,Y3及Y4分別獨立地表示氫原子、碳原子數1~12的烷基、氟原子、氯原子或氰基。),Z1、Z2及Z4存在多個時此等可相同也可不同;Z3表示-OCH2-、-CH2O-、-COO-、-OCO-、-CO-S-、-S-CO-、-CO-NH-、-NH-CO-、-SCH2-、-CH2S-、-CF2O-、-OCF2-、-CF2S-、-SCF2-、-CH2CH2-、-CH2CF2-、-CF2CH2-、-CF2CF2-、-CH=CH-COO-、-CH=CH-OCO-、-COO-CH=CH-、-OCO-CH=CH-、-COO-CH2CH2-、-OCO-CH2CH2-、-CH2CH2-COO-、-CH2CH2-OCO-、-COO-CH2-、-OCO-CH2-、-CH2-COO-、-CH2-OCO-、-CY5=CY6-或單鍵(式中,Y5及Y6分別獨立地表示氫原子、碳原子數1~12的烷基、氟原子、氯原子或氰基。);R表示氟原子、氯原子、氰基、碳原子數1~12的烷基或-X3-S3-P(式中,X3、S3及P分別表示與上述X1、S1及P相同含意,各自可為相同的基團也可為不同的基團。),存在於該 烷基中的1個以上的氫原子可以取代為氟原子、氯原子、氰基,另外,該烷基中的1個-CH2-或不相鄰的2個以上的-CH2-可以分別獨立地經-O-、-S-、-CO-、-COO-、-OCO-、-CO-S-、-S-CO-、-O-CO-O-、-CO-NH-、-NH-CO-、-CH=CH-、-CH=CF-、-CF=CH-或-C≡C-取代;m1及m2分別獨立地表示0或1,R表示-X3-S3-P,m1=0、m2=0時,A3表示萘-2,6-二基以外的基團,不存在S1及S3中僅一方表示單鍵的情況。)。 S 1 represents one -CH 2 -or two or more non-adjacent -CH 2 -which can be independently passed through -O-, -S-, -CO-, -COO-, -OCO-, -CO- S-, -S-CO-, -O-CO-O-, -CO-NH-, -NH-CO- substituted alkylene or single bond with 1 to 20 carbon atoms; X 1 represents each independently -O-, -S-, -OCH 2- , -CH 2 O-, -CO-, -COO-, -OCO-, -CO-S-, -S-CO-, -O-CO-O- , -CO-NH-, -NH-CO-, -SCH 2- , -CH 2 S-, -CF 2 O-, -OCF 2- , -CF 2 S-, -SCF 2- , -CH 2 CH 2- , -CH 2 CF 2- , -CF 2 CH 2- , -CF 2 CF 2- , -CH = CH-COO-, -CH = CH-OCO-, -COO-CH = CH-, -OCO -CH = CH -, - COO- CH 2 CH 2 -, - OCO-CH 2 CH 2 -, - CH 2 CH 2 -COO -, - CH 2 CH 2 -OCO -, - COO-CH 2 -, - OCO-CH 2- , -CH 2 -COO-, -CH 2 -OCO-, -CY 1 = CY 2- , -C≡C- or single bond (wherein Y 1 and Y 2 each independently represent hydrogen Atom, alkyl group having 1 to 12 carbon atoms, fluorine atom, chlorine atom or cyano group.); L 1 to L 6 each independently represent a hydrogen atom, a fluorine atom, a chlorine atom, a cyano group, a nitro group, and a carbon number. 1 to 7 alkyl groups, 1 to 7 carbon atoms, or 1 to 7 carbon alkyl groups, which are present in the alkyl group and alkoxy group One or more hydrogen atoms in the alkanoyl group may be substituted with a fluorine atom or a chlorine atom; M 1 ~ M 4 each independently represent a hydrogen atom, a fluorine atom, a chlorine atom, a cyano group, a nitro group, having 1 to 7 carbon atoms, Alkyl group, alkoxy group having 1 to 7 carbon atoms, alkanoyl group having 1 to 7 carbon atoms, or -X 2 -S 2 -P (wherein X 2 , S 2, and P each represent the same as X 1 , S 1 and P have the same meaning, and each may be the same group or different groups.), One or more hydrogen atoms present in the alkyl group, alkoxy group, or alkylfluorenyl group may be fluorine Atom or chlorine atom substitution, there is no case where all of M 1 to M 4 are the same hydrogen atom; A 1 , A 2 and A 3 each independently represent 1,4-phenylene, naphthalene-2,6-diyl , 1,4-cyclohexyl, 1,4-cyclohexenyl, 1,4-bicyclo [2.2.2] octyl, decahydronaphthalene-2,6-diyl, 1,2,3, 4-tetrahydronaphthalene-2,6-diyl, pyridine-2,6-diyl, pyrimidine-2,5-diyl, or 1,3-diyl Alkane-2,5-diyl, these groups may be unsubstituted, or may be fluorine, chlorine, cyano, nitro, 1 to 7 carbon atoms, 1 to 7 carbon atoms Alkoxy or alkanoyl having 1 to 7 carbon atoms may be substituted, and one or more hydrogen atoms of such alkyl, alkoxy or alkanoyl may be substituted by fluorine or chlorine atoms, A 1 and / or A These may be the same or different when there are two or more; Z 1 , Z 2 and Z 4 each independently represent -OCH 2- , -CH 2 O-, -COO-, -OCO-, -CO-S-, -S-CO-, -CO-NH-, -NH-CO-, -SCH 2- , -CH 2 S-, -CF 2 O-, -OCF 2- , -CF 2 S-, -SCF 2- , -CH 2 CH 2- , -CH 2 CF 2- , -CF 2 CH 2- , -CF 2 CF 2- , -CH = CH-COO-, -CH = CH-OCO-, -COO-CH = CH -, - OCO-CH = CH -, - COO-CH 2 CH 2 -, - OCO-CH 2 CH 2 -, - CH 2 CH 2 -COO -, - CH 2 CH 2 -OCO -, - COO- CH 2- , -OCO-CH 2- , -CH 2 -COO-, -CH 2 -OCO-, -CY 3 = CY 4- , -C≡C- or single bond (where Y 3 and Y 4 Each independently represents a hydrogen atom, an alkyl group having 1 to 12 carbon atoms, a fluorine atom, a chlorine atom, or a cyano group.), Z 1 , Z 2, and Z 4 may be the same or different when there are a plurality of them; Z 3 Means -O CH 2- , -CH 2 O-, -COO-, -OCO-, -CO-S-, -S-CO-, -CO-NH-, -NH-CO-, -SCH 2- , -CH 2 S-, -CF 2 O-, -OCF 2- , -CF 2 S-, -SCF 2- , -CH 2 CH 2- , -CH 2 CF 2- , -CF 2 CH 2- , -CF 2 CF 2- , -CH = CH-COO-, -CH = CH-OCO-, -COO-CH = CH-, -OCO-CH = CH-, -COO-CH 2 CH 2- , -OCO-CH 2 CH 2- , -CH 2 CH 2 -COO-, -CH 2 CH 2 -OCO-, -COO-CH 2- , -OCO-CH 2- , -CH 2 -COO-, -CH 2 -OCO-,- CY 5 = CY 6 -or a single bond (wherein Y 5 and Y 6 each independently represent a hydrogen atom, an alkyl group having 1 to 12 carbon atoms, a fluorine atom, a chlorine atom, or a cyano group); R represents a fluorine atom , A chlorine atom, a cyano group, an alkyl group having 1 to 12 carbon atoms, or -X 3 -S 3 -P (wherein X 3 , S 3, and P each have the same meaning as the above X 1 , S 1, and P, Each may be the same group or different groups. ), One or more hydrogen atoms in the alkyl group may be substituted with a fluorine atom, a chlorine atom, or a cyano group. In addition, one -CH 2 -or two or more adjacent- CH 2 -can be independently passed through -O-, -S-, -CO-, -COO-, -OCO-, -CO-S-, -S-CO-, -O-CO-O-, -CO -NH-, -NH-CO-, -CH = CH-, -CH = CF-, -CF = CH- or -C≡C- substitution; m 1 and m 2 each independently represent 0 or 1, R represents -X 3 -S 3 -P, when m 1 = 0, m 2 = 0, A 3 represents a group other than naphthalene-2,6-diyl, and there is no single bond in which only one of S 1 and S 3 represents a single bond. Happening. ).

本發明的聚合性化合物由於折射率各向異性大、且顯示出高保存穩定性,因此作為聚合性組成物的構成構件是有用的。另外,使用含有本發明的聚合性化合物的組成物的光學各向異性體由於具有高配向性,因此在光學膜等用途中是有用的。 The polymerizable compound of the present invention is useful as a constituent member of a polymerizable composition because it has a large refractive index anisotropy and exhibits high storage stability. In addition, an optical anisotropic body using a composition containing the polymerizable compound of the present invention is highly useful for applications such as an optical film because it has high alignment.

(實施發明之形態) (Form of Implementing Invention)

在通式(I)中,P表示式(P-1)~式(P-15)表示的聚合性基團,此等聚合性基團藉由自由基聚合、自由基加成聚合、陽離子聚合及陰離子聚合進行固化。特別是作為聚合方法進行紫外線聚合時,較佳為式(P-1)、式(P-2)、式(P-3)、式(P-4)、式(P-5)、式(P-7)、式(P-11)、式(P-13)或式(P-15),更佳為式(P-1)、式(P-2)、式(P-7)、式(P-11)或式(P-13),尤佳為式(P-1)或式(P-2)。 In the general formula (I), P represents a polymerizable group represented by the formula (P-1) to (P-15), and these polymerizable groups are subjected to radical polymerization, radical addition polymerization, and cationic polymerization. And anionic polymerization for curing. In particular, when ultraviolet polymerization is performed as a polymerization method, the formula (P-1), the formula (P-2), the formula (P-3), the formula (P-4), the formula (P-5), and the formula ( P-7), formula (P-11), formula (P-13) or formula (P-15), more preferably formula (P-1), formula (P-2), formula (P-7), Formula (P-11) or Formula (P-13), particularly preferably Formula (P-1) or Formula (P-2).

S1表示1個-CH2-或不相鄰的2個以上的-CH2-可分別獨立地經-O-、-S-、-CO-、-COO-、-OCO-、-CO-S-、-S-CO-、-O-CO-O-、-CO-NH-、-NH-CO-取代的碳原子數1~20的伸烷基或單鍵,從液晶性及與其他成分的互溶性的觀點尤佳為碳原子數2~8的伸烷基。 S 1 represents one -CH 2 -or two or more non-adjacent -CH 2 -which can be independently passed through -O-, -S-, -CO-, -COO-, -OCO-, -CO- S-, -S-CO-, -O-CO-O-, -CO-NH-, -NH-CO- substituted alkylene or single bond with 1 to 20 carbon atoms, from liquid crystal properties and other The viewpoint of the component's mutual solubility is particularly preferably an alkylene group having 2 to 8 carbon atoms.

X1表示-O-、-S-、-OCH2-、-CH2O-、-CO-、-COO-、-OCO-、-CO-S-、-S-CO-、-O-CO-O-、-CO-NH-、-NH-CO-、-SCH2-、-CH2S-、-CF2O-、-OCF2-、-CF2S-、-SCF2-、-CH2CH2-、-CH2CF2-、-CF2CH2-、-CF2CF2-、-CH=CH-COO-、-CH=CH-OCO-、-COO-CH=CH-、 -OCO-CH=CH-、-COO-CH2CH2-、-OCO-CH2CH2-、-CH2CH2-COO-、-CH2CH2-OCO-、-COO-CH2-、-OCO-CH2-、-CH2-COO-、-CH2-OCO-、-CY1=CY2-、-C≡C-或單鍵(式中,Y1及Y2分別獨立地表示氫原子、碳原子數1~12的烷基、氟原子、氯原子或氰基。),更佳為-O-、-COO-、-OCO-、-CH=CH-COO-、-CH=CH-OCO-、-COO-CH=CH-、-OCO-CH=CH-、-COO-CH2CH2-、-OCO-CH2CH2-、-CH2CH2-COO-、-CH2CH2-OCO-、-COO-CH2-、-OCO-CH2-、-CH2-COO-、-CH2-OCO-或單鍵,尤佳為-O-。 X 1 represents -O-, -S-, -OCH 2- , -CH 2 O-, -CO-, -COO-, -OCO-, -CO-S-, -S-CO-, -O-CO -O-, -CO-NH-, -NH-CO-, -SCH 2- , -CH 2 S-, -CF 2 O-, -OCF 2- , -CF 2 S-, -SCF 2 -,- CH 2 CH 2- , -CH 2 CF 2- , -CF 2 CH 2- , -CF 2 CF 2- , -CH = CH-COO-, -CH = CH-OCO-, -COO-CH = CH- , -OCO-CH = CH-, -COO-CH 2 CH 2- , -OCO-CH 2 CH 2- , -CH 2 CH 2 -COO-, -CH 2 CH 2 -OCO-, -COO-CH 2 -, -OCO-CH 2- , -CH 2 -COO-, -CH 2 -OCO-, -CY 1 = CY 2- , -C≡C- or single bond (where Y 1 and Y 2 are independent Ground means a hydrogen atom, an alkyl group having 1 to 12 carbon atoms, a fluorine atom, a chlorine atom, or a cyano group.), More preferably -O-, -COO-, -OCO-, -CH = CH-COO-,- CH = CH-OCO-, -COO-CH = CH-, -OCO-CH = CH-, -COO-CH 2 CH 2- , -OCO-CH 2 CH 2- , -CH 2 CH 2 -COO-, -CH 2 CH 2 -OCO-, -COO-CH 2- , -OCO-CH 2- , -CH 2 -COO-, -CH 2 -OCO- or a single bond, particularly preferably -O-.

L1~L6分別獨立地表示氫原子、氟原子、氯原子、氰基、硝基、碳原子數1~7的烷基、碳原子數1~7的烷氧基或碳原子數1~7的烷醯基,存在於烷基、烷氧基或烷醯基中的1個以上的氫原子可以被氟原子或氯原子取代,較佳為氫原子、氟原子或氯原子,較佳為L1、L2、L4及L5表示氫原子,L3及L6表示氫原子、氟原子或氯原子的組合,從製造簡便的觀點,尤佳為L1~L6全部表示氫原子的組合。 L 1 to L 6 each independently represent a hydrogen atom, a fluorine atom, a chlorine atom, a cyano group, a nitro group, an alkyl group having 1 to 7 carbon atoms, an alkoxy group having 1 to 7 carbon atoms or 1 to 7 carbon atoms. Alkyl group of 7, one or more hydrogen atoms present in the alkyl, alkoxy or alkyl group may be replaced by a fluorine atom or a chlorine atom, preferably a hydrogen atom, a fluorine atom or a chlorine atom, more preferably L 1 , L 2 , L 4, and L 5 each represent a hydrogen atom, and L 3 and L 6 each represent a combination of a hydrogen atom, a fluorine atom, or a chlorine atom. From the viewpoint of ease of production, it is particularly preferred that all of L 1 to L 6 represent hydrogen atoms The combination.

M1~M4分別獨立地表示氫原子、氟原子、氯原子、氰基、硝基、碳原子數1~7的烷基、碳原子數1~7的烷氧基、碳原子數1~7的烷醯基或-X2-S2-P(式中,X2、S2及P分別表示與上述X1、S1及P相同含意,各自可為相同的基團也可為不同的基團。),存在於該烷基、烷氧基或烷醯基中的1個以上的氫原子可以被氟原子或氯原子取代,不存在M1~M4全部同樣地為氫原子的情況,較佳為M1~M4的任1個表示氟原子、氯原子、氰基、硝基或1個以上的氫原子可取代為氟原子或氯原子的碳原子數1~7的烷基、烷氧基、烷醯基或-X2-S2-P(式中,X2、S2及P分別表示與上述X1、S1及P相同含意,各自可為相同的基團也可為不同的基團。),剩餘的3個表示氫原子的組合,表示-X2-S2-P時,P較佳為式(P-1)、式(P-2)、式(P-3)、式(P-4)、式(P-5)、式(P-7)、式(P-11)、式(P-13)或式(P-15),更佳為式(P-1)、式(P-2)、式(P-7)、式(P-11)或式(P-13),尤佳為式(P-1)或式(P-2),S2從液晶性及與其他成分的互溶性的觀點較佳為 碳原子數2~8的伸烷基,X2較佳為-O-、-COO-、-OCO-、-CH=CH-COO-、-CH=CH-OCO-、-COO-CH=CH-、-OCO-CH=CH-、-COO-CH2CH2-、-OCO-CH2CH2-、-CH2CH2-COO-、-CH2CH2-OCO-、-COO-CH2-、-OCO-CH2-、-CH2-COO-、-CH2-OCO-或單鍵,尤佳為-O-,M1~M4尤佳為M1表示氟原子、氯原子、氰基、甲基或甲氧基,M2~M4表示氫原子的組合。 M 1 to M 4 each independently represent a hydrogen atom, a fluorine atom, a chlorine atom, a cyano group, a nitro group, an alkyl group having 1 to 7 carbon atoms, an alkoxy group having 1 to 7 carbon atoms, or 1 to 7 carbon atoms. Alkyl group of 7 or -X 2 -S 2 -P (wherein X 2 , S 2 and P each have the same meaning as the above X 1 , S 1 and P, and each may be the same group or different Group.), One or more hydrogen atoms present in the alkyl group, alkoxy group, or alkylfluorenyl group may be replaced by fluorine atoms or chlorine atoms, and there is no M 1 to M 4 which are all hydrogen atoms in the same manner. In this case, it is preferable that any one of M 1 to M 4 represents a fluorine atom, a chlorine atom, a cyano group, a nitro group, or an alkane having 1 to 7 carbon atoms which may be substituted with a fluorine atom or a chlorine atom. Group, alkoxy group, alkylsulfonyl group or -X 2 -S 2 -P (wherein X 2 , S 2 and P each have the same meaning as the above X 1 , S 1 and P, and each may be the same group Different groups may also be used.), When the remaining three represent a combination of hydrogen atoms and represent -X 2 -S 2 -P, P is preferably formula (P-1), formula (P-2), formula (P-3), formula (P-4), formula (P-5), formula (P-7), formula (P-11), formula (P-13) or formula (P-15), more preferably Is the formula (P-1) , Formula (P-2), formula (P-7), formula (P-11) or formula (P-13), particularly preferably formula (P-1) or formula (P-2), S 2 from the liquid crystal The viewpoint of the solubility and compatibility with other components is preferably an alkylene group having 2 to 8 carbon atoms, and X 2 is preferably -O-, -COO-, -OCO-, -CH = CH-COO-,- CH = CH-OCO-, -COO-CH = CH-, -OCO-CH = CH-, -COO-CH 2 CH 2- , -OCO-CH 2 CH 2- , -CH 2 CH 2 -COO-, -CH 2 CH 2 -OCO-, -COO-CH 2- , -OCO-CH 2- , -CH 2 -COO-, -CH 2 -OCO- or single bond, especially -O-, M 1 ~ M 4 is particularly preferably a combination of M 1 representing a fluorine atom, a chlorine atom, a cyano group, a methyl group, or a methoxy group, and M 2 to M 4 representing a hydrogen atom.

A1、A2及A3分別獨立地表示1,4-伸苯基、萘-2,6-二基、1,4-伸環己基、1,4-伸環己烯基、1,4-雙環[2.2.2]伸辛基、十氫萘-2,6-二基、1,2,3,4-四氫萘-2,6-二基、吡啶-2,6-二基、嘧啶-2,5-二基、1,3-二烷-2,5-二基,此等基團可未經取代,也可以經氟原子、氯原子、氰基、硝基、碳原子數1~7的烷基、碳原子數1~7的烷氧基或碳原子數1~7的烷醯基取代,此等烷基、烷氧基或烷醯基可以1個以上的氫原子被氟原子或氯原子取代、A1及/或A2存在多個時此等可相同也可不同,較佳為非取代的或者被氟原子、氯原子、碳原子數1~4的烷基或碳原子數1~4的烷氧基取代的1,4-伸苯基、萘-2,6-二基、1,4-伸環己基、1,4-伸環己烯基、1,4-雙環[2.2.2]伸辛基、十氫萘-2,6-二基、1,2,3,4-四氫萘-2,6-二基、吡啶-2,6-二基、嘧啶-2,5-二基、1,3-二烷-2,5-二基,較佳為非取代的或者被氟原子、氯原子、碳原子數1~4的烷基或碳原子數1~4的烷氧基取代的1,4-伸苯基、萘-2,6-二基或1,4-伸環己基,尤佳為非取代的或者被氟原子、氯原子、CH3基或CH3O基取代的1,4-伸苯基或萘-2,6-二基,或非取代的1,4-伸環己基。 A 1 , A 2 and A 3 each independently represent 1,4-phenylene, naphthalene-2,6-diyl, 1,4-cyclohexyl, 1,4-cyclohexenyl, 1,4 -Bicyclo [2.2.2] octyl, decalin-2,6-diyl, 1,2,3,4-tetralin-2,6-diyl, pyridine-2,6-diyl, Pyrimidine-2,5-diyl, 1,3-diyl Alkane-2,5-diyl, these groups may be unsubstituted, or may be fluorine, chlorine, cyano, nitro, 1 to 7 carbon atoms, 1 to 7 carbon atoms Alkoxy or alkanoyl having 1 to 7 carbon atoms may be substituted. Such alkyl, alkoxy or alkanoyl may be substituted with one or more hydrogen atoms by fluorine or chlorine atoms, A 1 and / or A 2 These may be the same or different when there are a plurality, and are preferably unsubstituted or substituted with a fluorine atom, a chlorine atom, an alkyl group having 1 to 4 carbon atoms, or an alkoxy group having 1 to 4 carbon atoms. 4-phenylene, naphthalene-2,6-diyl, 1,4-cyclohexyl, 1,4-cyclohexenyl, 1,4-bicyclo [2.2.2] octyl, decahydronaphthalene -2,6-diyl, 1,2,3,4-tetrahydronaphthalene-2,6-diyl, pyridine-2,6-diyl, pyrimidine-2,5-diyl, 1,3-diyl Alkane-2,5-diyl is preferably unsubstituted or 1,4-diene substituted by fluorine atom, chlorine atom, alkyl group having 1 to 4 carbon atoms or alkoxy group having 1 to 4 carbon atoms. Phenyl, naphthalene-2,6-diyl or 1,4-cyclohexyl, particularly preferably 1,4-phenylene which is unsubstituted or substituted with a fluorine atom, a chlorine atom, a CH 3 group or a CH 3 O group Or naphthalene-2,6-diyl, or unsubstituted 1,4-cyclohexyl.

Z1、Z2及Z4分別獨立地表示-OCH2-、-CH2O-、-COO-、-OCO-、-CO-S-、-S-CO-、-CO-NH-、-NH-CO-、-SCH2-、-CH2S-、-CF2O-、-OCF2-、-CF2S-、-SCF2-、-CH2CH2-、-CH2CF2-、-CF2CH2-、-CF2CF2-、-CH=CH-COO-、-CH=CH-OCO-、-COO-CH=CH-、-OCO-CH=CH-、-COO-CH2CH2-、-OCO-CH2CH2-、-CH2CH2-COO-、-CH2CH2-OCO-、-COO-CH2-、-OCO-CH2-、-CH2-COO-、-CH2-OCO-、-CY3=CY4-、-C≡C-或單鍵(式中,Y3及Y4分別獨立地表示氫原子、碳原子數1~12的烷基、氟原子、氯原子或氰基。), 較佳為-COO-、-OCO-、-CH=CH-COO-、-CH=CH-OCO-、-COO-CH=CH-、-OCO-CH=CH-、-COO-CH2CH2-、-OCO-CH2CH2-、-CH2CH2-COO-、-CH2CH2-OCO-、-COO-CH2-、-OCO-CH2-、-CH2-COO-、-CH2-OCO-、-C≡C-或單鍵,尤佳為-COO-、-OCO-、-CH=CH-COO-、-CH=CH-OCO-、-COO-CH=CH-、-OCO-CH=CH-或單鍵。 Z 1 , Z 2 and Z 4 each independently represent -OCH 2- , -CH 2 O-, -COO-, -OCO-, -CO-S-, -S-CO-, -CO-NH-,- NH-CO-, -SCH 2- , -CH 2 S-, -CF 2 O-, -OCF 2- , -CF 2 S-, -SCF 2- , -CH 2 CH 2- , -CH 2 CF 2 -, -CF 2 CH 2- , -CF 2 CF 2- , -CH = CH-COO-, -CH = CH-OCO-, -COO-CH = CH-, -OCO-CH = CH-, -COO -CH 2 CH 2- , -OCO-CH 2 CH 2- , -CH 2 CH 2 -COO-, -CH 2 CH 2 -OCO-, -COO-CH 2- , -OCO-CH 2- , -CH 2 -COO-, -CH 2 -OCO-, -CY 3 = CY 4- , -C≡C-, or a single bond (where Y 3 and Y 4 each independently represent a hydrogen atom and a carbon number of 1 to 12 Alkyl group, fluorine atom, chlorine atom or cyano group.), Preferably -COO-, -OCO-, -CH = CH-COO-, -CH = CH-OCO-, -COO-CH = CH-, -OCO-CH = CH-, -COO-CH 2 CH 2- , -OCO-CH 2 CH 2- , -CH 2 CH 2 -COO-, -CH 2 CH 2 -OCO-, -COO-CH 2- , -OCO-CH 2- , -CH 2 -COO-, -CH 2 -OCO-, -C≡C- or single bond, particularly preferably -COO-, -OCO-, -CH = CH-COO-, -CH = CH-OCO-, -COO-CH = CH-, -OCO-CH = CH- or a single bond.

Z3表示-OCH2-、-CH2O-、-COO-、-OCO-、-CO-S-、-S-CO-、-CO-NH-、-NH-CO-、-SCH2-、-CH2S-、-CF2O-、-OCF2-、-CF2S-、-SCF2-、-CH2CH2-、-CH2CF2-、-CF2CH2-、-CF2CF2-、-CH=CH-COO-、-CH=CH-OCO-、-COO-CH=CH-、-OCO-CH=CH-、-COO-CH2CH2-、-OCO-CH2CH2-、-CH2CH2-COO-、-CH2CH2-OCO-、-COO-CH2-、-OCO-CH2-、-CH2-COO-、-CH2-OCO-、-CY5=CY6-或單鍵(式中,Y5及Y6分別獨立地表示氫原子、碳原子數1~12的烷基、氟原子、氯原子或氰基。),較佳為-COO-、-OCO-、-CH=CH-COO-、-CH=CH-OCO-、-COO-CH=CH-、-OCO-CH=CH-、-COO-CH2CH2-、-OCO-CH2CH2-、-CH2CH2-COO-、-CH2CH2-OCO-、-COO-CH2-、-OCO-CH2-、-CH2-COO-、-CH2-OCO-或單鍵,從液晶性及與其他成分的互溶性或者對基板的親和性的觀點,尤佳為-COO-、-OCO-、-CH=CH-COO-、-CH=CH-OCO-、-COO-CH=CH-、-OCO-CH=CH-或單鍵。 Z 3 represents -OCH 2- , -CH 2 O-, -COO-, -OCO-, -CO-S-, -S-CO-, -CO-NH-, -NH-CO-, -SCH 2- , -CH 2 S-, -CF 2 O-, -OCF 2- , -CF 2 S-, -SCF 2- , -CH 2 CH 2- , -CH 2 CF 2- , -CF 2 CH 2- , -CF 2 CF 2- , -CH = CH-COO-, -CH = CH-OCO-, -COO-CH = CH-, -OCO-CH = CH-, -COO-CH 2 CH 2- , -OCO -CH 2 CH 2- , -CH 2 CH 2 -COO-, -CH 2 CH 2 -OCO-, -COO-CH 2- , -OCO-CH 2- , -CH 2 -COO-, -CH 2- OCO-, -CY 5 = CY 6 -or a single bond (wherein Y 5 and Y 6 each independently represent a hydrogen atom, an alkyl group having 1 to 12 carbon atoms, a fluorine atom, a chlorine atom, or a cyano group), -COO-, -OCO-, -CH = CH-COO-, -CH = CH-OCO-, -COO-CH = CH-, -OCO-CH = CH-, -COO-CH 2 CH 2 -, -OCO-CH 2 CH 2- , -CH 2 CH 2 -COO-, -CH 2 CH 2 -OCO-, -COO-CH 2- , -OCO-CH 2- , -CH 2 -COO-, -CH 2 -OCO- or a single bond, particularly from the viewpoint of liquid crystallinity, mutual solubility with other components, or affinity to a substrate, -COO-, -OCO-, -CH = CH-COO-, -CH = CH-OCO-, -COO-CH = CH-, -OCO-CH = CH- or single bond.

R表示氟原子、氯原子、氰基、碳原子數1~12的烷基或-X3-S3-P(式中,X3、S3及P分別表示與上述X1、S1及P相同含意,各自可為相同的基團也可為不同的基團。),存在於該烷基中的1個以上的氫原子可以被氟原子、氯原子、氰基取代,另外,該烷基中的1個-CH2-或不相鄰的2個以上的-CH2-可以分別獨立地經-O-、-S-、-CO-、-COO-、-OCO-、-CO-S-、-S-CO-、-O-CO-O-、-CO-NH-、-NH-CO-、-CH=CH-、-CH=CF-、-CF=CH-或C≡C-取代,表示氟原子、氯原子、氰基、碳原子數1~12的烷基或-X3-S3-P(式中,X3、S3及P分別表示與上述X1、S1及P相同含意,各自可為 相同的基團也可為不同的基團。),較佳為該烷基中的1個-CH2-或不相鄰的2個以上的-CH2-可分別獨立地經-O-、-S-、-CO-、-COO-、-OCO-取代的情況,表示-X3-S3-P時,P較佳為式(P-1)、式(P-2)、式(P-3)、式(P-4)、式(P-5)、式(P-7)、式(P-11)、式(P-13)或式(P-15),更佳為式(P-1)、式(P-2)、式(P-7)、式(P-11)或式(P-13),尤佳為式(P-1)或式(P-2),S3從液晶性及與其他成分的互溶性的觀點較佳為碳原子數2~8的伸烷基,X3較佳為-O-、-COO-、-OCO-、-CH=CH-COO-、-CH=CH-OCO-、-COO-CH=CH-、-OCO-CH=CH-、-COO-CH2CH2-、-OCO-CH2CH2-、-CH2CH2-COO-、-CH2CH2-OCO-、-COO-CH2-、-OCO-CH2-、-CH2-COO-、-CH2-OCO-或單鍵,尤佳為-O-,R尤佳為氟原子、氯原子、氰基或碳原子數1~8的烷基。 R represents a fluorine atom, a chlorine atom, a cyano group, an alkyl group having 1 to 12 carbon atoms, or -X 3 -S 3 -P (wherein X 3 , S 3, and P are the same as those of X 1 , S 1, and P has the same meaning and each may be the same group or different groups.), One or more hydrogen atoms present in the alkyl group may be substituted by a fluorine atom, a chlorine atom, and a cyano group. One -CH 2 -or two or more -CH 2 -in the group may be independently passed through -O-, -S-, -CO-, -COO-, -OCO-, -CO- S-, -S-CO-, -O-CO-O-, -CO-NH-, -NH-CO-, -CH = CH-, -CH = CF-, -CF = CH- or C≡C -Substituted, which represents a fluorine atom, a chlorine atom, a cyano group, an alkyl group having 1 to 12 carbon atoms, or -X 3 -S 3 -P (wherein X 3 , S 3, and P represent the same as X 1 , S 1 and P have the same meaning, and each may be the same group or different groups.) It is preferably 1 -CH 2 -or two or more -CH 2 -which are not adjacent to each other in the alkyl group. When -O-, -S-, -CO-, -COO-, -OCO- can be substituted independently, when -X 3 -S 3 -P is represented, P is preferably formula (P-1), Formula (P-2), Formula (P-3), Formula (P-4), Formula (P-5), Formula (P-7), Formula (P-11), Formula (P-1 3) or formula (P-15), more preferably formula (P-1), formula (P-2), formula (P-7), formula (P-11) or formula (P-13), especially preferred Formula (P-1) or Formula (P-2), S 3 is preferably an alkylene group having 2 to 8 carbon atoms, and X 3 is preferably -O from the viewpoint of liquid crystallinity and mutual solubility with other components. -, -COO-, -OCO-, -CH = CH-COO-, -CH = CH-OCO-, -COO-CH = CH-, -OCO-CH = CH-, -COO-CH 2 CH 2- , -OCO-CH 2 CH 2- , -CH 2 CH 2 -COO-, -CH 2 CH 2 -OCO-, -COO-CH 2- , -OCO-CH 2- , -CH 2 -COO-,- CH 2 -OCO- or a single bond, particularly preferably -O-, and R is particularly preferably a fluorine atom, a chlorine atom, a cyano group, or an alkyl group having 1 to 8 carbon atoms.

m1及m2分別獨立地表示0或1,較佳為m1為0、m2為0或1的組合,尤佳為m1為0、m2為0的組合。 m 1 and m 2 each independently represent 0 or 1, preferably a combination of m 1 being 0 and m 2 being 0 or 1, particularly preferably a combination of m 1 being 0 and m 2 being 0.

其中,R表示-X3-S3-P,m1=0、m2=0時,A3表示萘-2,6-二基以外的基團,不存在S1及S3中僅一方表示單鍵的情況。此時,A3較佳為非取代的或者被氟原子、氯原子、碳原子數1~4的烷基或碳原子數1~4的烷氧基取代的1,4-伸苯基、1,4-伸環己基、1,4-伸環己烯基、1,4-雙環[2.2.2]伸辛基、十氫萘-2,6-二基、1,2,3,4-四氫萘-2,6-二基、吡啶-2,6-二基、嘧啶-2,5-二基、1,3-二烷-2,5-二基,更佳為非取代的或者被氟原子、氯原子、碳原子數1~4的烷基或碳原子數1~4的烷氧基取代的1,4-伸苯基或1,4-伸環己基,尤佳為非取代的或者被氟原子、氯原子、CH3基或CH3O基取代的1,4-伸苯基或非取代的1,4-伸環己基。 Among them, R represents -X 3 -S 3 -P, when m 1 = 0, m 2 = 0, A 3 represents a group other than naphthalene-2,6-diyl, and only one of S 1 and S 3 does not exist. Represents the case of a single key. At this time, A 3 is preferably a 1,4-phenylene group, an unsubstituted or 1,4-phenylene group substituted with a fluorine atom, a chlorine atom, an alkyl group having 1 to 4 carbon atoms, or an alkoxy group having 1 to 4 carbon atoms. , 4-cyclohexyl, 1,4-cyclohexenyl, 1,4-bicyclo [2.2.2] octyl, decalin-2,6-diyl, 1,2,3,4- Tetrahydronaphthalene-2,6-diyl, pyridine-2,6-diyl, pyrimidine-2,5-diyl, 1,3-diyl Alkane-2,5-diyl, more preferably unsubstituted or 1,4-ethanene substituted with fluorine atom, chlorine atom, alkyl group having 1 to 4 carbon atoms or alkoxy group having 1 to 4 carbon atoms Phenyl or 1,4-cyclohexyl, particularly preferably unsubstituted or substituted with a fluorine atom, a chlorine atom, a CH 3 group or a CH 3 O group, or a 1,4-phenylene group or an unsubstituted 1,4- Cyclohexyl.

另外,R表示-X3-S3-P,m1=1、m2=0或m1=0、m2=1時,不存在S1及S3中僅一方表示單鍵的情況。另外此時,較佳為Z1、Z2及Z4中的至少一個分別獨立地表示-CO-S-、-S-CO-、-CO-NH-、-NH-CO-、-SCH2-、-CH2S-、-CF2O-、-OCF2-、-CF2S-、-SCF2-、-CH2CH2-、-CH2CF2-、-CF2CH2-、-CF2CF2-、-CH=CH-COO-、-CH=CH-OCO-、-COO-CH=CH-、-OCO-CH=CH-、 -COO-CH2CH2-、-OCO-CH2CH2-、-CH2CH2-COO-、-CH2CH2-OCO-、-COO-CH2-、-OCO-CH2-、-CH2-COO-、-CH2-OCO-、-CY5=CY6-(式中,Y5及Y6分別獨立地表示氫原子、碳原子數1~12的烷基、氟原子、氯原子或氰基。)或單鍵,更佳為表示-CO-S-、-S-CO-、-CO-NH-、-NH-CO-、-SCH2-、-CH2S-、-CF2O-、-OCF2-、-CF2S-、-SCF2-、-CH2CH2-、-CH2CF2-、-CF2CH2-、-CF2CF2-、-COO-CH2CH2-、-OCO-CH2CH2-、-CH2CH2-COO-、-CH2CH2-OCO-、-COO-CH2-、-OCO-CH2-、-CH2-COO-、-CH2-OCO-或-CY5=CY6-(式中,Y5及Y6分別獨立地表示氫原子、碳原子數1~12的烷基、氟原子、氯原子或氰基。),尤佳為表示-CO-S-、-S-CO-、-CO-NH-、-NH-CO-、-SCH2-、-CH2S-、-CF2S-、-SCF2-或-CY5=CY6-(式中,Y5及Y6分別獨立地表示氫原子、碳原子數1~12的烷基、氟原子、氯原子或氰基,但不存在Y5及Y6同時表示氫原子的情況。)。 In addition, when R represents -X 3 -S 3 -P, and m 1 = 1, m 2 = 0, or m 1 = 0, and m 2 = 1, there is no case where only one of S 1 and S 3 represents a single bond. In this case, it is preferable that at least one of Z 1 , Z 2 and Z 4 independently represent -CO-S-, -S-CO-, -CO-NH-, -NH-CO-, -SCH 2 -, -CH 2 S-, -CF 2 O-, -OCF 2- , -CF 2 S-, -SCF 2- , -CH 2 CH 2- , -CH 2 CF 2- , -CF 2 CH 2- , -CF 2 CF 2- , -CH = CH-COO-, -CH = CH-OCO-, -COO-CH = CH-, -OCO-CH = CH-, -COO-CH 2 CH 2 -,- OCO-CH 2 CH 2- , -CH 2 CH 2 -COO-, -CH 2 CH 2 -OCO-, -COO-CH 2- , -OCO-CH 2- , -CH 2 -COO-, -CH 2 -OCO-, -CY 5 = CY 6- (wherein Y 5 and Y 6 each independently represent a hydrogen atom, an alkyl group having 1 to 12 carbon atoms, a fluorine atom, a chlorine atom, or a cyano group) or a single bond , More preferably -CO-S-, -S-CO-, -CO-NH-, -NH-CO-, -SCH 2- , -CH 2 S-, -CF 2 O-, -OCF 2- , -CF 2 S-, -SCF 2- , -CH 2 CH 2- , -CH 2 CF 2- , -CF 2 CH 2- , -CF 2 CF 2- , -COO-CH 2 CH 2 -,- OCO-CH 2 CH 2- , -CH 2 CH 2 -COO-, -CH 2 CH 2 -OCO-, -COO-CH 2- , -OCO-CH 2- , -CH 2 -COO-, -CH 2 -OCO- or -CY 5 = CY 6 - (wherein, Y 5 and Y 6 each independently represent a hydrogen atom, an alkyl group having 1 to 12 carbon atoms, and a fluorine atom, a chlorine atom, or Group), and particularly preferably represents -CO-S -., - S -CO -, - CO-NH -, - NH-CO -, - SCH 2 -, - CH 2 S -, - CF 2 S -, - SCF 2 -or -CY 5 = CY 6- (wherein Y 5 and Y 6 each independently represent a hydrogen atom, an alkyl group having 1 to 12 carbon atoms, a fluorine atom, a chlorine atom or a cyano group, but Y is not present 5 and Y 6 both represent a hydrogen atom.).

作為通式(I)表示的化合物,較佳為下述的式(I-1)~式(I-47)表示的化合物。 As a compound represented by general formula (I), the compound represented by following formula (I-1)-formula (I-47) is preferable.

本發明的化合物可藉由以下的製法進行製造。 The compound of the present invention can be produced by the following production method.

(製法1)下述化合物(S7)的合成 (Preparation method 1) Synthesis of the following compound (S7)

將保護基導入到羥基羧酸(S1)的羥基中。作為保護基PG,只要是在合成過程中可穩定地保護官能團、且容易脫離的基團就沒有特別限制,例如,可使用在PETER G.M.WUTS、THEODORA W.GREENE合著的約翰威立公司(John Wiley & Sons,Inc.)出 版物“有機合成中的保護基(GREENE’S PROTECTIVE GROUPS IN ORGANIG SYNTHESIS)”(第四版)中記載的保護基。藉由使具有被保護基PG保護的羥基的羧酸(S2)與苯酚衍生物(S3)進行縮合來製成酯(S4)。縮合可使用例如硫酸、鹽酸、硝酸、醋酸、甲酸、三氟醋酸、對甲苯磺酸等酸催化劑或N,N’-二環己基碳化二亞胺、N,N’-二異丙基碳化二亞胺、1-乙基-3-(3-二甲基胺基丙基)碳化二亞胺鹽酸鹽等碳化二亞胺系縮合劑來進行。另外,也可以是經由光延反應、羧醯鹵化物的方法。接著,例如使藉由上述文獻中記載的方法使保護基PG脫離而得到的中間體(S5)與羧酸(S6)進行縮合,可合成目標物(S7)。 A protective group is introduced into the hydroxyl group of the hydroxycarboxylic acid (S1). The protective group PG is not particularly limited as long as it is a group that can stably protect a functional group during synthesis and is easily detached. For example, it can be used by John Wiley Co. Wiley & Sons, Inc.) The protective group described in the edition "GREENE'S PROTECTIVE GROUPS IN ORGANIG SYNTHESIS" (Fourth Edition). An ester (S4) is produced by condensing a carboxylic acid (S2) having a hydroxyl group protected by a protecting group PG and a phenol derivative (S3). For the condensation, for example, an acid catalyst such as sulfuric acid, hydrochloric acid, nitric acid, acetic acid, formic acid, trifluoroacetic acid, p-toluenesulfonic acid, or N, N'-dicyclohexylcarbodiimide, N, N'-diisopropylcarbodicarbonate can be used. Carbodiimide-based condensing agents such as imine and 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride are used. Alternatively, it may be a method using a phototransition reaction or a carboxyphosphonium halide. Next, for example, the intermediate (S5) obtained by removing the protective group PG by the method described in the above-mentioned document is condensed with a carboxylic acid (S6) to synthesize a target compound (S7).

(製法2)下述化合物(S12)的合成 (Preparation method 2) Synthesis of the following compound (S12)

將保護基導入到羥基羧酸(S8)的羥基中。藉由使具有被保護基PG保護的羥基的羧酸(S9)與苯酚衍生物(S3)進行縮合來製成酯(S10)。接著,將藉由使保護基PG脫離而得到的中間體(S11)與羧酸(S6)進行縮合,可合成目標物(S12)。 A protective group is introduced into the hydroxyl group of the hydroxycarboxylic acid (S8). An ester (S10) is prepared by condensing a carboxylic acid (S9) having a hydroxyl group protected by a protecting group PG and a phenol derivative (S3). Next, the intermediate (S11) obtained by removing the protecting group PG and the carboxylic acid (S6) are condensed to synthesize a target compound (S12).

(製法3)下述化合物(S19)的合成 (Preparation method 3) Synthesis of the following compound (S19)

將保護基導入到氫醌(S13)的一個羥基中。藉由使具有被保護基PG保護的羥基的氫醌(S14)與羧酸(S15)進行縮合來製成酯(S16)。接著,將藉由使保護基PG脫離而得到的中間體(S17)與羧酸(S18)進行縮合,可合成目標物(S19)。 A protecting group was introduced into one hydroxyl group of hydroquinone (S13). An ester (S16) is produced by condensing a hydroquinone (S14) having a hydroxyl group protected by a protecting group PG and a carboxylic acid (S15). Next, the intermediate (S17) obtained by removing the protecting group PG and the carboxylic acid (S18) are condensed to synthesize a target compound (S19).

(製法4)下述化合物(S23)的合成 (Preparation method 4) Synthesis of the following compound (S23)

藉由使具有被保護基PG保護的羥基的氫醌(S14)與羧酸(S20)進行縮合來製成酯(S21)。接著,將藉由使保護基PG脫離而得到的中間體(S22)與羧酸(S6)進行縮合,可合成目標物(S23)。 An ester (S21) is prepared by condensing a hydroquinone (S14) having a hydroxyl group protected by a protecting group PG and a carboxylic acid (S20). Next, the intermediate (S22) obtained by removing the protecting group PG and the carboxylic acid (S6) are condensed to synthesize a target compound (S23).

本發明的化合物較佳為用於向列液晶組成物、近晶液晶組成物、手性近晶液晶組成物及膽甾醇液晶組成物,尤佳為用於膽甾醇液晶組成物。在使用本發明的聚合性化合物的液晶組成物中也可添加本發明以外的化合物。 The compound of the present invention is preferably used in a nematic liquid crystal composition, a smectic liquid crystal composition, a chiral smectic liquid crystal composition, and a cholesteric liquid crystal composition, and particularly preferably used in a cholesteric liquid crystal composition. A compound other than the present invention may be added to the liquid crystal composition using the polymerizable compound of the present invention.

作為與本發明的聚合性化合物混合而使用的其他聚合性化合物,具體較佳為通式(II)表示的化合物, The other polymerizable compound used as a mixture with the polymerizable compound of the present invention is specifically preferably a compound represented by the general formula (II),

(式中,R11及R12分別獨立地表示與通式(I)的P相同的意思;S11及S12分別獨立地表示單鍵或碳原子數1~18個的伸烷基,1個-CH2-或不相鄰的2個以上的-CH2-可經氧原子、-COO-、-OCO-、-OCOO-取代;L11、L12及L13相互獨立地表示單鍵、-O-、-S-、-OCH2-、-CH2O-、-CO-、-COO-、-OCO-、-CO-S-、-S-CO-、-O-CO-O-、-OCOOCH2-、-CH2OCOO-、-CO-NR13-、-NR13-CO-、-SCH2-、-CH2S-、-CH=N-、-SCH2-、-CH2S-、-CH=CH-COO-、-CH=CH-OCO-、-COO-CH=CH-、-OCO-CH=CH-、-COO-CH2CH2-、-OCO-CH2CH2-、-CH2CH2-COO-、-CH2CH2-OCO-、-COO-CH2-、-OCO-CH2-、-CH2-COO-、-CH2-OCO-、-CF2-、-CF2O-、-OCF2-、-CH2CH2-、-CF2CH2-、-CH2CF2-、-CF2CF2-、-CY11=CY12-或-C≡C-(式中,R13表示碳原子數1~4的烷基,Y11及Y12分別獨立地表示氫原子、碳原子數1~12的烷基、氟原子、氯原子或氰基。);M11及M12相互獨立地表示1,4-伸苯基、1,4-伸環己基、吡啶-2,5-二基、嘧啶-2,5-二基、萘-2,6-二 基、四氫萘-2,6-二基或1,3-二烷-2,5-二基,但較佳為M11及M12相互獨立地為非取代的或也可經烷基、鹵代烷基、烷氧基、鹵代烷氧基、鹵代基(halogeno group)、氰基或硝基取代;111表示0、1、2或3,111表示2或3時,存在2個或者3個的L12及/或M12可相同也可以不同的化合物,L11、L12及L13相互獨立地表示單鍵、-O-、-COO-或-OCO-,M11及M12相互獨立地表示1,4-伸苯基、1,4-伸環己基、吡啶-2,5-二基、嘧啶-2,5-二基、萘-2,6-二基。)。 (In the formula, R 11 and R 12 each independently have the same meaning as P of the general formula (I); S 11 and S 12 each independently represent a single bond or an alkylene group having 1 to 18 carbon atoms, 1 -CH 2 -or non-adjacent 2 or more -CH 2 -may be substituted by an oxygen atom, -COO-, -OCO-, -OCOO-; L 11 , L 12 and L 13 independently represent a single bond , -O-, -S-, -OCH 2- , -CH 2 O-, -CO-, -COO-, -OCO-, -CO-S-, -S-CO-, -O-CO-O -, -OCOOCH 2- , -CH 2 OCOO-, -CO-NR 13- , -NR 13 -CO-, -SCH 2- , -CH 2 S-, -CH = N-, -SCH 2 -,- CH 2 S-, -CH = CH-COO-, -CH = CH-OCO-, -COO-CH = CH-, -OCO-CH = CH-, -COO-CH 2 CH 2- , -OCO-CH 2 CH 2- , -CH 2 CH 2 -COO-, -CH 2 CH 2 -OCO-, -COO-CH 2- , -OCO-CH 2- , -CH 2 -COO-, -CH 2 -OCO- , -CF 2 -, - CF 2 O -, - OCF 2 -, - CH 2 CH 2 -, - CF 2 CH 2 -, - CH 2 CF 2 -, - CF 2 CF 2 -, - CY 11 = CY 12 -or -C≡C- (wherein R 13 represents an alkyl group having 1 to 4 carbon atoms, and Y 11 and Y 12 each independently represent a hydrogen atom, an alkyl group having 1 to 12 carbon atoms, a fluorine atom, A chlorine atom or a cyano group.); M 11 and M 12 independently represent 1,4-phenylene, 1 , 4-cyclohexyl, pyridine-2,5-diyl, pyrimidine-2,5-diyl, naphthalene-2,6-diyl, tetrahydronaphthalene-2,6-diyl, or 1,3-di Alkane-2,5-diyl, but preferably M 11 and M 12 are independently unsubstituted or may be alkyl, haloalkyl, alkoxy, haloalkoxy, halogeno group , Cyano or nitro substitution; 1 11 represents 0, 1, 2 or 3, and 1 11 represents 2 or 3, when there are 2 or 3 L 12 and / or M 12 compounds which may be the same or different, L 11 , L 12 and L 13 independently represent a single bond, -O-, -COO- or -OCO-, and M 11 and M 12 independently represent 1,4-phenylene and 1,4-cyclohexyl , Pyridine-2,5-diyl, pyrimidine-2,5-diyl, naphthalene-2,6-diyl. ).

通式(II)的R11及R12更佳為丙烯酸基(acryl)或甲基丙烯酸基。具體地說,較佳為通式(III)表示的化合物, R 11 and R 12 in the general formula (II) are more preferably an acryl group or a methacryl group. Specifically, a compound represented by the general formula (III) is preferable,

(式中,S3及S4分別獨立地表示碳原子數2~18的伸烷基,X3及X4分別獨立地表示-O-、-COO-、-OCO-或單鍵,Z5及Z6分別獨立地表示-COO-或-OCO-,A6、A7及A8分別獨立地表示非取代的或被氟原子、氯原子、碳原子數1~4的烷基或碳原子數1~4的烷氧基取代的1,4-伸苯基。),尤佳為下述式(III-1)~式(III-8)表示的化合物。 (In the formula, S 3 and S 4 each independently represent an alkylene group having 2 to 18 carbon atoms, X 3 and X 4 each independently represent -O-, -COO-, -OCO-, or a single bond, Z 5 And Z 6 each independently represent -COO- or -OCO-, and A 6 , A 7 and A 8 each independently represent an unsubstituted or fluorine atom, a chlorine atom, an alkyl group having 1 to 4 carbon atoms or a carbon atom An alkoxy-substituted 1,4-phenylene group having a number of 1 to 4) is particularly preferably a compound represented by the following formulae (III-1) to (III-8).

(式中,S3表示與通式(III)的S3相同的意思,S4表示與通式(III)的S4相同的意思。)在上述式(III-1)~式(III-8)中,更佳為S3及S4分別獨立地為碳原子數3~6的伸烷基的化合物。 (Wherein, S 3 represents the general formula (III) the same meaning of S 3, S 4 and S represents the general formula (III) is 4 the same meaning.) In the above formula (III-1) ~ formula (Ill In 8), it is more preferable that S 3 and S 4 are each independently an alkylene group having 3 to 6 carbon atoms.

另外,較佳為通式(Ⅳ)表示的化合物, In addition, a compound represented by the general formula (IV) is preferred,

(式中,S5及S6分別獨立地表示碳原子數2~18的伸烷基,X5及X6分別獨立地表示-O-、-COO-、-OCO-或單鍵,Z7表示-COO-或-OCO-,A9、A10及A11分別獨立地表示非取代的或經氟原子、氯原子、碳原子數1~4的烷基或碳原子數1~4的烷氧基取代的1,4-伸苯基。),尤佳為下述式(Ⅳ-1)~式(Ⅳ-8)表示的化合物。 (In the formula, S 5 and S 6 each independently represent an alkylene group having 2 to 18 carbon atoms, X 5 and X 6 each independently represent -O-, -COO-, -OCO-, or a single bond, Z 7 Represents -COO- or -OCO-, and A 9 , A 10 and A 11 each independently represent an unsubstituted or fluorine atom, a chlorine atom, an alkyl group having 1 to 4 carbon atoms or an alkyl group having 1 to 4 carbon atoms The oxy-substituted 1,4-phenylene.) Is particularly preferably a compound represented by the following formula (IV-1) to formula (IV-8).

(式中,S5表示與通式(Ⅳ)的S5相同的意思,S6表示與通式(Ⅳ)的S6相同的意思。)在上述式(Ⅳ-1)~式(Ⅳ-8)中,從耐熱性及耐久性的觀點,較佳為式(Ⅳ-2)、式(Ⅳ-5)、式(Ⅳ-6)、式(Ⅳ-7)及式(Ⅳ-8)表示的化合物,更佳為式(Ⅳ-2)表示的化合物,尤佳為S5及S6分別獨立地為碳原子數3~6的伸烷基的化合物。 (Wherein, S 5 and S denote the same general formula (Ⅳ) means 5, S 6 S represents the general formula (Ⅳ) 6 is the same meaning.) In the above formula (Ⅳ-1) ~ formula (IV- In 8), from the viewpoints of heat resistance and durability, Formula (IV-2), Formula (IV-5), Formula (IV-6), Formula (IV-7), and Formula (IV-8) are preferred. The compound represented is more preferably a compound represented by formula (IV-2), and particularly preferably a compound in which S 5 and S 6 are each independently an alkylene group having 3 to 6 carbon atoms.

此外,作為較佳的2官能聚合性化合物,可舉出下述通式(V-1)~式(V-4)表示的化合物。 Moreover, as a preferable bifunctional polymerizable compound, the compound represented by following General formula (V-1)-formula (V-4) is mentioned.

(式中,S7及S8分別獨立地表示碳原子數2~18的伸烷基。)在上述式(V-1)~式(V-4)中,較佳為式(V-2)及式(V-3)表示的化合物,尤佳為S7及S8分別獨立地為碳原子數3~6的伸烷基的化合物。 (In the formula, S 7 and S 8 each independently represent an alkylene group having 2 to 18 carbon atoms.) Among the above formulae (V-1) to (V-4), the formula (V-2) is preferred ) And the compound represented by the formula (V-3), and particularly preferably a compound in which S 7 and S 8 are each independently an alkylene group having 3 to 6 carbon atoms.

將本發明的化合物用於膽甾醇液晶組成物時,聚合性手性化合物的添加量較佳為0.1~40質量%。另外,含有本發明的化合物的聚合性液晶組成物中,也可在不損害該組成物的液晶性的程度內添加不顯示液晶性的聚合性化合物。具體地說,只要是在該技術領域中作為高分子形成性單體或者高分子形成性低聚物被熟悉的化合物就可沒有特別限制地使用。 When the compound of the present invention is used in a cholesteric liquid crystal composition, the addition amount of the polymerizable chiral compound is preferably 0.1 to 40% by mass. Moreover, in the polymerizable liquid crystal composition containing the compound of the present invention, a polymerizable compound that does not exhibit liquid crystallinity may be added to such an extent that the liquid crystallinity of the composition is not impaired. Specifically, any compound that is familiar as a polymer-forming monomer or a polymer-forming oligomer in this technical field can be used without particular limitation.

另外,添加於含有本發明的化合物的聚合性液晶組成物中的光聚合引發劑的濃度較佳為0.1~10質量%,更佳為0.2~5質量%。作為光聚合引發劑,可使用安息香醚類、二苯甲酮類、苯乙酮類、苄基縮酮(benzyl ketal)類、醯基膦氧化物等。 The concentration of the photopolymerization initiator added to the polymerizable liquid crystal composition containing the compound of the present invention is preferably 0.1 to 10% by mass, and more preferably 0.2 to 5% by mass. Examples of the photopolymerization initiator include benzoin ethers, benzophenones, acetophenones, benzyl ketals, and fluorenylphosphine oxides.

另外,含有本發明的化合物的聚合性液晶組成物中,為了提高其保存穩定性,還可添加穩定劑。作為穩定劑,例如可舉出氫醌、氫醌單烷基醚類、叔丁基鄰苯二酚類、連苯三酚類、苯硫酚類、硝基化合物類、β-萘胺類、β-萘酚類、亞硝基化合物等。使用穩定劑時的添加量相對於液晶組成物較佳為0.005~1質量%,更佳為0.02~0.5質量%。 In addition, a stabilizer may be added to the polymerizable liquid crystal composition containing the compound of the present invention in order to improve its storage stability. Examples of the stabilizer include hydroquinone, hydroquinone monoalkyl ethers, tert-butylcatechols, pyrogallols, thiophenols, nitro compounds, β-naphthylamines, β-naphthols, nitroso compounds, etc. The addition amount when using a stabilizer is preferably 0.005 to 1% by mass, and more preferably 0.02 to 0.5% by mass relative to the liquid crystal composition.

另外,將含有本發明的化合物的聚合性液晶組成物用於膜類、光學元件類、功能性顏料類、醫療用品類、化妝品類、塗佈 劑類、合成樹脂類等的用途時,也可根據其目的添加金屬、金屬錯合物、染料、顏料、色素、螢光材料、磷光材料、表面活性劑、流平劑、觸變劑、膠凝劑、多糖類、紫外線吸收劑、紅外線吸收劑、抗氧化劑、離子交換樹脂、氧化鈦等金屬氧化物等。 In addition, the polymerizable liquid crystal composition containing the compound of the present invention is used for films, optical elements, functional pigments, medical supplies, cosmetics, and coatings. For applications such as agents and synthetic resins, metals, metal complexes, dyes, pigments, pigments, fluorescent materials, phosphorescent materials, surfactants, leveling agents, thixotropic agents, glues can also be added according to their purpose. Coagulants, polysaccharides, ultraviolet absorbers, infrared absorbers, antioxidants, ion exchange resins, metal oxides such as titanium oxide, etc.

藉由聚合含有本發明化合物的聚合性液晶組成物所得到的聚合物可用於各種用途。例如,藉由將含有本發明的化合物的聚合性液晶組成物不進行配向而進行聚合所得到的聚合物可用作光散射板、偏光消除板、干涉條紋防止板。另外,藉由在配向後進行聚合所得到的聚合物具有光學各向異性,是有用的。這樣的光學各向異性體例如可藉由使含有本發明的化合物的聚合性液晶組成物負載於用布等進行了摩擦處理的基板、形成了有機薄膜的基板或具有斜射蒸鍍有SiO2的配向膜的基板上,或者使其夾持於基板間後,聚合該聚合性液晶組成物,從而進行製造。 The polymer obtained by polymerizing the polymerizable liquid crystal composition containing the compound of the present invention can be used in various applications. For example, a polymer obtained by polymerizing a polymerizable liquid crystal composition containing a compound of the present invention without alignment can be used as a light-scattering plate, a polarization-removing plate, and an interference fringe prevention plate. Moreover, it is useful that the polymer obtained by superposing | polymerizing after orientation has optical anisotropy. Such an optically anisotropic body can be, for example, by supporting a polymerizable liquid crystal composition containing the compound of the present invention on a substrate subjected to a rubbing treatment with a cloth or the like, a substrate on which an organic thin film is formed, or a substrate having oblique vapor deposition of SiO 2 . The polymerizable liquid crystal composition is polymerized on the substrate of the alignment film or sandwiched between the substrates to produce the polymerizable liquid crystal composition.

作為使聚合性液晶組成物負載於基板上時的方法,可舉出旋塗、模塗、擠壓塗佈、輥塗、繞線棒塗佈(wire bar coating)、凹版塗佈、噴塗、浸塗、印刷法等。另外塗佈時,可向聚合性液晶組成物中添加有機溶劑。作為有機溶劑,可使用烴系溶劑、鹵代烴系溶劑、醚系溶劑、醇系溶劑、酮系溶劑、酯系溶劑、非質子性溶劑等,例如作為烴系溶劑,可舉出甲苯或己烷,作為鹵代烴系溶劑,可舉出二氯甲烷,作為醚系溶劑,可舉出四氫呋喃、乙醯氧基-2-乙氧基乙烷或丙二醇單甲基醚醋酸酯,作為醇系溶劑,可舉出甲醇、乙醇或異丙醇,作為酮系溶劑,可舉出丙酮、甲基乙基酮、環己酮、γ-丁內酯或N-甲基吡咯烷酮類,作為酯系溶劑,可舉出醋酸乙酯或溶纖劑,作為非質子性溶劑,可舉出二甲基甲醯胺或乙腈。此等物質可單獨使用,也可組合使用,只要考慮其蒸氣壓和聚合性液晶組成物的溶解性而適宜選擇即可。作為使添加的有機溶劑揮發的方法,可使用自然乾燥、加熱乾燥、減壓乾燥、減壓加熱乾燥。為了進一步提高聚合性液晶材料的塗佈性,在基板上設置聚醯亞胺薄膜等的中間層、在聚合性液晶材料中添加流平劑也是有效的。在基板上設置聚醯亞胺薄膜等的中間層的 方法由於可提高藉由將聚合性液晶材料進行聚合所得到的聚合物與基板的密合性,因此有效。 Examples of a method for supporting a polymerizable liquid crystal composition on a substrate include spin coating, die coating, extrusion coating, roll coating, wire bar coating, gravure coating, spray coating, and dipping. Painting, printing, etc. During the application, an organic solvent may be added to the polymerizable liquid crystal composition. Examples of the organic solvent include a hydrocarbon-based solvent, a halogenated hydrocarbon-based solvent, an ether-based solvent, an alcohol-based solvent, a ketone-based solvent, an ester-based solvent, an aprotic solvent, and the like. Examples of the hydrocarbon-based solvent include toluene or hexane Examples of the halogenated hydrocarbon-based solvent include dichloromethane, and examples of the ether-based solvent include tetrahydrofuran, ethoxy-2-ethoxyethane, or propylene glycol monomethyl ether acetate, and examples of the alcohol-based solvent include Examples of the solvent include methanol, ethanol, and isopropanol. Examples of the ketone solvent include acetone, methyl ethyl ketone, cyclohexanone, γ-butyrolactone, and N-methylpyrrolidone. Examples of the solvent include ester solvents. Examples include ethyl acetate or cellosolve, and examples of the aprotic solvent include dimethylformamide or acetonitrile. These materials may be used alone or in combination, as long as the vapor pressure and the solubility of the polymerizable liquid crystal composition are appropriately selected. As a method for volatilizing the added organic solvent, natural drying, heating drying, drying under reduced pressure, and heating under reduced pressure can be used. In order to further improve the coatability of the polymerizable liquid crystal material, it is also effective to provide an intermediate layer such as a polyimide film on the substrate and add a leveling agent to the polymerizable liquid crystal material. An intermediate layer such as a polyimide film is provided on a substrate The method is effective because it can improve the adhesion between the polymer obtained by polymerizing the polymerizable liquid crystal material and the substrate.

作為上述以外的配向處理,可舉出液晶材料的流動配向的利用、電場或磁場的利用。此等配向方法可單獨使用,另外也可組合使用。進而,作為代替摩擦的配向處理方法,也可使用光配向法。作為基板的形狀,除了平板以外,也可具有曲面作為構成部分。就構成基板的材料而言,不論是有機材料、無機材料都可使用。作為成為基板的材料的有機材料,例如可舉出聚對苯二甲酸乙二醇酯、聚碳酸酯、聚醯亞胺、聚醯胺、聚甲基丙烯酸甲酯、聚苯乙烯、聚氯乙烯、聚四氟乙烯、聚氯三氟乙烯、聚芳酯、聚碸、三乙醯基纖維素、纖維素、聚醚醚酮等,另外,作為無機材料,例如可舉出矽、玻璃、方解石等。 Examples of the alignment treatment other than the above include the use of flow alignment of a liquid crystal material and the use of an electric field or a magnetic field. These alignment methods can be used alone or in combination. Furthermore, as an alignment processing method instead of friction, a photo-alignment method may be used. The shape of the substrate may have a curved surface as a constituent in addition to a flat plate. As the material constituting the substrate, any of organic materials and inorganic materials can be used. Examples of the organic material used as the material of the substrate include polyethylene terephthalate, polycarbonate, polyimide, polyimide, polymethyl methacrylate, polystyrene, and polyvinyl chloride. , Polytetrafluoroethylene, polychlorotrifluoroethylene, polyarylate, polyfluorene, triethylcellulose, cellulose, polyetheretherketone, and the like. Examples of the inorganic material include silicon, glass, and calcite. Wait.

使含有本發明的化合物的聚合性液晶組成物聚合時,希望迅速地進行聚合,因此較佳為藉由照射紫外線或電子束等活性能量射線而進行聚合的方法。使用紫外線時,可使用偏光光源,也可以使用非偏光光源。另外,在將液晶組成物夾持於2片基板間的狀態下進行聚合時,至少照射面側的基板對於活性能量射線必須具有適當的透明性。另外,也可使用以下這樣的方法:光照射時使用遮罩僅使特定的部分進行聚合後,藉由使電場、磁場或溫度等條件變化而使未聚合部分的配向狀態變化,進而照射活性能量射線進行聚合。另外,照射時的溫度較佳為在可保持本發明的聚合性液晶組成物的液晶狀態的溫度範圍內。特別是想要藉由光聚合來製造光學各向異性體時,從避免引起不想要的熱聚合的用意出發,還較佳為在盡可能接近室溫的溫度、即典型地在25℃的溫度下進行聚合。活性能量射線的強度較佳為0.1mW/cm2~2W/cm2。強度為0.1mW/cm2以下時,為了完成光聚合,需要很多的時間,生產性惡化,2W/cm2以上時,存在聚合性液晶化合物或聚合性液晶組成物劣化的危險。 When polymerizing a polymerizable liquid crystal composition containing a compound of the present invention, it is desirable to perform the polymerization quickly. Therefore, it is preferable to perform the polymerization by irradiating active energy rays such as ultraviolet rays or electron beams. When using ultraviolet light, a polarized light source or a non-polarized light source can be used. In addition, when the polymerization is performed while the liquid crystal composition is sandwiched between two substrates, at least the substrate on the irradiation surface side must have appropriate transparency for active energy rays. In addition, the following method can also be used: after a specific portion is polymerized using a mask during light irradiation, the orientation state of the unpolymerized portion is changed by changing conditions such as an electric field, a magnetic field, or a temperature, and then active energy is irradiated The rays are polymerized. The temperature during irradiation is preferably within a temperature range in which the liquid crystal state of the polymerizable liquid crystal composition of the present invention can be maintained. In particular, when it is desired to produce an optically anisotropic body by photopolymerization, from the intention of avoiding undesired thermal polymerization, it is also preferable that the temperature is as close to room temperature as possible, that is, typically 25 ° C. Polymerization was carried out. The intensity of the active energy ray is preferably from 0.1 mW / cm 2 to 2 W / cm 2 . When the strength is 0.1 mW / cm 2 or less, it takes a lot of time to complete photopolymerization and productivity deteriorates. When the strength is 2 W / cm 2 or more, the polymerizable liquid crystal compound or the polymerizable liquid crystal composition may be deteriorated.

以減輕初期的特性變化、謀求穩定的特性表現為目的,藉由聚合而得到的該光學各向異性體也可以實施熱處理。熱處理的溫 度較佳為50~250℃的範圍,熱處理時間較佳為30秒鐘~12小時的範圍。 The optically anisotropic body obtained by polymerization may be subjected to heat treatment for the purpose of reducing initial characteristic changes and achieving stable characteristic expression. Heat treatment temperature The degree is preferably in the range of 50 to 250 ° C, and the heat treatment time is preferably in the range of 30 seconds to 12 hours.

藉由這樣的方法製造的該光學各向異性體可由基板剝離並以單體來使用,也可以不剝離來使用。另外,也可以層疊所得到的光學各向異性體,還可以黏貼於其他的基板來使用。 The optically anisotropic body produced by such a method may be peeled from the substrate and used as a single body, or may be used without peeling. In addition, the obtained optical anisotropic body may be laminated, and it may be used by being stuck to another substrate.

[實施例] [Example]

以下,舉出實施例來進一步記述本發明,但本發明並不限定於此等實施例。另外,以下的實施例及比較例的組成物中的“%”表示“質量%”。 Hereinafter, the present invention will be further described with examples, but the present invention is not limited to these examples. In addition, "%" in the composition of the following examples and comparative examples means "mass%."

(實施例1)式(I-1)表示的化合物的製造 (Example 1) Production of compound represented by formula (I-1)

於具有攪拌裝置、冷卻器及溫度計的反應容器中加入4-羥基-3-甲氧基苯甲酸(式(A-1)表示的化合物)200g(1.2莫耳)、醋酸700mL、醋酸酐133g(1.3莫耳)、硫酸3g,加熱至60℃反應9小時。於反應液中加入水1L,一邊用冰冷卻一邊攪拌2小時後,過濾析出的固體。用水1L對得到的固體再進行分散洗滌。藉由乾燥固體而得到式(A-2)表示的化合物203g。 In a reaction vessel having a stirring device, a cooler, and a thermometer, 200 g (1.2 mol) of 4-hydroxy-3-methoxybenzoic acid (a compound represented by the formula (A-1)), 700 mL of acetic acid, and 133 g of acetic anhydride ( 1.3 mol), 3 g sulfuric acid, and heated to 60 ° C. for 9 hours. 1 L of water was added to the reaction solution, and after stirring for 2 hours while cooling with ice, the precipitated solid was filtered. The obtained solid was re-dispersed and washed with 1 L of water. By drying the solid, 203 g of a compound represented by the formula (A-2) was obtained.

於具有攪拌裝置及溫度計的反應容器中加入式(A-2)表示的化合物25.0g(0.12莫耳)、2,4-二甲基苯酚13.2g(0.11莫耳)、N,N-二甲基胺基吡啶(DMAP)0.7g(5.4毫莫耳)、二氯甲烷125mL,一邊用冰冷卻一邊進行攪拌。將反應液的溫度保持在15℃以下的同時滴加N,N’-二異丙基碳化二亞胺(DIC)16.4g(0.13莫耳)。滴加完成後,在室溫下攪拌5小時進行反應。過濾反應液並除去析出物後,餾 去溶劑。使得到的固體物溶解於二氯甲烷,並藉由管柱層析(精製劑:矽膠33g、洗提液:二氯甲烷264mL)進行精製後,餾去溶劑。將得到的固體物用甲醇102mL進行分散洗滌後,藉由進行乾燥而得到式(A-3)表示的化合物29.0g。 In a reaction vessel having a stirring device and a thermometer, 25.0 g (0.12 mole) of the compound represented by the formula (A-2), 13.2 g of 2,4-dimethylphenol (0.11 mole), and N, N-dimethyl 0.7 g (5.4 mmol) of aminoaminopyridine (DMAP) and 125 mL of dichloromethane were stirred while cooling with ice. While maintaining the temperature of the reaction solution at 15 ° C or lower, 16.4 g (0.13 mole) of N, N'-diisopropylcarbodiimide (DIC) was added dropwise. After completion of the dropwise addition, the reaction was carried out by stirring at room temperature for 5 hours. The reaction solution was filtered and the precipitate was removed, and then distilled. Remove the solvent. The obtained solid was dissolved in dichloromethane and purified by column chromatography (refined preparation: 33 g of silica gel, eluent: 264 mL of dichloromethane), and then the solvent was distilled off. The obtained solid substance was dispersedly washed with 102 mL of methanol, and then dried to obtain 29.0 g of a compound represented by the formula (A-3).

於具有攪拌裝置及溫度計的反應容器中加入式(A-3)表示的化合物29.0g(0.092莫耳)、甲苯87mL及四氫呋喃87mL。一邊攪拌一邊滴加丁胺10.1g(0.14莫耳)。滴加完成後,在室溫下攪拌一夜。用5%鹽酸100mL進行中和並分液後,將有機層用食鹽水100mL洗滌2次。餾去溶劑,將得到的油狀物質由甲醇90mL和水90mL的混合溶劑進行再結晶。藉由使所得到的固體乾燥而獲得式(A-4)表示的化合物20.1g。 A reaction vessel having a stirring device and a thermometer was charged with 29.0 g (0.092 mol) of a compound represented by the formula (A-3), 87 mL of toluene, and 87 mL of tetrahydrofuran. While stirring, 10.1 g (0.14 mol) of butylamine was added dropwise. After the dropwise addition was completed, the mixture was stirred at room temperature overnight. After neutralizing and separating with 100 mL of 5% hydrochloric acid, the organic layer was washed twice with 100 mL of saline. The solvent was distilled off, and the obtained oily substance was recrystallized from a mixed solvent of 90 mL of methanol and 90 mL of water. 20.1 g of a compound represented by the formula (A-4) was obtained by drying the obtained solid.

於具有攪拌裝置及溫度計的反應容器中加入式(A-4)表示的化合物20.1g(0.074莫耳)、6-(3-丙烯醯氧基-丙氧基)-2-萘甲酸(式(A-5)表示的化合物)24.4g(0.081莫耳)、N,N-二甲基胺基吡啶0.45g(3.7毫莫耳)及二氯甲烷122mL,一邊用冰冷卻一邊進行攪拌。將反應液的溫度保持在15℃以下的同時滴加N,N’-二異丙基碳化二亞胺11.2g(0.089莫耳)。滴加完成後,在室溫下攪拌6小時進行反應。過濾反應液並除去析出物後,餾去溶劑。使得到的固體物溶解於二氯甲烷,藉由管柱層析(精製劑:矽膠41g、洗提液:二氯甲烷328mL)進行精製後,餾去溶劑。將得到的固體物由二氯甲烷41mL及甲醇123mL的混合溶劑進行2次再結晶後,藉由進行乾燥而得到式(I-1)表示的化合物32.7g。 A reaction vessel having a stirring device and a thermometer was charged with 20.1 g (0.074 mole) of a compound represented by formula (A-4) and 6- (3-propenyloxy-propoxy) -2-naphthoic acid (formula ( Compound represented by A-5)) 24.4 g (0.081 mol), 0.45 g (3.7 mmol) of N, N-dimethylaminopyridine and 122 mL of dichloromethane were stirred while cooling with ice. While maintaining the temperature of the reaction solution at 15 ° C or lower, 11.2 g (0.089 mole) of N, N'-diisopropylcarbodiimide was added dropwise. After completion of the dropwise addition, the reaction was carried out by stirring at room temperature for 6 hours. The reaction solution was filtered to remove precipitates, and then the solvent was distilled off. The obtained solid was dissolved in dichloromethane and purified by column chromatography (refined preparation: 41 g of silica gel, eluent: 328 mL of dichloromethane), and then the solvent was distilled off. The obtained solid was recrystallized twice from a mixed solvent of 41 mL of methylene chloride and 123 mL of methanol, and then dried to obtain 32.7 g of a compound represented by the formula (I-1).

(式(I-1)表示的化合物的物性值) (Physical property value of the compound represented by formula (I-1))

1H NMR(CDCl3)δ 2.21(s,3H),2.27(五重峰(quin),2H),2.35(s,3H),3.92(s,3H),4.24(t,2H),4.43(t,2H),5.85(dd,1H),6.15(dd,1H),6.43(dd,1H),7.01~7.10(m,3H),7.20~7.24(m,2H),7.34(d,1H),7.81~7.95(m,4H),8.17(dd,1H),8.74(s,1H)ppm。 1 H NMR (CDCl 3 ) δ 2.21 (s, 3H), 2.27 (quintet, 2H), 2.35 (s, 3H), 3.92 (s, 3H), 4.24 (t, 2H), 4.43 ( t, 2H), 5.85 (dd, 1H), 6.15 (dd, 1H), 6.43 (dd, 1H), 7.01 to 7.10 (m, 3H), 7.20 to 7.24 (m, 2H), 7.34 (d, 1H) , 7.81 ~ 7.95 (m, 4H), 8.17 (dd, 1H), 8.74 (s, 1H) ppm.

13C NMR(CDCl3)δ 16.2,20.9,28.6,56.2,61.3,64.5,106.5,114.0,120.0,121.6,123.2,123.3,123.9,126.3,127.0,127.5,127.9,128.2,128.3,129.8,131.0,131.1,131.8,132.0,135.7, 137.6,144.6,147.3,151.6,159.1,164.4,164.6,166.2ppm。 13 C NMR (CDCl 3 ) δ 16.2, 20.9, 28.6, 56.2, 61.3, 64.5, 106.5, 114.0, 120.0, 121.6, 123.2, 123.3, 123.9, 126.3, 127.0, 127.5, 127.9, 128.2, 128.3, 129.8, 131.0, 131.1, 131.8, 132.0, 135.7, 137.6, 144.6, 147.3, 151.6, 159.1, 164.4, 164.6, 166.2 ppm.

LRMS(EI)m/z 554(100)。 LRMS (EI) m / z 554 (100).

(實施例2)式(I-3)表示的化合物的製造 (Example 2) Production of compound represented by formula (I-3)

於具有攪拌裝置及溫度計的反應容器中加入式(A-2)表示的化合物30.0g(0.14莫耳)、對甲酚14.0g(0.13莫耳)、N,N-二甲基胺基吡啶0.8g(6.5毫莫耳)、二氯甲烷150mL,一邊用冰冷卻一邊進行攪拌。將反應液的溫度保持在15℃以下的同時滴加N,N’-二異丙基碳化二亞胺19.7g(0.16莫耳)。滴加完成後,在室溫下攪拌8小時進行反應。過濾反應液並除去析出物後,餾去溶劑。使得到的固體物溶解於二氯甲烷,藉由管柱層析(精製劑:矽膠39g、洗提液:二氯甲烷312mL)進行精製後,餾去溶劑。將得到的固體物用甲醇117mL進行分散洗滌後,藉由進行乾燥而得到式(B-1)表示的化合物35.8g。 In a reaction vessel having a stirring device and a thermometer, 30.0 g (0.14 mol) of the compound represented by the formula (A-2), 14.0 g (0.13 mol) of p-cresol, and N, N-dimethylaminopyridine 0.8 were added. g (6.5 mmol), 150 mL of dichloromethane, and stirred while cooling with ice. While maintaining the temperature of the reaction solution at 15 ° C or lower, 19.7 g (0.16 mol) of N, N'-diisopropylcarbodiimide was added dropwise. After completion of the dropwise addition, the reaction was stirred at room temperature for 8 hours. The reaction solution was filtered to remove precipitates, and then the solvent was distilled off. The obtained solid was dissolved in dichloromethane and purified by column chromatography (refined preparation: 39 g of silica gel, eluent: 312 mL of dichloromethane), and then the solvent was distilled off. The obtained solid matter was dispersed and washed with 117 mL of methanol, and then dried to obtain 35.8 g of a compound represented by the formula (B-1).

於具有攪拌裝置及溫度計的反應容器中加入式(B-1)表示的化合物35.8g(0.12莫耳)、甲苯107mL及四氫呋喃107mL。一邊攪拌一邊滴加丁胺13.1g(0.18莫耳)。滴加完成後,在室溫下攪拌一夜。用5%鹽酸200mL進行中和並分液後,將有機層用食鹽水200mL洗滌2次。餾去溶劑,將得到的油狀物質由甲醇120mL和水120mL的混合溶劑進行再結晶。藉由使所得到的固體乾燥而獲得式(B-2)表示的化合物30.1g。 A reaction vessel having a stirring device and a thermometer was charged with 35.8 g (0.12 mol) of a compound represented by the formula (B-1), 107 mL of toluene, and 107 mL of tetrahydrofuran. While stirring, 13.1 g (0.18 mol) of butylamine was added dropwise. After the dropwise addition was completed, the mixture was stirred at room temperature overnight. After neutralization and separation with 200 mL of 5% hydrochloric acid, the organic layer was washed twice with 200 mL of brine. The solvent was distilled off, and the obtained oily substance was recrystallized from a mixed solvent of 120 mL of methanol and 120 mL of water. 30.1 g of a compound represented by the formula (B-2) was obtained by drying the obtained solid.

於具有攪拌裝置及溫度計的反應容器中加入式(B-2)表示的化合物30.1g(0.12莫耳)、6-(3-丙烯醯氧基-丙氧基)-2-萘甲酸38.7g(0.13莫耳)、N,N-二甲基胺基吡啶0.71g(5.8毫莫耳)及二氯甲烷193mL,一邊用冰冷卻一邊進行攪拌。將反應液的溫度保持在 15℃以下的同時滴加N,N’-二異丙基碳化二亞胺17.7g(0.14莫耳)。滴加完成後,在室溫下攪拌5小時進行反應。過濾反應液並除去析出物後,餾去溶劑。將得到的固體物溶解於二氯甲烷,藉由管柱層析(精製劑:矽膠63g、洗提液:二氯甲烷504mL)進行精製後,餾去溶劑。將得到的固體物由二氯甲烷63mL及甲醇189mL的混合溶劑進行2次再結晶後,藉由進行乾燥而得到式(I-3)表示的化合物51.6g。 In a reaction vessel having a stirring device and a thermometer, 30.1 g (0.12 mol) of a compound represented by the formula (B-2) and 38.7 g of 6- (3-propenyloxy-propoxy) -2-naphthoic acid ( 0.13 mole), 0.71 g (5.8 mmol) of N, N-dimethylaminopyridine, and 193 mL of dichloromethane, and stirred while cooling with ice. Keep the temperature of the reaction solution at At 15 ° C or lower, 17.7 g (0.14 mole) of N, N'-diisopropylcarbodiimide was added dropwise. After completion of the dropwise addition, the reaction was carried out by stirring at room temperature for 5 hours. The reaction solution was filtered to remove precipitates, and then the solvent was distilled off. The obtained solid was dissolved in dichloromethane and purified by column chromatography (refined preparation: 63 g of silica gel, eluent: 504 mL of dichloromethane), and then the solvent was distilled off. The obtained solid was recrystallized twice from a mixed solvent of 63 mL of methylene chloride and 189 mL of methanol, and then dried to obtain 51.6 g of a compound represented by the formula (I-3).

(式(I-3)表示的化合物的物性值) (Physical properties of the compound represented by formula (I-3))

1H NMR(CDCl3)δ 2.27(五重峰,2H),2.39(s,3H),3.91(s,3H),4.24(t,2H),4.42(t,2H),5.85(dd,1H),6.15(dd,1H),6.43(dd,1H),7.10(d,2H),7.19~7.26(m,4H),7.33(d,1H),7.81~7.84(m,2H),7.89~7.93(m,2H),8.17(dd,1H),8.73(s,1H)ppm。 1 H NMR (CDCl 3 ) δ 2.27 (quintet, 2H), 2.39 (s, 3H), 3.91 (s, 3H), 4.24 (t, 2H), 4.42 (t, 2H), 5.85 (dd, 1H ), 6.15 (dd, 1H), 6.43 (dd, 1H), 7.10 (d, 2H), 7.19 ~ 7.26 (m, 4H), 7.33 (d, 1H), 7.81 ~ 7.84 (m, 2H), 7.89 ~ 7.93 (m, 2H), 8.17 (dd, 1H), 8.73 (s, 1H) ppm.

13C NMR(CDCl3)δ 20.9,28.6,56.2,61.3,64.6,76.7,77.0,77.2,77.3,106.5,113.9,115.5,120.0,121.4,123.2,123.2,123.3,123.9,126.4,127.1,128.0,128.3,130.0,131.0,131.2,132.0,135.6,137.6,144.6,148.7,151.5,159.1,164.5,164.8,166.2ppm。 13 C NMR (CDCl 3 ) δ 20.9, 28.6, 56.2, 61.3, 64.6, 76.7, 77.0, 77.2, 77.3, 106.5, 113.9, 115.5, 120.0, 121.4, 123.2, 123.2, 123.3, 123.9, 126.4, 127.1, 128.0, 128.3, 130.0, 131.0, 131.2, 132.0, 135.6, 137.6, 144.6, 148.7, 151.5, 159.1, 164.5, 164.8, 166.2 ppm.

LRMS(EI)m/z 540(100)。 LRMS (EI) m / z 540 (100).

(實施例3)式(I-7)表示的化合物的製造 (Example 3) Production of compound represented by formula (I-7)

在實施例2中,使用4-乙基苯酚來替換對甲酚,除此以外,同樣操作來製造式(I-7)表示的化合物。 In Example 2, except that p-cresol was replaced with 4-ethylphenol, a compound represented by the formula (I-7) was produced in the same manner.

(式(I-7)表示的化合物的物性值) (Physical properties of the compound represented by formula (I-7))

1H NMR(CDCl3)δ 1.27(t,3H),2.27(五重峰,2H),2.69(q,2H),3.91(s,3H),4.24(t,2H),4.43(t,2H),5.85(dd,1H),6.15(dd, 1H),6.44(dd,1H),7.14(d,2H),7.20~7.27(m,4H),7.33,(d,1H),7.81~7.85(m,2H),7.91(td,2H),8.17(dd,1H),8.73(1H)ppm。 1 H NMR (CDCl 3 ) δ 1.27 (t, 3H), 2.27 (quintet, 2H), 2.69 (q, 2H), 3.91 (s, 3H), 4.24 (t, 2H), 4.43 (t, 2H ), 5.85 (dd, 1H), 6.15 (dd, 1H), 6.44 (dd, 1H), 7.14 (d, 2H), 7.20 ~ 7.27 (m, 4H), 7.33, (d, 1H), 7.81 ~ 7.85 (m, 2H), 7.91 (td, 2H), 8.17 (dd, 1H), 8.73 (1H) ppm.

13C NMR(CDCl3)δ 15.6,28.3,28.6,56.2,61.3,64.6,106.5,114.0,120.0,121.4,123.2,123.4,123.9,126.4,127.1,128.0,128.3,128.9,131.0,131.2,132.0,137.6,141.9,144.6,148.8,151.5,159.1,164.5,164.8,166.2ppm。 13 C NMR (CDCl 3 ) δ 15.6, 28.3, 28.6, 56.2, 61.3, 64.6, 106.5, 114.0, 120.0, 121.4, 123.2, 123.4, 123.9, 126.4, 127.1, 128.0, 128.3, 128.9, 131.0, 131.2, 132.0, 137.6, 141.9, 144.6, 148.8, 151.5, 159.1, 164.5, 164.8, 166.2 ppm.

LRMS(EI)m/z 554(100)。 LRMS (EI) m / z 554 (100).

(實施例4)式(I-8)表示的化合物的製造 (Example 4) Production of compound represented by formula (I-8)

於具有攪拌裝置、冷卻器及溫度計的反應容器中加入3-氯-4-羥基苯甲酸0.5水合物(式(D-1)表示的化合物)105g(0.58莫耳)、醋酸350mL、醋酸酐65.0g(0.64莫耳)及硫酸1.5g,加熱至60℃進行8小時反應。於反應液中加入水1L,一邊用冰冷卻一邊攪拌1小時後,過濾析出的固體。將得到的固體用水1L再進行分散洗滌。藉由乾燥固體而得到式(D-2)表示的化合物120.6g。 In a reaction vessel having a stirring device, a cooler, and a thermometer, 105 g (0.58 mol) of 3-chloro-4-hydroxybenzoic acid 0.5 hydrate (compound represented by the formula (D-1)), 350 mL of acetic acid, and 65.0 of acetic anhydride were added. g (0.64 mole) and 1.5 g of sulfuric acid were heated to 60 ° C. for 8 hours to react. 1 L of water was added to the reaction solution, and after stirring for 1 hour while cooling with ice, the precipitated solid was filtered. The obtained solid was washed with 1 L of water. 120.6 g of a compound represented by the formula (D-2) was obtained by drying the solid.

於具有攪拌裝置及溫度計的反應容器中加入式(D-2)表示的化合物25.0g(0.12莫耳)、對甲酚11.4g(0.11莫耳)、N,N-二甲基胺基吡啶0.6g(5.2毫莫耳)及二氯甲烷125mL,一邊用冰冷卻一邊進行攪拌。將反應液的溫度保持在15℃以下的同時滴加N,N’-二異丙基碳化二亞胺15.9g(0.13莫耳)。滴加完成後,在室溫下攪拌5小時進行反應。過濾反應液並除去析出物後,餾去溶劑。使得到的固體物溶解於二氯甲烷,藉由管柱層析(精製劑:矽膠32g、洗提液:二氯甲烷256mL)進行精製後,餾去溶劑。將得到的固體物用甲醇96mL進行分散洗滌後,藉由進行乾燥而得到式(D-3)表示的化合物28.5g。 In a reaction vessel having a stirring device and a thermometer, 25.0 g (0.12 mole) of the compound represented by the formula (D-2), 11.4 g (0.11 mole) of p-cresol, and N, N-dimethylaminopyridine 0.6 were added. g (5.2 mmol) and 125 mL of dichloromethane were stirred while cooling with ice. While maintaining the temperature of the reaction solution at 15 ° C or lower, 15.9 g (0.13 mol) of N, N'-diisopropylcarbodiimide was added dropwise. After completion of the dropwise addition, the reaction was carried out by stirring at room temperature for 5 hours. The reaction solution was filtered to remove precipitates, and then the solvent was distilled off. The obtained solid was dissolved in dichloromethane and purified by column chromatography (refined preparation: 32 g of silica gel, eluent: 256 mL of dichloromethane), and then the solvent was distilled off. The obtained solid matter was dispersed and washed with 96 mL of methanol, and then dried to obtain 28.5 g of a compound represented by the formula (D-3).

於具有攪拌裝置及溫度計的反應容器中加入式(D-3)表示的化合物28.5g(0.094莫耳)、甲苯86mL及四氫呋喃86mL。一邊攪拌一邊滴加丁胺10.3g(0.14莫耳)。滴加完成後,在室溫下攪拌一夜。用5%鹽酸150mL進行中和並分液後,將有機層用食鹽水150mL洗滌2次。餾去溶劑,將得到的油狀物質由甲醇74mL和水74mL的混合溶劑進行再結晶。藉由乾燥所得到的固體而獲得式(D-4)表示的化合物23.8g。 A reaction vessel having a stirring device and a thermometer was charged with 28.5 g (0.094 mol) of a compound represented by the formula (D-3), 86 mL of toluene, and 86 mL of tetrahydrofuran. 10.3 g (0.14 mole) of butylamine was added dropwise while stirring. After the dropwise addition was completed, the mixture was stirred at room temperature overnight. After neutralization and separation with 150 mL of 5% hydrochloric acid, the organic layer was washed twice with 150 mL of saline. The solvent was distilled off, and the obtained oily substance was recrystallized from a mixed solvent of 74 mL of methanol and 74 mL of water. 23.8 g of a compound represented by the formula (D-4) was obtained by drying the obtained solid.

於具有攪拌裝置及溫度計的反應容器中加入式(D-4)表示的化合物23.8g(0.091莫耳)、6-(3-丙烯醯氧基-丙氧基)-2-萘甲酸29.9g(0.099莫耳)、N,N-二甲基胺基吡啶0.55g(4.5毫莫耳)及二氯甲烷150mL,一邊用冰冷卻一邊進行攪拌。將反應液的溫度保持在15℃以下的同時滴加N,N’-二異丙基碳化二亞胺13.7g(0.11莫耳)。滴加完成後,在室溫下攪拌6小時進行反應。過濾反應液並除去析出物後,餾去溶劑。使得到的固體物溶解於二氯甲烷,藉由管柱層析(精製劑:矽膠49g、洗提液:二氯甲烷392mL)進行精製後,餾去溶劑。將得到的固體物由二氯甲烷49mL及甲醇147mL的混合溶劑進行2次再結晶後,藉由進行乾燥而得到式(I-8)表示的化合物40.5g。 A reaction vessel with a stirring device and a thermometer was charged with 23.8 g (0.091 mole) of a compound represented by formula (D-4) and 29.9 g of 6- (3-propenyloxy-propoxy) -2-naphthoic acid ( 0.099 mole), 0.55 g (4.5 mmol) of N, N-dimethylaminopyridine, and 150 mL of dichloromethane, and the mixture was stirred while cooling with ice. While maintaining the temperature of the reaction solution at 15 ° C or lower, 13.7 g (0.11 mole) of N, N'-diisopropylcarbodiimide was added dropwise. After completion of the dropwise addition, the reaction was carried out by stirring at room temperature for 6 hours. The reaction solution was filtered to remove precipitates, and then the solvent was distilled off. The obtained solid was dissolved in dichloromethane and purified by column chromatography (refined preparation: 49 g of silica gel, eluent: 392 mL of dichloromethane), and then the solvent was distilled off. The obtained solid was recrystallized twice from a mixed solvent of 49 mL of dichloromethane and 147 mL of methanol, and then dried to obtain 40.5 g of a compound represented by the formula (I-8).

(式(I-8)表示的化合物的物性值) (Physical properties of the compound represented by formula (I-8))

1H NMR(CDCl3)δ 2.25(五重峰,2H),2.38(s,3H),4.24(t,2H),4.43(t,2H),5.86(dd,1H),6.15(dd,1H),6.44(dd,1H),7.11(d,2H),7.20~7.26(m,4H),7.49(d,1H),7.83(d,1H),7.91(d,1H),8.18(m,2H),8.36(m,1H),8.76(s,1H)ppm。 1 H NMR (CDCl 3 ) δ 2.25 (quintet, 2H), 2.38 (s, 3H), 4.24 (t, 2H), 4.43 (t, 2H), 5.86 (dd, 1H), 6.15 (dd, 1H) ), 6.44 (dd, 1H), 7.11 (d, 2H), 7.20 ~ 7.26 (m, 4H), 7.49 (d, 1H), 7.83 (d, 1H), 7.91 (d, 1H), 8.18 (m, 2H), 8.36 (m, 1H), 8.76 (s, 1H) ppm.

13C NMR(CDCl3)δ 20.9,28.6,61.3,64.6,106.5,120.2,121.2,123.3,124.2,126.2,127.3,127.8,127.9,128.3,128.6,129.8,130.1,131.0,131.2,132.3,135.8,137.8,148.5,151.6,159.3,163.7,164.0,166.2ppm。 13 C NMR (CDCl 3 ) δ 20.9, 28.6, 61.3, 64.6, 106.5, 120.2, 121.2, 123.3, 124.2, 126.2, 127.3, 127.8, 127.9, 128.3, 128.6, 129.8, 130.1, 131.0, 131.2, 132.3, 135.8, 137.8, 148.5, 151.6, 159.3, 163.7, 164.0, 166.2 ppm.

LRMS(EI)m/z 544(100),546(30)。 LRMS (EI) m / z 544 (100), 546 (30).

(實施例5)式(I-15)表示的化合物的製造 (Example 5) Production of compound represented by formula (I-15)

在實施例2中,使用6-丙基-2-萘酚來替換對甲酚,除此以外,同樣操作來製造式(I-15)表示的化合物。 A compound represented by formula (I-15) was produced in the same manner as in Example 2 except that p-cresol was replaced with 6-propyl-2-naphthol.

(式(I-15)表示的化合物的物性值) (Physical properties of the compound represented by formula (I-15))

1H NMR(CDCl3)δ 1.27(t,3H),1.66(m,2H),2.27(五重峰,2H),2.66(t,2H),3.91(s,3H),4.24(t,2H),4.43(t,2H),5.85(dd,1H),6.15(dd,1H),6.44(dd,1H),7.14(d,2H),7.20~7.27(m,4H),7.30~7.45,(m,3H),7.81~7.90(m,4H),8.17(dd,1H),8.73(1H)ppm。 1 H NMR (CDCl 3 ) δ 1.27 (t, 3H), 1.66 (m, 2H), 2.27 (quintet, 2H), 2.66 (t, 2H), 3.91 (s, 3H), 4.24 (t, 2H ), 4.43 (t, 2H), 5.85 (dd, 1H), 6.15 (dd, 1H), 6.44 (dd, 1H), 7.14 (d, 2H), 7.20 ~ 7.27 (m, 4H), 7.30 ~ 7.45, (m, 3H), 7.81 to 7.90 (m, 4H), 8.17 (dd, 1H), 8.73 (1H) ppm.

13C NMR(CDCl3)δ 13.6,25.2,30.3,38.4,56.0,63.1,68.5,105.5,108.9,116.1,117.4,119.7,122.3,122.8,125.5,125.8,126.1,126.4,127.0,128.0,128.4,128.4,128.6,128.8,129.2,130.3,130.4,130.8,132.5,132.8,136.1,143.9,152.1,154.8,160.1,164.0,164.0,165.0ppm。 13 C NMR (CDCl 3 ) δ 13.6, 25.2, 30.3, 38.4, 56.0, 63.1, 68.5, 105.5, 108.9, 116.1, 117.4, 119.7, 122.3, 122.8, 125.5, 125.8, 126.1, 126.4, 127.0, 128.0, 128.4, 128.4, 128.6, 128.8, 129.2, 130.3, 130.4, 130.8, 132.5, 132.8, 136.1, 143.9, 152.1, 154.8, 160.1, 164.0, 164.0, 165.0 ppm.

LRMS(EI)m/z 618(100)。 LRMS (EI) m / z 618 (100).

(實施例6)式(I-16)表示的化合物的製造 (Example 6) Production of compound represented by formula (I-16)

在實施例2中,使用反式-4-丙基環己醇來替換對甲酚,除此 以外,同樣操作來製造式(I-16)表示的化合物。 In Example 2, trans-4-propylcyclohexanol was used instead of p-cresol, except Other than that, the compound represented by Formula (I-16) was produced similarly.

(式(I-16)表示的化合物的物性值) (Physical properties of the compound represented by formula (I-16))

1H NMR(CDCl3)δ 1.27~1.43(m,12H),2.27~2.35(m,6H),3.91(s,3H),4.02(五重峰,1H),4.24(t,2H),4.43(t,2H),5.85(dd,1H),6.15(dd,1H),6.44(dd,1H),7.14(d,2H),7.20(d,1H),7.81~7.85(m,2H),7.91(td,2H),8.17(dd,1H),8.73(1H)ppm。 1 H NMR (CDCl 3 ) δ 1.27 to 1.43 (m, 12H), 2.27 to 2.35 (m, 6H), 3.91 (s, 3H), 4.02 (five heavy peaks, 1H), 4.24 (t, 2H), 4.43 (t, 2H), 5.85 (dd, 1H), 6.15 (dd, 1H), 6.44 (dd, 1H), 7.14 (d, 2H), 7.20 (d, 1H), 7.81 ~ 7.85 (m, 2H), 7.91 (td, 2H), 8.17 (dd, 1H), 8.73 (1H) ppm.

13C NMR(CDCl3)δ 14.3,20.9,25.8,25.8,29.2,29.2,30.3,32.0,36.9,56.0,63.1,68.5,72.3,105.5,115.7,119.7,122.3,122.4,125.8,126.1,127.0,128.0,128.8,128.8,130.3,130.4,130.8,136.1,143.0,154.8,160.1,165.0,164.0,167.0ppm。 13 C NMR (CDCl 3 ) δ 14.3, 20.9, 25.8, 25.8, 29.2, 29.2, 30.3, 32.0, 36.9, 56.0, 63.1, 68.5, 72.3, 105.5, 115.7, 119.7, 122.3, 122.4, 125.8, 126.1, 127.0, 128.0, 128.8, 128.8, 130.3, 130.4, 130.8, 136.1, 143.0, 154.8, 160.1, 165.0, 164.0, 167.0 ppm.

LRMS(EI)m/z 574(100)。 LRMS (EI) m / z 574 (100).

(實施例7)式(I-17)表示的化合物的製造 (Example 7) Production of compound represented by formula (I-17)

於具有攪拌裝置、冷卻器及溫度計的反應容器中加入4-羥基-3-甲氧基肉桂酸(式(G-1)表示的化合物)100g(0.52莫耳)、醋酸350mL、醋酸酐57.8g(0.57莫耳)及硫酸1.5g,加熱至60℃進行10小時反應。於反應液中加入水1L,一邊用冰冷卻一邊攪拌1小時後,過濾析出的固體。將得到的固體用水1L再進行分散洗滌。藉由乾燥固體而得到式(G-2)表示的化合物111g。 In a reaction vessel equipped with a stirring device, a cooler, and a thermometer, 100 g (0.52 mole) of 4-hydroxy-3-methoxycinnamic acid (a compound represented by the formula (G-1)), 350 mL of acetic acid, and 57.8 g of acetic anhydride (0.57 moles) and 1.5 g of sulfuric acid were heated to 60 ° C. for 10 hours to react. 1 L of water was added to the reaction solution, and after stirring for 1 hour while cooling with ice, the precipitated solid was filtered. The obtained solid was washed with 1 L of water. 111 g of a compound represented by formula (G-2) was obtained by drying the solid.

於具有攪拌裝置及溫度計的反應容器中加入式(G-2)表示的化合物25.0g(0.106莫耳)、對甲酚10.4g(0.096莫耳)、N,N-二甲基胺基吡啶0.6g(4.8毫莫耳)及二氯甲烷125mL,一邊用冰冷卻一邊進行攪拌。將反應液的溫度保持在15℃以下的同時滴加N,N’-二異丙基碳化二亞胺14.6g(0.12莫耳)。滴加完成後,在室溫下攪拌5小時進行反應。過濾反應液並除去析出物後,餾去溶劑。使得到的固體物溶解於二氯甲烷,藉由管柱層析(精製劑:矽膠31g、洗 提液:二氯甲烷248mL)進行精製後,餾去溶劑。將得到的固體物用甲醇124mL進行分散洗滌後,藉由進行乾燥而得到式(G-3)表示的化合物26.7g。 In a reaction vessel having a stirring device and a thermometer, 25.0 g (0.106 mole) of the compound represented by the formula (G-2), 10.4 g (0.096 mole) of p-cresol, and N, N-dimethylaminopyridine 0.6 were added. g (4.8 mmol) and 125 mL of dichloromethane were stirred while cooling with ice. While maintaining the temperature of the reaction solution at 15 ° C or lower, 14.6 g (0.12 mol) of N, N'-diisopropylcarbodiimide was added dropwise. After completion of the dropwise addition, the reaction was carried out by stirring at room temperature for 5 hours. The reaction solution was filtered to remove precipitates, and then the solvent was distilled off. The obtained solid was dissolved in dichloromethane, and column chromatography (refined preparation: 31 g of silica gel, washed Extraction liquid: 248 mL of dichloromethane), and the solvent was distilled off. The obtained solid matter was dispersed and washed with 124 mL of methanol, and then dried to obtain 26.7 g of a compound represented by the formula (G-3).

於具有攪拌裝置及溫度計的反應容器中加入式(G-3)表示的化合物26.7g(0.082莫耳)、甲苯80mL及四氫呋喃80mL。一邊攪拌一邊滴加丁胺9.0g(0.12莫耳)。滴加完成後,在室溫下攪拌一夜。用5%鹽酸180mL進行中和並分液後,將有機層用食鹽水180mL洗滌2次。餾去溶劑,將得到的油狀物質由甲醇70mL和水70mL的混合溶劑進行再結晶。藉由乾燥所得到的固體而獲得式(G-4)表示的化合物22.6g。 A reaction vessel having a stirring device and a thermometer was charged with 26.7 g (0.082 mol) of a compound represented by formula (G-3), 80 mL of toluene, and 80 mL of tetrahydrofuran. While stirring, 9.0 g (0.12 mol) of butylamine was added dropwise. After the dropwise addition was completed, the mixture was stirred at room temperature overnight. After neutralization and separation with 180 mL of 5% hydrochloric acid, the organic layer was washed twice with 180 mL of brine. The solvent was distilled off, and the obtained oily substance was recrystallized from a mixed solvent of 70 mL of methanol and 70 mL of water. 22.6 g of a compound represented by formula (G-4) was obtained by drying the obtained solid.

於具有攪拌裝置及溫度計的反應容器中加入式(G-4)表示的化合物22.6g(0.079莫耳)、6-(3-丙烯醯氧基-丙氧基)-2-萘甲酸26.2g(0.087莫耳)、N,N-二甲基胺基吡啶0.49g(4.0毫莫耳)及二氯甲烷131mL,一邊用冰冷卻一邊進行攪拌。將反應液的溫度保持在15℃以下的同時滴加N,N’-二異丙基碳化二亞胺12.0g(0.095莫耳)。滴加完成後,在室溫下攪拌6小時進行反應。過濾反應液並除去析出物後,餾去溶劑。使得到的固體物溶解於二氯甲烷,藉由管柱層析(精製劑:矽膠45g、洗提液:二氯甲烷360mL)進行精製後,餾去溶劑。將得到的固體物由二氯甲烷45mL及甲醇135mL的混合溶劑進行2次再結晶後,藉由進行乾燥而得到式(I-17)表示的化合物36.9g。 A reaction vessel with a stirring device and a thermometer was charged with 22.6 g (0.079 mole) of a compound represented by formula (G-4) and 26.2 g of 6- (3-propenyloxy-propoxy) -2-naphthoic acid ( 0.087 mole), 0.49 g (4.0 mmol) of N, N-dimethylaminopyridine and 131 mL of dichloromethane, and the mixture was stirred while cooling with ice. While maintaining the temperature of the reaction solution at 15 ° C or lower, 12.0 g (0.095 mol) of N, N'-diisopropylcarbodiimide was added dropwise. After completion of the dropwise addition, the reaction was carried out by stirring at room temperature for 6 hours. The reaction solution was filtered to remove precipitates, and then the solvent was distilled off. The obtained solid was dissolved in dichloromethane and purified by column chromatography (refined preparation: 45 g of silica gel, eluent: 360 mL of dichloromethane), and then the solvent was distilled off. The obtained solid was recrystallized twice from a mixed solvent of 45 mL of methylene chloride and 135 mL of methanol, and then dried to obtain 36.9 g of a compound represented by the formula (I-17).

(式(I-17)表示的化合物的物性值) (Physical properties of the compound represented by formula (I-17))

1H NMR(CDCl3)δ 1.99(五重峰,2H),2.35(s,3H),3.73(s,3H),4.04(t,2H),4.15(t,2H),5.80(dd,1H),6.05(dd,1H),6.43(dd,1H),6.39(d,1H),6.88(d,1H),6.93(d,1H),6.95(d,2H),6.97(s,1H),6.99(d,1H),7.03(d,2H),7.04(d,1H),7.60(d,1H),7.64(d,1H),7.75(d,1H),8.20(d,1H),8.52(s,1H)ppm。 1 H NMR (CDCl 3 ) δ 1.99 (quintet, 2H), 2.35 (s, 3H), 3.73 (s, 3H), 4.04 (t, 2H), 4.15 (t, 2H), 5.80 (dd, 1H ), 6.05 (dd, 1H), 6.43 (dd, 1H), 6.39 (d, 1H), 6.88 (d, 1H), 6.93 (d, 1H), 6.95 (d, 2H), 6.97 (s, 1H) , 6.99 (d, 1H), 7.03 (d, 2H), 7.04 (d, 1H), 7.60 (d, 1H), 7.64 (d, 1H), 7.75 (d, 1H), 8.20 (d, 1H), 8.52 (s, 1H) ppm.

13C NMR(CDCl3)δ 20.9,30.3,56.0,63.1,68.5,105.5,112.2,115.7,118.9,119.7,122.3,122.4,122.4,127.0,125.8,126.1,128.0,128.6,129.6,129.6,130.3,130.4,130.8,132.7,134.5, 136.1,137.9,145.6,150.1,154.8,160.1,162.0,164.0,165.0ppm。 13 C NMR (CDCl 3 ) δ 20.9, 30.3, 56.0, 63.1, 68.5, 105.5, 112.2, 115.7, 118.9, 119.7, 122.3, 122.4, 122.4, 127.0, 125.8, 126.1, 128.0, 128.6, 129.6, 129.6, 130.3, 130.4, 130.8, 132.7, 134.5, 136.1, 137.9, 145.6, 150.1, 154.8, 160.1, 162.0, 164.0, 165.0 ppm.

LRMS(EI)m/z 566(100)。 LRMS (EI) m / z 566 (100).

(實施例8)式(I-13)表示的化合物的製造 (Example 8) Production of compound represented by formula (I-13)

於具有攪拌裝置及溫度計的反應容器中加入式(A-2)表示的化合物30.0g(0.14莫耳)、4-氰基-3-氟苯酚17.8g(0.13莫耳)、N,N-二甲基胺基吡啶0.8g(6.5毫莫耳)及二氯甲烷150mL,一邊用冰冷卻一邊進行攪拌。將反應液的溫度保持在15℃以下的同時滴加N,N’-二異丙基碳化二亞胺19.7g(0.16莫耳)。滴加完成後,在室溫下攪拌5小時進行反應。過濾反應液並除去析出物後,餾去溶劑。使得到的固體物溶解於二氯甲烷,藉由管柱層析(精製劑:矽膠31g、洗提液:二氯甲烷248mL)進行精製後,餾去溶劑。將得到的固體物用甲醇124mL進行分散洗滌後,藉由進行乾燥而得到式(H-1)表示的化合物39.0g。 In a reaction vessel having a stirring device and a thermometer, 30.0 g (0.14 mole) of a compound represented by the formula (A-2), 17.8 g (0.13 mole) of 4-cyano-3-fluorophenol, and N, N-di 0.8 g (6.5 mmol) of methylaminopyridine and 150 mL of dichloromethane were stirred while cooling with ice. While maintaining the temperature of the reaction solution at 15 ° C or lower, 19.7 g (0.16 mol) of N, N'-diisopropylcarbodiimide was added dropwise. After completion of the dropwise addition, the reaction was carried out by stirring at room temperature for 5 hours. The reaction solution was filtered to remove precipitates, and then the solvent was distilled off. The obtained solid was dissolved in dichloromethane and purified by column chromatography (refined preparation: 31 g of silica gel, eluent: 248 mL of dichloromethane), and then the solvent was distilled off. The obtained solid matter was dispersed and washed with 124 mL of methanol, and then dried to obtain 39.0 g of a compound represented by the formula (H-1).

於具有攪拌裝置及溫度計的反應容器中加入式(H-1)表示的化合物39.0g(0.12莫耳)、甲苯80mL及四氫呋喃80mL。一邊攪拌一邊滴加丁胺13.0g(0.18莫耳)。滴加完成後,在室溫下攪拌一夜。用5%鹽酸180mL進行中和並分液後,將有機層用食鹽水180mL洗滌2次。餾去溶劑,藉由快速(flash)管柱層析(精製劑:矽膠、洗提液:二氯甲烷)進行精製。藉由乾燥所得到的固體而獲得式(H-2)表示的化合物18.3g。 A reaction vessel having a stirring device and a thermometer was charged with 39.0 g (0.12 mol) of a compound represented by the formula (H-1), 80 mL of toluene, and 80 mL of tetrahydrofuran. While stirring, 13.0 g (0.18 mol) of butylamine was added dropwise. After the dropwise addition was completed, the mixture was stirred at room temperature overnight. After neutralization and separation with 180 mL of 5% hydrochloric acid, the organic layer was washed twice with 180 mL of brine. The solvent was distilled off, and purification was performed by flash column chromatography (refining agent: silica gel, eluent: dichloromethane). 18.3 g of a compound represented by the formula (H-2) was obtained by drying the obtained solid.

於具有攪拌裝置及溫度計的反應容器中加入式(H-2)表示的化合物18.3g(0.064莫耳)、6-(3-丙烯醯氧基-丙氧基)-2-萘甲酸21.0g(0.071莫耳)、N,N-二甲基胺基吡啶0.4g(3.2毫莫耳)及二氯甲 烷105mL,一邊用冰冷卻一邊進行攪拌。將反應液的溫度保持在15℃以下的同時滴加N,N’-二異丙基碳化二亞胺9.7g(0.077莫耳)。滴加完成後,在室溫下攪拌6小時進行反應。過濾反應液並除去析出物後,餾去溶劑。使得到的固體物溶解於二氯甲烷,藉由管柱層析(精製劑:矽膠40g、洗提液:二氯甲烷360mL)進行精製後,餾去溶劑。將得到的固體物由二氯甲烷45mL及甲醇135mL的混合溶劑進行2次再結晶後,藉由進行乾燥而得到式(I-13)表示的化合物30.5g。 In a reaction vessel having a stirring device and a thermometer, 18.3 g (0.064 mol) of a compound represented by formula (H-2) and 21.0 g of 6- (3-propenyloxy-propoxy) -2-naphthoic acid ( 0.071 mole), N, N-dimethylaminopyridine 0.4 g (3.2 mmol) and dichloromethane 105 mL of alkane was stirred while cooling with ice. While maintaining the temperature of the reaction solution at 15 ° C or lower, 9.7 g (0.077 mol) of N, N'-diisopropylcarbodiimide was added dropwise. After completion of the dropwise addition, the reaction was carried out by stirring at room temperature for 6 hours. The reaction solution was filtered to remove precipitates, and then the solvent was distilled off. The obtained solid was dissolved in dichloromethane and purified by column chromatography (refined preparation: 40 g of silica gel, eluent: 360 mL of dichloromethane), and then the solvent was distilled off. The obtained solid was recrystallized twice from a mixed solvent of 45 mL of methylene chloride and 135 mL of methanol, and then dried to obtain 30.5 g of a compound represented by the formula (I-13).

(式(I-13)表示的化合物的物性值) (Physical properties of the compound represented by formula (I-13))

1H NMR(CDCl3)δ 1.99(五重峰,2H),3.73(s,3H),4.04(t,2H),4.15(t,2H),5.80(dd,1H),6.05(dd,1H),6.43(dd,1H),6.97(s,1H),7.04(s,1H),7.04(d,1H),7.10(d,1H),7.19(d,1H),7.56(d,1H),7.60(d,1H),7.72(s,1H),7.75(d,1H),7.77(d,1H),8.20(d,1H),8.52(s,1H)ppm。 1 H NMR (CDCl 3 ) δ 1.99 (quintet, 2H), 3.73 (s, 3H), 4.04 (t, 2H), 4.15 (t, 2H), 5.80 (dd, 1H), 6.05 (dd, 1H) ), 6.43 (dd, 1H), 6.97 (s, 1H), 7.04 (s, 1H), 7.04 (d, 1H), 7.10 (d, 1H), 7.19 (d, 1H), 7.56 (d, 1H) , 7.60 (d, 1H), 7.72 (s, 1H), 7.75 (d, 1H), 7.77 (d, 1H), 8.20 (d, 1H), 8.52 (s, 1H) ppm.

13C NMR(CDCl3)δ 30.3,56.0,63.1,68.5,96.3,105.5,109.1,116.1,116.5,117.7,119.7,122.3,122.8,125.8,126.1,127.0,128.0,128.4,128.6,130.3,130.4,130.8,134.0,136.1,143.9,154.8,159.0,160.1,164.0,164.0,165.0,166.0ppm。 13 C NMR (CDCl 3 ) δ 30.3, 56.0, 63.1, 68.5, 96.3, 105.5, 109.1, 116.1, 116.5, 117.7, 119.7, 122.3, 122.8, 125.8, 126.1, 127.0, 128.0, 128.4, 128.6, 130.3, 130.4, 130.8, 134.0, 136.1, 143.9, 154.8, 159.0, 160.1, 164.0, 164.0, 165.0, 166.0 ppm.

LRMS(EI)m/z 569(100)。 LRMS (EI) m / z 569 (100).

(實施例9)式(I-14)表示的化合物的製造 (Example 9) Production of compound represented by formula (I-14)

於具有攪拌裝置、冷卻器及溫度計的反應容器中加入2-氟-4-羥基苯甲酸(式(J-1)表示的化合物)50.0g(0.32莫耳)、醋酸150mL、醋酸酐39.2g(0.38莫耳)及硫酸2.5g,加熱至60℃進行10小時反應。於反應液中加入水1L,一邊用冰冷卻一邊攪拌1小時後,過 濾析出的固體。將得到的固體用水1L再進行分散洗滌。藉由乾燥固體而得到式(J-2)表示的化合物60.9g。 In a reaction vessel having a stirring device, a cooler, and a thermometer, 50.0 g (0.32 mole) of 2-fluoro-4-hydroxybenzoic acid (a compound represented by the formula (J-1)), 150 mL of acetic acid, and 39.2 g of acetic anhydride ( 0.38 mole) and 2.5 g of sulfuric acid, and the mixture was heated to 60 ° C for 10 hours for reaction. 1 L of water was added to the reaction solution, and the mixture was stirred for 1 hour while cooling with ice. The precipitated solid was filtered. The obtained solid was washed with 1 L of water. 60.9 g of a compound represented by the formula (J-2) was obtained by drying the solid.

於具有攪拌裝置及溫度計的反應容器中加入式(J-2)表示的化合物60.9g(0.31莫耳)、4-氟苯酚31.3g(0.28莫耳)、N,N-二甲基胺基吡啶1.7g(14毫莫耳)及二氯甲烷300mL,一邊用冰冷卻一邊進行攪拌。將反應液的溫度保持在15℃以下的同時滴加N,N’-二異丙基碳化二亞胺42.3g(0.34莫耳)。滴加完成後,在室溫下攪拌5小時進行反應。過濾反應液並除去析出物後,餾去溶劑。使得到的固體物溶解於二氯甲烷,藉由管柱層析(精製劑:矽膠100g、洗提液:二氯甲烷1L)進行精製後,餾去溶劑。將得到的固體物用甲醇240mL進行分散洗滌後,藉由進行乾燥而得到式(J-3)表示的化合物81.5g。 In a reaction vessel having a stirring device and a thermometer, 60.9 g (0.31 mole) of a compound represented by the formula (J-2), 31.3 g (0.28 mole) of 4-fluorophenol, and N, N-dimethylaminopyridine were added. 1.7 g (14 mmol) and 300 mL of dichloromethane were stirred while cooling with ice. While maintaining the temperature of the reaction solution at 15 ° C or lower, 42.3 g (0.34 mol) of N, N'-diisopropylcarbodiimide was added dropwise. After completion of the dropwise addition, the reaction was carried out by stirring at room temperature for 5 hours. The reaction solution was filtered to remove precipitates, and then the solvent was distilled off. The obtained solid was dissolved in dichloromethane and purified by column chromatography (refined preparation: 100 g of silica gel, eluent: 1L of dichloromethane), and then the solvent was distilled off. The obtained solid matter was dispersed and washed with 240 mL of methanol, and then dried to obtain 81.5 g of a compound represented by the formula (J-3).

於具有攪拌裝置及溫度計的反應容器中加入式(J-3)表示的化合物81.5g(0.28莫耳)、甲苯240mL及四氫呋喃240mL。一邊攪拌一邊滴加丁胺30.6g(0.42莫耳)。滴加完成後,在室溫下攪拌一夜。用5%鹽酸240mL進行中和並分液後,將有機層用食鹽水480mL洗滌2次。餾去溶劑,藉由快速管柱層析(精製劑:矽膠、洗提液:二氯甲烷)進行精製。藉由乾燥所得到的固體而獲得式(J-4)表示的化合物25.1g。 A reaction vessel having a stirring device and a thermometer was charged with 81.5 g (0.28 mol) of a compound represented by formula (J-3), 240 mL of toluene, and 240 mL of tetrahydrofuran. While stirring, 30.6 g (0.42 mole) of butylamine was added dropwise. After the dropwise addition was completed, the mixture was stirred at room temperature overnight. After neutralizing and separating with 240 mL of 5% hydrochloric acid, the organic layer was washed twice with 480 mL of brine. The solvent was distilled off, and purification was performed by flash column chromatography (refining agent: silica gel, eluent: dichloromethane). 25.1 g of a compound represented by the formula (J-4) was obtained by drying the obtained solid.

於具有攪拌裝置及溫度計的反應容器中加入式(J-4)表示的化合物25.1g(0.10莫耳)、6-(6-丙烯醯氧基己氧基)-2-萘甲酸37.7g(0.11莫耳)、N,N-二甲基胺基吡啶0.61g(5.0毫莫耳)及二氯甲烷180mL,一邊用冰冷卻一邊進行攪拌。將反應液的溫度保持在15℃以下的同時滴加N,N’-二異丙基碳化二亞胺15.1g(0.12莫耳)。滴加完成後,在室溫下攪拌6小時進行反應。過濾反應液並除去析出物後,餾去溶劑。使得到的固體物溶解於二氯甲烷,藉由管柱層析(精製劑:矽膠60g、洗提液:二氯甲烷600mL)進行精製後,餾去溶劑。將得到的固體物由二氯甲烷60mL及甲醇120mL的混合溶劑進行2次再結晶後,藉由進行乾燥而得到式(I-14)表示的化合物50.6g。 A reaction vessel with a stirring device and a thermometer was charged with 25.1 g (0.10 mol) of a compound represented by formula (J-4) and 37.7 g (0.11 Mol), 0.61 g (5.0 mmol) of N, N-dimethylaminopyridine, and 180 mL of dichloromethane, and stirred while cooling with ice. 15.1 g (0.12 mole) of N, N'-diisopropylcarbodiimide was added dropwise while maintaining the temperature of the reaction solution at 15 ° C or lower. After completion of the dropwise addition, the reaction was carried out by stirring at room temperature for 6 hours. The reaction solution was filtered to remove precipitates, and then the solvent was distilled off. The obtained solid was dissolved in dichloromethane and purified by column chromatography (refined preparation: 60 g of silica gel, eluent: 600 mL of dichloromethane), and then the solvent was distilled off. The obtained solid was recrystallized twice from a mixed solvent of 60 mL of dichloromethane and 120 mL of methanol, and then dried to obtain 50.6 g of a compound represented by the formula (I-14).

(式(I-14)表示的化合物的物性值) (Physical properties of the compound represented by formula (I-14))

1H NMR(CDCl3)δ 1.29(五重峰,4H),1.57(五重峰,2H),1.71(五重峰,2H),4.04(t,2H),4.15(t,2H),5.80(dd,1H),6.05(dd,1H),6.43(dd,1H),6.97(s,1H),7.04(m,3H),7.13(d,2H),7.28(d,1H),7.60(d,1H),7.75(d,1H),7.92(s,1H),7.98(d,1H),8.20(d,1H),8.52(s,1H)ppm。 1 H NMR (CDCl 3 ) δ 1.29 (quintet, 4H), 1.57 (quintet, 2H), 1.71 (quintet, 2H), 4.04 (t, 2H), 4.15 (t, 2H), 5.80 (dd, 1H), 6.05 (dd, 1H), 6.43 (dd, 1H), 6.97 (s, 1H), 7.04 (m, 3H), 7.13 (d, 2H), 7.28 (d, 1H), 7.60 ( d, 1H), 7.75 (d, 1H), 7.92 (s, 1H), 7.98 (d, 1H), 8.20 (d, 1H), 8.52 (s, 1H) ppm.

13C NMR(CDCl3)δ 26.3,26.5,30.0,30.6,66.8,72.3,105.5,115.9,115.9,117.5,119.7,122.9,123.0,123.0,125.8,126.1,126.1,127.0,128.0,128.6,129.0,130.3,130.4,130.8,136.1,145.3,148.7,154.9,158.9,160.1,164.0,164.0,165.0ppm。 13 C NMR (CDCl 3 ) δ 26.3, 26.5, 30.0, 30.6, 66.8, 72.3, 105.5, 115.9, 115.9, 117.5, 119.7, 122.9, 123.0, 123.0, 125.8, 126.1, 126.1, 127.0, 128.0, 128.6, 129.0, 130.3, 130.4, 130.8, 136.1, 145.3, 148.7, 154.9, 158.9, 160.1, 164.0, 164.0, 165.0 ppm.

LRMS(EI)m/z 574(100)。 LRMS (EI) m / z 574 (100).

(實施例10) (Example 10) 式(I-2)表示的化合物的製造 Production of compound represented by formula (I-2)

在實施例9中,將4-氟苯酚替換成對甲酚,除此以外,藉由同樣的方法來製造式(I-2)表示的化合物。 In Example 9, except having replaced 4-fluorophenol with p-cresol, the compound represented by formula (I-2) was produced by the same method.

(式(I-2)表示的化合物的物性值) (Physical property value of the compound represented by formula (I-2))

1H NMR(CDCl3)δ 1.43(m,4H),1.62(t,2H),1.76(t,2H),2.34(s,3H),3.97(t,2H),4.16(t,2H),5.59(dd,1H),6.05(dd,1H),6.27(dd,1H),7.23(d,1H),7.25(d,2H),7.30(d,2H),7.39(s,1H),7.50(d,1H),7.87(d,1H),7.88(d,1H),7.93(d,1H),8.06(d,1H),8.32(d,1H),8.64(s,1H)ppm。 1 H NMR (CDCl 3 ) δ 1.43 (m, 4H), 1.62 (t, 2H), 1.76 (t, 2H), 2.34 (s, 3H), 3.97 (t, 2H), 4.16 (t, 2H), 5.59 (dd, 1H), 6.05 (dd, 1H), 6.27 (dd, 1H), 7.23 (d, 1H), 7.25 (d, 2H), 7.30 (d, 2H), 7.39 (s, 1H), 7.50 (d, 1H), 7.87 (d, 1H), 7.88 (d, 1H), 7.93 (d, 1H), 8.06 (d, 1H), 8.32 (d, 1H), 8.64 (s, 1H) ppm.

13C NMR(CDCl3)δ 21.3,25.6,25.8,29.0,29.6,65.3,68.7,108.2,117.8,118.8,121.5,121.5,123.1,126.3,126.3,126.4,127.1,128.2,128.2,128.6,129.4,129.4,130.1,130.9,131.3,135.2,141.0,142.8,146.4,153.7,158.0,165.2,165.2,166.5ppm。 13 C NMR (CDCl 3 ) δ 21.3, 25.6, 25.8, 29.0, 29.6, 65.3, 68.7, 108.2, 117.8, 118.8, 121.5, 121.5, 123.1, 126.3, 126.3, 126.4, 127.1, 128.2, 128.2, 128.6, 129.4, 129.4, 130.1, 130.9, 131.3, 135.2, 141.0, 142.8, 146.4, 153.7, 158.0, 165.2, 165.2, 166.5 ppm.

LRMS(EI)m/z 570(100)。 LRMS (EI) m / z 570 (100).

(實施例11) (Example 11) 式(I-4)表示的化合物的製造 Production of compound represented by formula (I-4)

在實施例2中,將式(A-5)表示的化合物替換成式(I-4-1)表示的化合物,除此以外,藉由同樣的方法來製造式(I-4)表示的化合物。 In Example 2, the compound represented by formula (I-4) was produced by the same method except that the compound represented by formula (A-5) was replaced with a compound represented by formula (I-4-1). .

(式(I-4)表示的化合物的物性值) (Physical properties of the compound represented by formula (I-4))

1H NMR(CDCl3)δ 2.11(五重峰,2H),2.34(s,3H),3.83(s,3H),4.20(d,2H),4.39(d,2H),5.59(dd,1H),6.05(dd,1H),6.27(dd,1H),7.03(d,1H),7.25(d,2H),7.30(d,2H),7.41(d,1H),7.58(d,1H),7.84(s,1H),7.85(d,1H),7.99(d,1H),8.16(d,1H),8.49(d,1H)ppm。 1 H NMR (CDCl 3 ) δ 2.11 (quintet, 2H), 2.34 (s, 3H), 3.83 (s, 3H), 4.20 (d, 2H), 4.39 (d, 2H), 5.59 (dd, 1H ), 6.05 (dd, 1H), 6.27 (dd, 1H), 7.03 (d, 1H), 7.25 (d, 2H), 7.30 (d, 2H), 7.41 (d, 1H), 7.58 (d, 1H) , 7.84 (s, 1H), 7.85 (d, 1H), 7.99 (d, 1H), 8.16 (d, 1H), 8.49 (d, 1H) ppm.

13C NMR(CDCl3)δ 21.3,28.4,55.8,61.6,64.9,113.7,120.2,120.5,121.5,121.5,123.0,124.4,120.6,126.4,127.3,127.3,128.0,128.2,129.4,129.4,130.2,131.3,131.6,135.2,137.0,143.6,144.0,146.4,151.5,165.2,165.2,166.5ppm。 13 C NMR (CDCl 3 ) δ 21.3, 28.4, 55.8, 61.6, 64.9, 113.7, 120.2, 120.5, 121.5, 121.5, 123.0, 124.4, 120.6, 126.4, 127.3, 127.3, 128.0, 128.2, 129.4, 129.4, 130.2, 131.3, 131.6, 135.2, 137.0, 143.6, 144.0, 146.4, 151.5, 165.2, 165.2, 166.5 ppm.

LRMS(EI)m/z 558(100)。 LRMS (EI) m / z 558 (100).

(實施例12) (Example 12) 式(I-5)表示的化合物的製造 Production of compound represented by formula (I-5)

於具有攪拌裝置及溫度計的反應容器中加入式(D-4)表示的化合物25.0g(0.095莫耳)、4-乙醯氧基苯甲酸17.1g(0.095莫耳)、N,N- 二甲基胺基吡啶0.6g(5.2毫莫耳)及二氯甲烷125mL,一邊用冰冷卻一邊進行攪拌。將反應液的溫度保持在15℃以下的同時滴加N,N’-二異丙基碳化二亞胺14.4g(0.11莫耳)。滴加完成後,在室溫下攪拌5小時進行反應。過濾反應液並除去析出物後,餾去溶劑。使得到的固體物溶解於二氯甲烷,藉由管柱層析(精製劑:矽膠32g、洗提液:二氯甲烷256mL)進行精製後,餾去溶劑。將得到的固體物用甲醇96mL進行分散洗滌後,藉由進行乾燥而得到式(K-1)表示的化合物32.3g。 In a reaction vessel having a stirring device and a thermometer, 25.0 g (0.095 mol) of a compound represented by the formula (D-4), 17.1 g (0.095 mol) of 4-ethoxybenzoic acid, and N, N- 0.6 g (5.2 mmol) of dimethylaminopyridine and 125 mL of dichloromethane were stirred while cooling with ice. While maintaining the temperature of the reaction solution at 15 ° C or lower, 14.4 g (0.11 mole) of N, N'-diisopropylcarbodiimide was added dropwise. After completion of the dropwise addition, the reaction was carried out by stirring at room temperature for 5 hours. The reaction solution was filtered to remove precipitates, and then the solvent was distilled off. The obtained solid was dissolved in dichloromethane and purified by column chromatography (refined preparation: 32 g of silica gel, eluent: 256 mL of dichloromethane), and then the solvent was distilled off. The obtained solid matter was dispersedly washed with 96 mL of methanol, and then dried to obtain 32.3 g of a compound represented by the formula (K-1).

於具有攪拌裝置及溫度計的反應容器中加入式(K-1)表示的化合物32.3g(0.076莫耳)、甲苯64mL及四氫呋喃64mL。一邊攪拌一邊滴加丁胺6.68g(0.091莫耳)。滴加完成後,在室溫下攪拌一夜。用5%鹽酸150mL進行中和並分液後,將有機層用食鹽水150mL洗滌2次。餾去溶劑,將得到的油狀物質由甲醇64mL和水64mL的混合溶劑進行再結晶。藉由乾燥所得到的固體而獲得式(K-2)表示的化合物28.3g。 A reaction vessel having a stirring device and a thermometer was charged with 32.3 g (0.076 mol) of a compound represented by formula (K-1), 64 mL of toluene, and 64 mL of tetrahydrofuran. While stirring, 6.68 g (0.091 mol) of butylamine was added dropwise. After the dropwise addition was completed, the mixture was stirred at room temperature overnight. After neutralization and separation with 150 mL of 5% hydrochloric acid, the organic layer was washed twice with 150 mL of saline. The solvent was distilled off, and the obtained oily substance was recrystallized from a mixed solvent of 64 mL of methanol and 64 mL of water. 28.3 g of a compound represented by the formula (K-2) was obtained by drying the obtained solid.

於具有攪拌裝置及溫度計的反應容器中加入式(K-2)表示的化合物28.3g(0.074莫耳)、式(A-5)表示的化合物22.2g(0.074莫耳)、N,N-二甲基胺基吡啶0.55g(4.5毫莫耳)及二氯甲烷150mL,一邊用冰冷卻一邊進行攪拌。將反應液的溫度保持在15℃以下的同時滴加N,N’-二異丙基碳化二亞胺13.7g(0.11莫耳)。滴加完成後,在室溫下攪拌6小時進行反應。過濾反應液並除去析出物後,餾去溶劑。使得到的固體物溶解於二氯甲烷,藉由管柱層析(精製劑:矽膠49g、洗提液:二氯甲烷392mL)進行精製後,餾去溶劑。將得到的固體物由二氯甲烷49mL及甲醇147mL的混合溶劑進行2次再結晶後,藉由進行乾燥而得到式(I-5)表示的化合物39.3g。 In a reaction vessel having a stirring device and a thermometer, 28.3 g (0.074 moles) of a compound represented by formula (K-2), 22.2 g (0.074 moles) of a compound represented by formula (A-5), and N, N-di 0.55 g (4.5 mmol) of methylaminopyridine and 150 mL of dichloromethane were stirred while cooling with ice. While maintaining the temperature of the reaction solution at 15 ° C or lower, 13.7 g (0.11 mole) of N, N'-diisopropylcarbodiimide was added dropwise. After completion of the dropwise addition, the reaction was carried out by stirring at room temperature for 6 hours. The reaction solution was filtered to remove precipitates, and then the solvent was distilled off. The obtained solid was dissolved in dichloromethane and purified by column chromatography (refined preparation: 49 g of silica gel, eluent: 392 mL of dichloromethane), and then the solvent was distilled off. The obtained solid was recrystallized twice from a mixed solvent of 49 mL of dichloromethane and 147 mL of methanol, and then dried to obtain 39.3 g of a compound represented by the formula (I-5).

(式(I-5)表示的化合物的物性值) (Physical properties of the compound represented by formula (I-5))

1H NMR(CDCl3)δ 2.11(五重峰,2H),2.34(s,3H),4.20(t,2H),4.39(t,2H),5.59(dd,1H),6.05(dd,1H),6.27(dd,1H),7.23(d,1H),7.25(d,2H),7.30(d,2H),7.39(s,1H),7.46(d,1H),7.52(d,2H),7.88(d,1H),7.93(d,1H),8.17(d,1H),8.21(s, 1H),8.32(d,1H),8.64(s,1H)ppm。 1 H NMR (CDCl 3 ) δ 2.11 (quintet, 2H), 2.34 (s, 3H), 4.20 (t, 2H), 4.39 (t, 2H), 5.59 (dd, 1H), 6.05 (dd, 1H) ), 6.27 (dd, 1H), 7.23 (d, 1H), 7.25 (d, 2H), 7.30 (d, 2H), 7.39 (s, 1H), 7.46 (d, 1H), 7.52 (d, 2H) , 7.88 (d, 1H), 7.93 (d, 1H), 8.17 (d, 1H), 8.21 (s, 1H), 8.32 (d, 1H), 8.64 (s, 1H) ppm.

13C NMR(CDCl3)δ 21.3,28.4,61.6,64.9,108.2,117.8,121.5,121.5,121.5,121.5,122.9,126.3,126.4,127.0,127.1,128.2,128.2,128.4,128.8,129.4,129.4,129.8,130.1,130.7,130.7,130.9,131.3,132.0,135.2,141.0,146.4,152.6,154.6,158.0,165.2,165.2,165.2,166.5ppm。 13 C NMR (CDCl 3 ) δ 21.3, 28.4, 61.6, 64.9, 108.2, 117.8, 121.5, 121.5, 121.5, 121.5, 122.9, 122.9, 126.3, 126.4, 127.0, 127.1, 128.2, 128.2, 128.4, 128.8, 129.4, 129.4, 129.8, 130.1, 130.7, 130.7, 130.9, 131.3, 132.0, 135.2, 141.0, 146.4, 152.6, 154.6, 158.0, 165.2, 165.2, 165.2, 166.5 ppm.

LRMS(EI)m/z 665(100),667(30)。 LRMS (EI) m / z 665 (100), 667 (30).

(實施例13) (Example 13) 式(I-6)表示的化合物的製造 Production of compound represented by formula (I-6)

在實施例12中,將3-氯-4-羥基苯甲酸替換成4-羥基苯甲酸、對甲酚替換成反式-4-丙基環己醇、4-乙醯氧基苯甲酸替換成3-氟-4-乙醯氧基苯甲酸、式(A-5)表示的化合物替換成式(L-5)表示的化合物,除此以外,藉由同樣的方法來製造式(I-6)表示的化合物。 In Example 12, 3-chloro-4-hydroxybenzoic acid was replaced with 4-hydroxybenzoic acid, p-cresol was replaced with trans-4-propylcyclohexanol, and 4-acetoxybenzoic acid was replaced with 3-Fluoro-4-ethoxybenzoic acid and the compound represented by the formula (A-5) were replaced with the compound represented by the formula (L-5), and the formula (I-6) was produced by the same method. ).

(式(I-6)表示的化合物的物性值) (Physical property value of the compound represented by formula (I-6))

1H NMR(CDCl3)δ 0.90(t,3H),1.25(q,2H),1.43-1.99(m,18H),2.00(五重峰,2H),2.87(五重峰,2H),3.21(dd,1H),3.37(t,2H),3.46(dd,1H),3.91(五重峰,1H),4.39(d,2H),7.23(d,1H),7.39(s,1H),7.48(d,2H),7.50(d,1H),7.87(d,1H),7.88(d,1H),7.93(d,1H),8.06(d,1H),8.14(d,2H),8.32(d,1H),8.64(s,1H)ppm。 1 H NMR (CDCl 3 ) δ 0.90 (t, 3H), 1.25 (q, 2H), 1.43-1.99 (m, 18H), 2.00 (quintet, 2H), 2.87 (quintet, 2H), 3.21 (dd, 1H), 3.37 (t, 2H), 3.46 (dd, 1H), 3.91 (quintet, 1H), 4.39 (d, 2H), 7.23 (d, 1H), 7.39 (s, 1H), 7.48 (d, 2H), 7.50 (d, 1H), 7.87 (d, 1H), 7.88 (d, 1H), 7.93 (d, 1H), 8.06 (d, 1H), 8.14 (d, 2H), 8.32 (d, 1H), 8.64 (s, 1H) ppm.

13C NMR(CDCl3)δ 14.4,20.5,21.3,25.8,29.0,29.4,29.7,29.7,31.0,31.0,32.3,34.7,37.1,52.0,62.0,65.0,69.0,70.9, 77.9,108.2,117.8,118.8,121.5,121.5,123.1,126.3,126.3,126.4,126.9,127.1,128.2,128.6,130.1,130.3,130.3,130.9,141.0,142.8,153.7,153.7,158.0,165.2,165.2,165.9ppm。 13 C NMR (CDCl 3 ) δ 14.4, 20.5, 21.3, 25.8, 29.0, 29.4, 29.7, 29.7, 31.0, 31.0, 32.3, 34.7, 37.1, 52.0, 62.0, 65.0, 69.0, 70.9, 77.9, 108.2, 117.8, 118.8, 121.5, 121.5, 123.1, 126.3, 126.3, 126.4, 126.9, 127.1, 128.2, 128.6, 130.1, 130.3, 130.3, 130.9, 141.0, 142.8, 153.7, 153.7, 158.0, 165.2, 165.2, 165.9 ppm.

LRMS(EI)m/z 738(100)。 LRMS (EI) m / z 738 (100).

(實施例14) (Example 14) 式(I-19)表示的化合物的製造 Production of compound represented by formula (I-19)

在具有攪拌裝置的燒瓶中加入氯氫醌20.0g(0.14莫耳)、對甲苯磺酸吡啶鎓1.74g(6.9毫莫耳),並溶解於二氯甲烷60mL。一邊用冰冷卻一邊滴加3,4-二氫-2H-吡喃17.5g(0.17莫耳)。反應完成後,利用管柱層析進行精製,得到式(M-1)表示的化合物20.5g。 In a flask equipped with a stirring device, 20.0 g (0.14 mol) of chlorohydroquinone and 1.74 g (6.9 mmol) of pyridinium p-toluenesulfonate were added and dissolved in 60 mL of dichloromethane. While cooling with ice, 17.5 g (0.17 mole) of 3,4-dihydro-2H-pyran was added dropwise. After completion of the reaction, purification was performed by column chromatography to obtain 20.5 g of a compound represented by the formula (M-1).

在具有溫度計及攪拌裝置的燒瓶中加入式(M-1)表示的化合物20.5g(0.090莫耳)、4-丙基苯甲醇13.5g(0.090莫耳)、三苯基膦28.3g(0.11莫耳),並溶解於二氯甲烷80mL。一邊用冰冷卻一邊以不超過15℃的方式滴加偶氮二羧酸二異丙酯21.8g(0.11莫耳)。在室溫下攪拌5小時後,利用管柱層析進行精製,得到式(M-2)表示的化合物28.6g。 A flask with a thermometer and a stirring device was charged with 20.5 g (0.090 mole) of the compound represented by formula (M-1), 13.5 g (0.090 mole) of 4-propylbenzyl alcohol, and 28.3 g (0.11 mole) of triphenylphosphine Ear) and dissolved in 80 mL of dichloromethane. While cooling with ice, 21.8 g (0.11 mole) of diisopropyl azodicarboxylate was added dropwise so as not to exceed 15 ° C. After stirring at room temperature for 5 hours, purification was performed by column chromatography to obtain 28.6 g of a compound represented by the formula (M-2).

在燒瓶中加入式(M-2)表示的化合物28.6g(0.079莫耳)並溶解於四氫呋喃50mL及甲醇50mL。加入濃鹽酸0.5mL並在室溫下攪拌10小時。進行分液處理後,利用管柱層析進行精製,得到式(M-3)表示的化合物21.6g。 28.6 g (0.079 mol) of the compound represented by the formula (M-2) was added to a flask, and dissolved in 50 mL of tetrahydrofuran and 50 mL of methanol. 0.5 mL of concentrated hydrochloric acid was added and stirred at room temperature for 10 hours. After liquid separation treatment, purification was performed by column chromatography to obtain 21.6 g of a compound represented by the formula (M-3).

於具有攪拌裝置及溫度計的反應容器中加入式(M-3)表示的化合物21.6g(0.078莫耳)、式(M-4)表示的化合物24.9g(0.078莫耳)、N,N-二甲基胺基吡啶0.55g(4.5毫莫耳)及二氯甲烷150mL,一邊用冰冷卻一邊進行攪拌。將反應液的溫度保持在15℃以下的同時滴加N,N’-二異丙基碳化二亞胺11.9g(0.094莫耳)。滴加完成 後,在室溫下攪拌6小時進行反應。過濾反應液並除去析出物後,餾去溶劑。使得到的固體物溶解於二氯甲烷,利用管柱層析進行精製後,由二氯甲烷及甲醇的混合溶劑進行2次再結晶後,藉由進行乾燥而得到式(I-19)表示的化合物36.1g。 In a reaction vessel having a stirring device and a thermometer, 21.6 g (0.078 moles) of a compound represented by formula (M-3), 24.9 g (0.078 moles) of a compound represented by formula (M-4), and N, N-di 0.55 g (4.5 mmol) of methylaminopyridine and 150 mL of dichloromethane were stirred while cooling with ice. While maintaining the temperature of the reaction solution at 15 ° C or lower, 11.9 g (0.094 mol) of N, N'-diisopropylcarbodiimide was added dropwise. Addition completed Then, it stirred at room temperature for 6 hours and reacted. The reaction solution was filtered to remove precipitates, and then the solvent was distilled off. The obtained solid was dissolved in dichloromethane, purified by column chromatography, and recrystallized twice from a mixed solvent of dichloromethane and methanol, and then dried to obtain a formula (I-19) Compound 36.1 g.

(式(I-19)表示的化合物的物性值) (Physical properties of the compound represented by formula (I-19))

1H NMR(CDCl3)δ 0.90(t,3H),1.65(六重峰(sextet),2H),2.11(五重峰,2H),2.62(t,2H),4.20(t,2H),4.39(t,2H),5.16(s,2H),5.59(dd,1H),6.05(dd,1H),6.27(dd,1H),7.00(d,1H),7.03(d,1H),7.14(d,1H),7.18(d,2H),7.38(d,2H),7.46(d,1H),7.58(d,1H),7.99(d,1H),8.16(d,1H),8.49(d,1H)ppm。 1 H NMR (CDCl 3 ) δ 0.90 (t, 3H), 1.65 (sexet, 2H), 2.11 (quintet, 2H), 2.62 (t, 2H), 4.20 (t, 2H), 4.39 (t, 2H), 5.16 (s, 2H), 5.59 (dd, 1H), 6.05 (dd, 1H), 6.27 (dd, 1H), 7.00 (d, 1H), 7.03 (d, 1H), 7.14 (d, 1H), 7.18 (d, 2H), 7.38 (d, 2H), 7.46 (d, 1H), 7.58 (d, 1H), 7.99 (d, 1H), 8.16 (d, 1H), 8.49 ( d, 1H) ppm.

13C NMR(CDCl3)δ 13.7,24.1,28.4,37.9,61.6,64.9,70.3,116.1,120.2,120.5,120.7,123.0,123.4,126.0,126.4,127.2,127.2,127.3,127.3,128.2,128.3,128.3,130.2,131.3,131.6,134.0,137.0,140.9,144.0,145.0,151.4,165.2,166.5ppm。 13 C NMR (CDCl 3 ) δ 13.7, 24.1, 28.4, 37.9, 61.6, 64.9, 70.3, 116.1, 120.2, 120.5, 120.7, 123.0, 123.4, 126.0, 126.4, 127.2, 127.2, 127.3, 127.3, 128.2, 128.3, 128.3, 130.2, 131.3, 131.6, 134.0, 137.0, 140.9, 144.0, 145.0, 151.4, 165.2, 166.5 ppm.

LRMS(EI)m/z 577(100),579(30)。 LRMS (EI) m / z 577 (100), 579 (30).

(實施例15) (Example 15) 式(I-28)表示的化合物的製造 Production of compound represented by formula (I-28)

在具有溫度計及攪拌裝置的反應容器中加入4-乙醯氧基苯甲酸10.0g(0.056莫耳)、甲基氫醌3.45g(0.028莫耳)、N,N-二甲基胺基吡啶0.34g(2.8毫莫耳)及二氯甲烷150mL,一邊用冰冷卻一邊進行攪拌。將反應液的溫度保持在15℃以下的同時滴加N,N’-二異丙基碳化二亞胺7.71g(0.061莫耳)。滴加完成後,在室溫下攪拌6小時進行反應。過濾反應液並除去析出物後,餾去溶劑。使得到 的固體物溶解於二氯甲烷,利用管柱層析進行精製後,由二氯甲烷及甲醇的混合溶劑進行2次再結晶後,藉由進行乾燥而得到式(N-1)表示的化合物9.96g。 In a reaction vessel with a thermometer and a stirring device, add 10.0 g (0.056 mole) of 4-acetoxybenzoic acid, 3.45 g (0.028 mole) of methylhydroquinone, and 0.34 of N, N-dimethylaminopyridine. g (2.8 mmol) and 150 mL of dichloromethane, and stirred while cooling with ice. While maintaining the temperature of the reaction solution at 15 ° C or lower, 7.71 g (0.061 mol) of N, N'-diisopropylcarbodiimide was added dropwise. After completion of the dropwise addition, the reaction was carried out by stirring at room temperature for 6 hours. The reaction solution was filtered to remove precipitates, and then the solvent was distilled off. Make it to The solid substance was dissolved in dichloromethane, purified by column chromatography, and recrystallized twice from a mixed solvent of dichloromethane and methanol, and then dried to obtain a compound represented by formula (N-1) 9.96 g.

於具有攪拌裝置及溫度計的反應容器中加入式(N-1)表示的化合物9.96g(0.022莫耳)、甲苯50mL及四氫呋喃50mL。一邊攪拌一邊滴加丁胺3.57g(0.061莫耳)。滴加完成後,在室溫下攪拌一夜。用5%鹽酸進行中和並分液後,利用管柱層析進行精製。藉由乾燥所得到的固體而獲得式(N-2)表示的化合物9.61g。 A reaction vessel having a stirring device and a thermometer was charged with 9.96 g (0.022 mol) of a compound represented by the formula (N-1), 50 mL of toluene, and 50 mL of tetrahydrofuran. 3.57 g (0.061 mole) of butylamine was added dropwise while stirring. After the dropwise addition was completed, the mixture was stirred at room temperature overnight. After neutralization and liquid separation with 5% hydrochloric acid, purification was performed by column chromatography. By drying the obtained solid, 9.61 g of a compound represented by the formula (N-2) was obtained.

於具有攪拌裝置及溫度計的反應容器中加入式(N-2)表示的化合物9.61g(0.026莫耳)、式(A-5)表示的化合物15.8g(0.053莫耳)、N,N-二甲基胺基吡啶0.32g(2.6毫莫耳)及二氯甲烷100mL,一邊用冰冷卻一邊進行攪拌。將反應液的溫度保持在15℃以下的同時滴加N,N’-二異丙基碳化二亞胺7.32g(0.058莫耳)。滴加完成後,在室溫下攪拌6小時進行反應。過濾反應液並除去析出物後,餾去溶劑。使得到的固體物溶解於二氯甲烷,利用管柱層析進行精製後,由二氯甲烷及甲醇的混合溶劑進行2次再結晶後,藉由進行乾燥而得到式(I-28)表示的化合物19.6g。 In a reaction vessel having a stirring device and a thermometer, 9.61 g (0.026 moles) of a compound represented by formula (N-2), 15.8 g (0.053 moles) of a compound represented by formula (A-5), and N, N-di 0.32 g (2.6 mmol) of methylaminopyridine and 100 mL of dichloromethane were stirred while cooling with ice. While maintaining the temperature of the reaction solution at 15 ° C or lower, 7.32 g (0.058 mol) of N, N'-diisopropylcarbodiimide was added dropwise. After completion of the dropwise addition, the reaction was carried out by stirring at room temperature for 6 hours. The reaction solution was filtered to remove precipitates, and then the solvent was distilled off. The obtained solid was dissolved in dichloromethane, purified by column chromatography, and then recrystallized twice from a mixed solvent of dichloromethane and methanol, followed by drying to obtain a formula (I-28). Compound 19.6 g.

(式(I-28)表示的化合物的物性值) (Physical properties of the compound represented by formula (I-28))

1H NMR(CDCl3)δ 2.11(五重峰,4H),2.15(s,3H),4.20(t,4H),4.39(t,4H),5.59(dd,2H),6.05(dd,2H),6.27(dd,2H),7.23(d,2H),7.25(d,1H),7.39(s,2H),7.42(d,1H),7.46(d,1H),7.52(d,4H),7.88(d,2H),7.93(d,2H),8.29(d,4H),8.32(d,2H)ppm。 1 H NMR (CDCl 3 ) δ 2.11 (quintet, 4H), 2.15 (s, 3H), 4.20 (t, 4H), 4.39 (t, 4H), 5.59 (dd, 2H), 6.05 (dd, 2H) ), 6.27 (dd, 2H), 7.23 (d, 2H), 7.25 (d, 1H), 7.39 (s, 2H), 7.42 (d, 1H), 7.46 (d, 1H), 7.52 (d, 4H) , 7.88 (d, 2H), 7.93 (d, 2H), 8.29 (d, 4H), 8.32 (d, 2H) ppm.

13C NMR(CDCl3)δ 15.3,28.4,61.6,64.9,108.2,117.8,119.0,121.5,121.5,121.9,123.6,126.3,126.4,127.0,127.1,128.2,128.2,130.1,130.7,130.9,131.1,131.3,141.0,147.1,150.2,154.6,158.0,165.2,165.2,166.5ppm。 13 C NMR (CDCl 3 ) δ 15.3, 28.4, 61.6, 64.9, 108.2, 117.8, 119.0, 121.5, 121.5, 121.9, 123.6, 126.3, 126.4, 127.0, 127.1, 128.2, 128.2, 130.1, 130.7, 130.9, 131.1, 131.3, 141.0, 147.1, 150.2, 154.6, 158.0, 165.2, 165.2, 166.5 ppm.

LRMS(EI)m/z 928(100)。 LRMS (EI) m / z 928 (100).

(實施例16) (Example 16) 式(I-30)表示的化合物的製造 Production of compound represented by formula (I-30)

在具有溫度計及攪拌裝置的反應容器中加入式(N-2)表示的化合物15.0g(0.041莫耳)、2-乙醯氧基-6-萘甲酸19.0g(0.082莫耳)、N,N-二甲基胺基吡啶0.50g(4.1毫莫耳)及二氯甲烷150mL,一邊用冰冷卻一邊進行攪拌。將反應液的溫度保持在15℃以下的同時滴加N,N’-二異丙基碳化二亞胺11.4g(0.091莫耳)。滴加完成後,在室溫下攪拌6小時進行反應。過濾反應液並除去析出物後,餾去溶劑。使得到的固體物溶解於二氯甲烷,利用管柱層析進行精製後,由二氯甲烷及甲醇的混合溶劑進行2次再結晶後,藉由進行乾燥而得到式(AA-1)表示的化合物26.0g。 A reaction vessel having a thermometer and a stirring device was charged with 15.0 g (0.041 mole) of a compound represented by the formula (N-2), 19.0 g (0.082 mole) of 2-ethoxyl-6-naphthoic acid, and N, N. -0.50 g (4.1 mmol) of dimethylaminopyridine and 150 mL of dichloromethane, and stirred while cooling with ice. While maintaining the temperature of the reaction solution at 15 ° C or lower, 11.4 g (0.091 mol) of N, N'-diisopropylcarbodiimide was added dropwise. After completion of the dropwise addition, the reaction was carried out by stirring at room temperature for 6 hours. The reaction solution was filtered to remove precipitates, and then the solvent was distilled off. The obtained solid was dissolved in dichloromethane, purified by column chromatography, and recrystallized twice from a mixed solvent of dichloromethane and methanol, and then dried to obtain a formula (AA-1). Compound 26.0 g.

於具有攪拌裝置及溫度計的反應容器中加入式(AA-1)表示的化合物26.0g(0.033莫耳)、甲苯50mL及四氫呋喃50mL。一邊攪拌一邊滴加丁胺6.62g(0.091莫耳)。滴加完成後,在室溫下攪拌一夜。用5%鹽酸進行中和並分液後,利用管柱層析進行精製。藉由乾燥所得到的固體而獲得式(AA-2)表示的化合物27.6g。 A reaction vessel having a stirring device and a thermometer was charged with 26.0 g (0.033 mol) of a compound represented by formula (AA-1), 50 mL of toluene, and 50 mL of tetrahydrofuran. While stirring, 6.62 g (0.091 mol) of butylamine was added dropwise. After the dropwise addition was completed, the mixture was stirred at room temperature overnight. After neutralization and liquid separation with 5% hydrochloric acid, purification was performed by column chromatography. 27.6 g of a compound represented by the formula (AA-2) was obtained by drying the obtained solid.

於具有攪拌裝置及溫度計的反應容器中加入式(AA-2)表示的化合物27.6g(0.039莫耳)、三乙胺5.1g(0.086莫耳)並懸浮於二氯甲烷100mL中。一邊用冰冷卻一邊以反應溫度不超過15℃的方式滴加丙烯醯氯7.43g(0.082莫耳)。室溫下攪拌5小時後,用5%鹽酸及食鹽水進行分液處理。利用管柱層析進行精製後,由二氯甲烷及甲醇的混合溶劑進行2次再結晶,得到式(I-30)表示的化合物31.2g。 In a reaction vessel having a stirring device and a thermometer, 27.6 g (0.039 mol) of a compound represented by the formula (AA-2) and 5.1 g (0.086 mol) of triethylamine were added and suspended in 100 mL of dichloromethane. While cooling with ice, 7.43 g (0.082 mol) of propylene chloride was added dropwise so that the reaction temperature did not exceed 15 ° C. After stirring for 5 hours at room temperature, the solution was separated with 5% hydrochloric acid and brine. After purification by column chromatography, recrystallization was performed twice from a mixed solvent of dichloromethane and methanol to obtain 31.2 g of a compound represented by the formula (I-30).

(式(I-30)表示的化合物的物性值) (Physical properties of the compound represented by formula (I-30))

1H NMR(CDCl3)δ 2.15(s,3H),5.59(dd,2H),6.05(dd,2H),6.27(dd,2H),7.23(d,2H),7.25(d,1H),7.39(s,2H),7.42(d,1H),7.46(d,1H),7.52(d,4H),7.88(d,2H),7.93(d,2H),8.29(d,4H),8.32(d,2H)ppm。 1 H NMR (CDCl 3 ) δ 2.15 (s, 3H), 5.59 (dd, 2H), 6.05 (dd, 2H), 6.27 (dd, 2H), 7.23 (d, 2H), 7.25 (d, 1H), 7.39 (s, 2H), 7.42 (d, 1H), 7.46 (d, 1H), 7.52 (d, 4H), 7.88 (d, 2H), 7.93 (d, 2H), 8.29 (d, 4H), 8.32 (d, 2H) ppm.

13C NMR(CDCl3)δ 15.3,108.2,117.8,119.0,121.5,121.5,121.9,123.6,126.3,126.4,127.0,127.1,128.2,128.2,130.1,130.7,130.9,131.1,131.3,141.0,147.1,150.2,154.6,158.0,165.2,165.2,166.5ppm。 13 C NMR (CDCl 3 ) δ 15.3, 108.2, 117.8, 119.0, 121.5, 121.5, 121.9, 123.6, 126.3, 126.4, 127.0, 127.1, 128.2, 128.2, 130.1, 130.7, 130.9, 131.1, 131.3, 141.0, 147.1, 150.2, 154.6, 158.0, 165.2, 165.2, 166.5 ppm.

LRMS(EI)m/z 939(100)。 LRMS (EI) m / z 939 (100).

(實施例17) (Example 17) 式(I-42)表示的化合物的製造 Production of compound represented by formula (I-42)

在具有攪拌裝置的燒瓶中加入3-氯-4-羥基苯甲醛20.0g(0.13莫耳)、對甲苯磺酸吡啶鎓1.74g(6.9毫莫耳),並溶解於二氯甲烷80mL。一邊用冰冷卻一邊滴加3,4-二氫-2H-吡喃17.5g(0.17莫耳)。反應完成後,利用管柱層析進行精製,得到式(AB-1)表示的 化合物30.1g。 A flask equipped with a stirring device was charged with 20.0 g (0.13 mol) of 3-chloro-4-hydroxybenzaldehyde and 1.74 g (6.9 mmol) of pyridinium p-toluenesulfonate, and dissolved in 80 mL of dichloromethane. While cooling with ice, 17.5 g (0.17 mole) of 3,4-dihydro-2H-pyran was added dropwise. After the reaction is completed, purification is performed by column chromatography to obtain the formula (AB-1) Compound 30.1 g.

於具有攪拌裝置及溫度計的反應容器中加入三苯基膦36.1g(0.14莫耳)、叔丁醇鉀15.5g(0.14莫耳)並懸浮於四氫呋喃100mL中。冷卻至-20℃的同時滴加4-溴苄基溴31.3g(0.13莫耳)的四氫呋喃溶液。在-20℃下攪拌1小時後,滴加式(AB-1)表示的化合物30.1g(0.13莫耳)的四氫呋喃溶液。進而在-20℃下攪拌1小時後,在室溫下攪拌5小時。利用管柱層析進行精製,得到式(AB-2)表示的化合物39.4g。 In a reaction vessel having a stirring device and a thermometer, 36.1 g (0.14 mol) of triphenylphosphine and 15.5 g (0.14 mol) of potassium tert-butoxide were added and suspended in 100 mL of tetrahydrofuran. While cooling to -20 ° C, a solution of 31.3 g (0.13 mole) of 4-bromobenzyl bromide was added dropwise. After stirring at -20 ° C for 1 hour, a solution of 30.1 g (0.13 mole) of a compound represented by the formula (AB-1) in tetrahydrofuran was added dropwise. After further stirring at -20 ° C for 1 hour, it was stirred at room temperature for 5 hours. Purification by column chromatography gave 39.4 g of a compound represented by the formula (AB-2).

於耐壓反應容器中加入式(AB-2)表示的化合物39.4g(0.10莫耳)、四氫呋喃200mL、2.5%負載鈀的絲心蛋白1.9g,在氫氣氛圍(0.5MPa)下進行6小時反應。過濾催化劑後,利用管柱層析進行精製,得到式(AB-3)表示的化合物35.7g。 In a pressure-resistant reaction vessel, 39.4 g (0.10 mole) of a compound represented by the formula (AB-2), 200 mL of tetrahydrofuran, and 1.9 g of silk fibroin loaded with 2.5% palladium were loaded, and the reaction was performed in a hydrogen atmosphere (0.5 MPa) for 6 hours . After the catalyst was filtered, purification was performed by column chromatography to obtain 35.7 g of a compound represented by the formula (AB-3).

在具有加熱裝置、溫度計及攪拌裝置的反應容器中加入式(AB-3)表示的化合物35.7g(0.090莫耳)、碘化銅(I)0.34g(1.8毫莫耳)、三甲基矽基乙炔13.3g(0.14莫耳),並溶解於三乙胺35mL及N,N-二甲基甲醯胺105mL。使反應容器為氮氣氛圍後,加入肆(三苯基膦)鈀(0)1.04g(0.90毫莫耳),在90℃下加熱攪拌10小時。加入甲苯及水並進行分液處理後,利用管柱層析進行精製,得到式(AB-4)表示的化合物24.2g。 In a reaction vessel having a heating device, a thermometer, and a stirring device, 35.7 g (0.090 mol) of a compound represented by the formula (AB-3), 0.34 g (1.8 mmol) of copper (I) iodide, and trimethyl silicon were added. 13.3 g (0.14 mole) of acetylacetylene was dissolved in 35 mL of triethylamine and 105 mL of N, N-dimethylformamide. After the reaction vessel was brought to a nitrogen atmosphere, 1.04 g (0.90 mmol) of tris (triphenylphosphine) palladium (0) was added, and the mixture was heated and stirred at 90 ° C for 10 hours. After adding toluene and water to carry out a liquid separation treatment, purification was performed by column chromatography to obtain 24.2 g of a compound represented by the formula (AB-4).

於具有攪拌裝置的反應容器中加入式(AB-4)表示的化合物24.2g(0.059莫耳),並溶解於甲醇150mL。加入碳酸鉀12.1g(0.088莫耳),在室溫下攪拌10小時。加入5%鹽酸及醋酸乙酯並進行分液處理後,利用管柱層析進行精製,得到式(AB-5)表示的化合物19.4g。 A reaction container having a stirring device was charged with 24.2 g (0.059 mole) of a compound represented by the formula (AB-4), and dissolved in 150 mL of methanol. 12.1 g (0.088 mole) of potassium carbonate was added, and it stirred at room temperature for 10 hours. After adding 5% hydrochloric acid and ethyl acetate and performing a liquid separation treatment, purification was performed by column chromatography to obtain 19.4 g of a compound represented by the formula (AB-5).

在具有加熱裝置、溫度計及攪拌裝置的反應容器中加入式(AB-5)表示的化合物19.4g(0.057莫耳)、碘化銅(I)0.22g(1.1毫莫耳)、6-溴-2-萘酚12.7g(0.057莫耳),並溶解於三乙胺20mL及N,N-二甲基甲醯胺60mL。使反應容器為氮氣氛圍後,加入肆(三苯基膦)鈀(0)0.66g(0.57毫莫耳),在90℃下加熱攪拌10小時。加入甲苯及水並進行分液處理後,利用管柱層析進行精製,得到式(AB-6) 表示的化合物13.7g。 A reaction vessel having a heating device, a thermometer, and a stirring device was charged with 19.4 g (0.057 mol) of a compound represented by formula (AB-5), 0.22 g (1.1 mmol) of copper (I) iodide, 12.7 g (0.057 mole) of 2-naphthol was dissolved in 20 mL of triethylamine and 60 mL of N, N-dimethylformamide. After making the reaction vessel into a nitrogen atmosphere, 0.66 g (0.57 mmol) of tris (triphenylphosphine) palladium (0) was added, and the mixture was heated and stirred at 90 ° C for 10 hours. After adding toluene and water for liquid separation treatment, purification was performed by column chromatography to obtain formula (AB-6) The represented compound is 13.7 g.

於具有攪拌裝置及溫度計的反應容器中加入式(AB-6)表示的化合物13.7g(0.028莫耳)、三乙胺3.7g(0.037莫耳)並懸浮於二氯甲烷80mL中。一邊用冰冷卻一邊以反應溫度不超過15℃的方式滴加丙烯醯氯3.1g(0.034莫耳)。室溫下攪拌5小時後,用5%鹽酸及食鹽水進行分液處理。利用管柱層析進行精製後,由二氯甲烷及甲醇的混合溶劑進行2次再結晶,得到式(AB-7)表示的化合物14.5g。 In a reaction vessel having a stirring device and a thermometer, 13.7 g (0.028 mole) of a compound represented by the formula (AB-6) and 3.7 g (0.037 mole) of triethylamine were added and suspended in 80 mL of dichloromethane. While cooling with ice, 3.1 g (0.034 mol) of propylene chloride was added dropwise so that the reaction temperature did not exceed 15 ° C. After stirring for 5 hours at room temperature, the solution was separated with 5% hydrochloric acid and brine. After purification by column chromatography, recrystallization was performed twice from a mixed solvent of dichloromethane and methanol to obtain 14.5 g of a compound represented by the formula (AB-7).

在燒瓶中加入式(AB-7)表示的化合物14.5g(0.027莫耳)並溶解於四氫呋喃50mL及甲醇50mL。加入濃鹽酸0.5mL並在室溫下攪拌10小時。進行分液處理後,利用管柱層析進行精製,得到式(AB-8)表示的化合物12.0g。 14.5 g (0.027 moles) of a compound represented by the formula (AB-7) was added to a flask, and dissolved in 50 mL of tetrahydrofuran and 50 mL of methanol. 0.5 mL of concentrated hydrochloric acid was added and stirred at room temperature for 10 hours. After liquid separation treatment, purification was performed by column chromatography to obtain 12.0 g of a compound represented by the formula (AB-8).

於具有攪拌裝置及溫度計的反應容器中加入式(AB-8)表示的化合物12.0g(0.026莫耳)、4-乙醯氧基-3-甲氧基苯甲酸5.56g(0.026莫耳)、N,N-二甲基胺基吡啶0.32g(2.6毫莫耳)及二氯甲烷50mL,一邊用冰冷卻一邊進行攪拌。將反應液的溫度保持在15℃以下的同時滴加N,N’-二異丙基碳化二亞胺4.0g(0.032莫耳)。滴加完成後,在室溫下攪拌6小時進行反應。過濾反應液並除去析出物後,餾去溶劑。使得到的固體物溶解於二氯甲烷,利用管柱層析進行精製後,由二氯甲烷及甲醇的混合溶劑進行2次再結晶後,藉由進行乾燥而得到式(AB-9)表示的化合物13.7g。 In a reaction vessel having a stirring device and a thermometer, 12.0 g (0.026 mol) of a compound represented by the formula (AB-8), 5.56 g (0.026 mol) of 4-acetoxy-3-methoxybenzoic acid, 0.32 g (2.6 mmol) of N, N-dimethylaminopyridine and 50 mL of dichloromethane were stirred while cooling with ice. While maintaining the temperature of the reaction solution at 15 ° C or lower, 4.0 g (0.032 mol) of N, N'-diisopropylcarbodiimide was added dropwise. After completion of the dropwise addition, the reaction was carried out by stirring at room temperature for 6 hours. The reaction solution was filtered to remove precipitates, and then the solvent was distilled off. The obtained solid was dissolved in dichloromethane, purified by column chromatography, and recrystallized twice from a mixed solvent of dichloromethane and methanol, and then dried to obtain a formula (AB-9). Compound 13.7 g.

於具有攪拌裝置及溫度計的反應容器中加入式(AB-9)表示的化合物13.7g(0.021莫耳)、甲苯30mL及四氫呋喃30mL。一邊攪拌一邊滴加丁胺2.32g(0.032莫耳)。滴加完成後,在室溫下攪拌一夜。用5%鹽酸100mL進行中和並分液後,將有機層用食鹽水進行洗滌。用丙酮/己烷混合溶劑進行再結晶,藉由乾燥所得到的固體而獲得式(AB-10)表示的化合物11.1g。 A reaction vessel having a stirring device and a thermometer was charged with 13.7 g (0.021 mole) of a compound represented by the formula (AB-9), 30 mL of toluene, and 30 mL of tetrahydrofuran. 2.32 g (0.032 mol) of butylamine was added dropwise while stirring. After the dropwise addition was completed, the mixture was stirred at room temperature overnight. After neutralizing and separating with 100 mL of 5% hydrochloric acid, the organic layer was washed with brine. Recrystallization was performed using a mixed solvent of acetone / hexane, and the obtained solid was dried to obtain 11.1 g of a compound represented by the formula (AB-10).

於具有攪拌裝置及溫度計的反應容器中加入式(AB-10)表示的化合物11.1g(0.018莫耳)、式(A-5)表示的化合物5.53g(0.018莫耳)、N,N-二甲基胺基吡啶0.22g(1.8毫莫耳)及二氯甲烷100mL, 一邊用冰冷卻一邊進行攪拌。將反應液的溫度保持在15℃以下的同時滴加N,N’-二異丙基碳化二亞胺2.8g(0.022莫耳)。滴加完成後,在室溫下攪拌6小時進行反應。過濾反應液並除去析出物後,餾去溶劑。利用管柱層析進行精製後,由二氯甲烷及甲醇的混合溶劑進行2次再結晶後,藉由進行乾燥而得到式(I-42)表示的化合物13.0g。 In a reaction vessel having a stirring device and a thermometer, 11.1 g (0.018 mole) of a compound represented by formula (AB-10), 5.53 g (0.018 mole) of a compound represented by formula (A-5), and N, N-di 0.22 g (1.8 mmol) of methylaminopyridine and 100 mL of dichloromethane, Stir while cooling with ice. While maintaining the temperature of the reaction solution at 15 ° C or lower, 2.8 g (0.022 mol) of N, N'-diisopropylcarbodiimide was added dropwise. After completion of the dropwise addition, the reaction was carried out by stirring at room temperature for 6 hours. The reaction solution was filtered to remove precipitates, and then the solvent was distilled off. After purification by column chromatography, recrystallization was performed twice from a mixed solvent of dichloromethane and methanol, and then drying was performed to obtain 13.0 g of a compound represented by the formula (I-42).

(式(I-42)表示的化合物的物性值) (Physical properties of the compound represented by formula (I-42))

1H NMR(CDCl3)δ 2.11(五重峰,2H),2.82(t,4H),3.83(s,3H),4.20(t,2H),4.39(t,2H),5.50(dd,1H),5.59(dd,1H),6.03(dd,1H),6.05(dd,1H),6.10(dd,1H),6.27(dd,1H),7.16(d,1H),7.23(d,1H),7.24(d,1H),7.25(d,2H),7.39(s,1H),7.40(d,1H),7.41(d,1H),7.54(d,2H),7.55(d,1H),7.56(s,1H),7.63(d,1H),7.84(s,1H),7.85(d,1H),7.88(d,1H),7.93(d,1H),7.95(d,1H),8.29(d,1H),8.32(d,1H),8.64(s,1H)ppm。 1 H NMR (CDCl 3 ) δ 2.11 (quintet, 2H), 2.82 (t, 4H), 3.83 (s, 3H), 4.20 (t, 2H), 4.39 (t, 2H), 5.50 (dd, 1H ), 5.59 (dd, 1H), 6.03 (dd, 1H), 6.05 (dd, 1H), 6.10 (dd, 1H), 6.27 (dd, 1H), 7.16 (d, 1H), 7.23 (d, 1H) , 7.24 (d, 1H), 7.25 (d, 2H), 7.39 (s, 1H), 7.40 (d, 1H), 7.41 (d, 1H), 7.54 (d, 2H), 7.55 (d, 1H), 7.56 (s, 1H), 7.63 (d, 1H), 7.84 (s, 1H), 7.85 (d, 1H), 7.88 (d, 1H), 7.93 (d, 1H), 7.95 (d, 1H), 8.29 (d, 1H), 8.32 (d, 1H), 8.64 (s, 1H) ppm.

13C NMR(CDCl3)δ 28.4,36.9,37.4,55.8,61.6,64.9,89.7,93.3,108.2,109.5,113.7,117.3,117.6,117.8,119.9,122.9,123.0,124.4,126.0,126.3,126.4,127.1,127.3,127.5,128.0,128.2,128.2,128.7,129.7,129.8,129.8,129.8,129.9,130.0,130.1,130.9,131.3,131.5,132.2,132.2,134.1,134.4,137.6,141.0,141.8,143.6,144.6,151.5,153.4,158.0,164.3,165.2,165.2,166.5ppm。 13 C NMR (CDCl 3 ) δ 28.4, 36.9, 37.4, 55.8, 61.6, 64.9, 89.7, 93.3, 108.2, 109.5, 113.7, 117.3, 117.6, 117.8, 119.9, 122.9, 123.0, 124.4, 126.0, 126.3, 126.4, 127.1, 127.3, 127.5, 128.0, 128.2, 128.2, 128.7, 129.7, 129.8, 129.8, 129.8, 129.9, 130.0, 130.1, 130.9, 131.3, 131.5, 132.2, 132.2, 134.1, 134.4, 137.6, 141.0, 141.8, 143.6, 144.6, 151.5, 153.4, 158.0, 164.3, 165.2, 165.2, 166.5 ppm.

LRMS(EI)m/z 885(100),887(30)。 LRMS (EI) m / z 885 (100), 887 (30).

(實施例18) (Example 18) 式(I-46)表示的化合物的製造 Production of compound represented by formula (I-46)

在實施例8中,將式(A-2)表示的化合物替換成4-乙醯氧基-2-氯苯甲酸、4-氰基-3-氟苯酚替換成2,4-二甲基苯酚,除此以外,藉由同樣的方法來製造式(I-46)表示的化合物。 In Example 8, the compound represented by the formula (A-2) was replaced with 4-acetoxy-2-chlorobenzoic acid, and 4-cyano-3-fluorophenol was replaced with 2,4-dimethylphenol. Except this, the compound represented by Formula (I-46) was manufactured by the same method.

(式(I-46)表示的化合物的物性值) (Physical properties of the compound represented by formula (I-46))

1H NMR(CDCl3)δ 2.11(五重峰,2H),2.15(s,3H),2.34(s,3H),4.20(t,2H),4.39(t,2H),5.59(dd,1H),6.05(dd,1H),6.27(dd,1H),7.11(d,1H),7.13(d,1H),7.17(s,1H),7.23(d,1H),7.39(s,1H),7.40(d,1H),7.72(s,1H),7.88(d,1H),7.93(d,1H),8.23(d,1H),8.32(d,1H),8.64(s,1H)ppm。 1 H NMR (CDCl 3 ) δ 2.11 (quintet, 2H), 2.15 (s, 3H), 2.34 (s, 3H), 4.20 (t, 2H), 4.39 (t, 2H), 5.59 (dd, 1H ), 6.05 (dd, 1H), 6.27 (dd, 1H), 7.11 (d, 1H), 7.13 (d, 1H), 7.17 (s, 1H), 7.23 (d, 1H), 7.39 (s, 1H) , 7.40 (d, 1H), 7.72 (s, 1H), 7.88 (d, 1H), 7.93 (d, 1H), 8.23 (d, 1H), 8.32 (d, 1H), 8.64 (s, 1H) ppm .

13C NMR(CDCl3)δ 15.6,21.6,28.4,61.6,64.9,108.2,117.8,119.6,122.3,122.9,126.3,126.4,126.4,127.1,128.2,128.2,128.6,130.1,130.4,130.9,131.3,131.3,132.1,135.1,135.4,141.0,147.3,157.9,158.0,165.2,165.2,166.5ppm。 13 C NMR (CDCl 3 ) δ 15.6, 21.6, 28.4, 61.6, 64.9, 108.2, 117.8, 119.6, 122.3, 122.9, 126.3, 126.4, 126.4, 127.1, 128.2, 128.2, 128.6, 130.1, 130.4, 130.9, 131.3, 131.3, 132.1, 135.1, 135.4, 141.0, 147.3, 157.9, 158.0, 165.2, 165.2, 166.5 ppm.

LRMS(EI)m/z 559(100),561(30)。 LRMS (EI) m / z 559 (100), 561 (30).

(實施例19) (Example 19) 式(I-48)表示的化合物的製造 Production of compound represented by formula (I-48)

在實施例1中,將式(A-5)表示的化合物替換成式(AC-1)表示的化合物,除此以外,藉由同樣的方法來製造式(I-48)表示的化合物。 In Example 1, the compound represented by formula (I-48) was produced by the same method except that the compound represented by formula (A-5) was replaced with the compound represented by formula (AC-1).

(式(I-48)表示的化合物的物性值) (Physical properties of the compound represented by formula (I-48))

1H NMR(CDCl3)δ 2.01(s,3H),2.21(s,3H),2.27(五重峰,2H),2.35(s,3H),3.92(s,3H),4.24(t,2H),4.43(t,2H),5.85(dd,1H),6.15(dd,1H),6.43(dd,1H),7.01~7.10(m,3H),7.20~7.24(m,2H),7.34(d,1H),7.81~7.95(m,4H),8.17(dd,1H),8.74(s,1H)ppm。 1 H NMR (CDCl 3 ) δ 2.01 (s, 3H), 2.21 (s, 3H), 2.27 (quintet, 2H), 2.35 (s, 3H), 3.92 (s, 3H), 4.24 (t, 2H ), 4.43 (t, 2H), 5.85 (dd, 1H), 6.15 (dd, 1H), 6.43 (dd, 1H), 7.01 ~ 7.10 (m, 3H), 7.20 ~ 7.24 (m, 2H), 7.34 ( d, 1H), 7.81 to 7.95 (m, 4H), 8.17 (dd, 1H), 8.74 (s, 1H) ppm.

13C NMR(CDCl3)δ 16.2,17.9,20.9,28.6,56.2,61.3,64.5,106.5,114.0,120.0,121.6,123.2,123.3,123.9,126.3,127.0,127.5,127.9,128.2,128.3,129.8,131.0,131.1,131.8,132.0,135.7,137.6,144.6,147.3,151.6,159.1,164.4,164.6,166.2ppm。 13 C NMR (CDCl 3 ) δ 16.2, 17.9, 20.9, 28.6, 56.2, 61.3, 64.5, 106.5, 114.0, 120.0, 121.6, 123.2, 123.3, 123.9, 126.3, 127.0, 127.5, 127.9, 128.2, 128.3, 129.8, 131.0, 131.1, 131.8, 132.0, 135.7, 137.6, 144.6, 147.3, 151.6, 159.1, 164.4, 164.6, 166.2 ppm.

LRMS(EI)m/z 568(100)。 LRMS (EI) m / z 568 (100).

(實施例20) (Example 20) 式(I-49)表示的化合物的製造 Production of compound represented by formula (I-49)

在實施例10中,將式(I-2-1)表示的化合物替換成式(AD-1)表示的化合物,除此以外,藉由同樣的方法來製造式(I-49)表示的化合物。 In Example 10, the compound represented by formula (I-49) was produced by the same method except that the compound represented by formula (I-2-1) was replaced with a compound represented by formula (AD-1). .

(式(I-49)表示的化合物的物性值) (Physical properties of the compound represented by formula (I-49))

1H NMR(CDCl3)δ 1.43(m,4H),1.62(t,2H),1.76(t,2H),2.01(s,3H),2.34(s,3H),3.97(t,2H),4.16(t,2H),5.59(dd,1H),6.05(dd,1H),6.27(dd,1H),7.23(d,1H),7.25(d,2H),7.30(d,2H),7.39(s,1H),7.50(d,1H),7.87(d,1H),7.88(d,1H),7.93(d,1H),8.06(d,1H),8.32(d,1H),8.64(s,1H)ppm。 1 H NMR (CDCl 3 ) δ 1.43 (m, 4H), 1.62 (t, 2H), 1.76 (t, 2H), 2.01 (s, 3H), 2.34 (s, 3H), 3.97 (t, 2H), 4.16 (t, 2H), 5.59 (dd, 1H), 6.05 (dd, 1H), 6.27 (dd, 1H), 7.23 (d, 1H), 7.25 (d, 2H), 7.30 (d, 2H), 7.39 (s, 1H), 7.50 (d, 1H), 7.87 (d, 1H), 7.88 (d, 1H), 7.93 (d, 1H), 8.06 (d, 1H), 8.32 (d, 1H), 8.64 ( s, 1H) ppm.

13C NMR(CDCl3)δ 17.9,21.3,25.6,25.8,29.0,29.6,65.3,68.7,108.2,117.8,118.8,121.5,121.5,123.1,126.3,126.3,126.4,127.1,128.2,128.2,128.6,129.4,129.4,130.1,130.9,131.3,135.2,141.0,142.8,146.4,153.7,158.0,165.2,165.2,166.5ppm。 13 C NMR (CDCl 3 ) δ 17.9, 21.3, 25.6, 25.8, 29.0, 29.6, 65.3, 68.7, 108.2, 117.8, 118.8, 121.5, 121.5, 123.1, 126.3, 126.3, 126.4, 127.1, 128.2, 128.2, 128.6, 129.4, 129.4, 130.1, 130.9, 131.3, 135.2, 141.0, 142.8, 146.4, 153.7, 158.0, 165.2, 165.2, 166.5 ppm.

LRMS(EI)m/z 584(100)。 LRMS (EI) m / z 584 (100).

(實施例21) (Example 21) 式(I-52)表示的化合物的製造 Production of compound represented by formula (I-52)

在實施例12中,將式(A-5)表示的化合物替換成式(AC-1)表示的化合物,除此以外,藉由同樣的方法來製造式(I-52)表示的化合物。 In Example 12, the compound represented by formula (I-52) was produced by the same method except that the compound represented by formula (A-5) was replaced with the compound represented by formula (AC-1).

(式(I-52)表示的化合物的物性值) (Physical properties of the compound represented by formula (I-52))

1H NMR(CDCl3)δ 2.01(s,3H),2.11(五重峰,2H),2.34(s,3H),4.20(t,2H),4.39(t,2H),5.59(dd,1H),6.05(dd,1H),6.27(dd,1H),7.23(d,1H),7.25(d,2H),7.30(d,2H),7.39(s,1H),7.46(d,1H),7.52(d,2H),7.88(d,1H),7.93(d,1H),8.17(d,1H),8.21(s,1H),8.32(d,1H),8.64(s,1H)ppm。 1 H NMR (CDCl 3 ) δ 2.01 (s, 3H), 2.11 (quintet, 2H), 2.34 (s, 3H), 4.20 (t, 2H), 4.39 (t, 2H), 5.59 (dd, 1H) ), 6.05 (dd, 1H), 6.27 (dd, 1H), 7.23 (d, 1H), 7.25 (d, 2H), 7.30 (d, 2H), 7.39 (s, 1H), 7.46 (d, 1H) , 7.52 (d, 2H), 7.88 (d, 1H), 7.93 (d, 1H), 8.17 (d, 1H), 8.21 (s, 1H), 8.32 (d, 1H), 8.64 (s, 1H) ppm .

13C NMR(CDCl3)δ 17.9,21.3,28.4,61.6,64.9,108.2,117.8,121.5,121.5,121.5,121.5,122.9,126.3,126.4,127.0,127.1,128.2,128.2,128.4,128.8,129.4,129.4,129.8,130.1,130.7,130.7,130.9,131.3,132.0,135.2,141.0,146.4,152.6,154.6,158.0,165.2,165.2,165.2,166.5ppm。 13 C NMR (CDCl 3 ) δ 17.9, 21.3, 28.4, 61.6, 64.9, 108.2, 117.8, 121.5, 121.5, 121.5, 121.5, 121.5, 122.9, 126.3, 126.4, 127.0, 127.1, 128.2, 128.2, 128.4, 128.8, 129.4, 129.4, 129.8, 130.1, 130.7, 130.7, 130.9, 131.3, 132.0, 135.2, 141.0, 146.4, 152.6, 154.6, 158.0, 165.2, 165.2, 165.2, 166.5 ppm.

LRMS(EI)m/z 678(100),680(30)。 LRMS (EI) m / z 678 (100), 680 (30).

(實施例22,比較例1) (Example 22, Comparative Example 1)

將實施例1~實施例4中記載的本發明的式(I-1)、式(I-3)、式(I-7)及式(I-8)表示的化合物及在該技術領域中已知具有高的折射率各向異性的日本特開2008-88291號公報記載的比較化合物1、日本特開2008-195762號公報記載的比較化合物2、日本特開平2-238087號公報記載的比較化合物3及EP1786887B1號公報記載的比較化合物4、日本特開2008-179654號公報記載的比較化合物5、日本特開2007-119415號公報記載的比較化合物6的物性值記載於下述表1。 The compounds represented by Formula (I-1), Formula (I-3), Formula (I-7) and Formula (I-8) of the present invention described in Examples 1 to 4 are used in the technical field. Comparative compound described in Japanese Patent Application Laid-Open No. 2008-88291, which is known to have high refractive index anisotropy. The physical properties of Compound 3 and Comparative Compound 4 described in EP1786887B1, Comparative Compound 5 described in JP-A-2008-179654, and Comparative Compound 6 described in JP-A-2007-119415 are shown in Table 1 below.

本發明的式(I-1)、式(I-3)、式(I-7)及式(I-8)表示的化合物均在寬的溫度範圍內顯示向列液晶相,因此藉由添加於組成物中,可期待有穩定組成物的液晶相的效果。比較化合物2是單體,在升溫過程中不顯示液晶相,因此添加於組成物中時有組成物的液晶相溫度範圍變窄的缺點。 The compounds represented by formula (I-1), formula (I-3), formula (I-7), and formula (I-8) of the present invention all show a nematic liquid crystal phase in a wide temperature range. In the composition, an effect of stabilizing the liquid crystal phase of the composition can be expected. Comparative compound 2 is a monomer, and does not show a liquid crystal phase during the temperature rise. Therefore, when added to the composition, there is a disadvantage that the temperature range of the liquid crystal phase of the composition becomes narrow.

另外,為了評價該化合物的保存穩定性,分別調製相對於包含化合物VI(30%)、化合物VII(30%)、化合物VIII(30%)及化合物 IX(10%)的母體液晶從10%至60%每5%添加有該化合物的聚合性液晶組成物。將調製的聚合性液晶組成物在25℃下放置10小時後不發生結晶析出的該化合物的最大添加濃度記載於上述表1。可知本發明的式(I-1)、式(I-3)、式(I-7)及式(I-8)表示的化合物任一個與比較化合物1~比較化合物6中之任一者化合物相比,不發生結晶析出的該化合物的最大添加濃度均較高,顯示出高保存穩定性。 In addition, in order to evaluate the storage stability of the compound, the compounds were prepared with respect to compounds VI (30%), compound VII (30%), compound VIII (30%), and compound. IX (10%) is a polymerizable liquid crystal composition in which the parent liquid crystal is added from 10% to 60% per 5% of the compound. The maximum added concentration of the prepared polymerizable liquid crystal composition without crystal precipitation after standing at 25 ° C for 10 hours is described in Table 1 above. It can be seen that any one of the compounds represented by the formula (I-1), the formula (I-3), the formula (I-7), and the formula (I-8) of the present invention is any one of the compounds of the comparative compound 1 to the comparative compound 6. In contrast, the maximum added concentration of the compound without crystal precipitation was high, and showed high storage stability.

製備包含本發明的式(I-1)、式(I-3)、式(I-7)、式(I-8)、式(I-28)、式(I-30)、式(I-48)及式(I-52)表示的化合物及比較化合物1~比較化合物6的聚合性液晶組成物如下述表2及3。 Preparation of the formula (I-1), formula (I-3), formula (I-7), formula (I-8), formula (I-28), formula (I-30), formula (I) -48) and the polymerizable liquid crystal composition of the compound represented by Formula (I-52) and Comparative Compound 1 to Comparative Compound 6 are shown in Tables 2 and 3 below.

可知,含有本發明的式(I-1)、式(I-3)、式(I-7)及式(I-8)表示的化合物的本申請案組成物1~本申請案組成物4,任一個都在寬的溫度範圍內顯示手性向列液晶相,且具有高的折射率各向異性。 It can be seen that the present composition 1 to the present composition 4 containing the compounds represented by formula (I-1), formula (I-3), formula (I-7) and formula (I-8) of the present invention Each of them shows a chiral nematic liquid crystal phase in a wide temperature range and has a high refractive index anisotropy.

接著,在本申請案組成物1~本申請案組成物8及比較組成物1~比較組成物6的聚合性液晶組成物98%中分別添加2%光聚合引發劑豔佳固(Irgacure)907(汽巴精化公司製)後溶解於環己酮中,旋塗於帶聚醯亞胺玻璃上,使用高壓汞燈對其照射4mW/cm2的紫外線120秒鐘,得到本申請聚合物1~本申請聚合物8及比較聚合物1~比較聚合物6。評價得到的聚合物的霧度值和外觀。霧度值以下述式表示霧度(%)=Td/Tt×100 Next, 2% of the photopolymerization initiator Irgacure 907 was added to 98% of the polymerizable liquid crystal composition of the present application composition 1 to the present application composition 8 and the comparative composition 1 to the comparative composition 6. (Produced by Ciba Refining Co., Ltd.), dissolved in cyclohexanone, spin-coated on glass with polyimide, and irradiated with 4 mW / cm 2 of ultraviolet light for 120 seconds using a high-pressure mercury lamp to obtain polymer 1 of the present application ~ Polymer 8 and Comparative Polymer 1-Comparative Polymer 6 of the present application. The haze value and appearance of the obtained polymer were evaluated. Haze value is expressed by the following formula: Haze (%) = Td / Tt × 100

(式中,Td為擴散透過率,Tt表示全光線透過率。),測定中使用霧度測定裝置(日本電色工業公司製NHD2000),對於基板上5個地方進行測定,取其平均。另外,藉由目視,如果在聚合物上沒有斑點等且整體均勻則記作◎,發現斑點時根據斑點的程度記作△或×。在含有本發明的式(I-1)、式(I-3)、式(I-7)、式(I-8)、式 (I-28)、式(I-30)、式(I-48)及式(I-52)表示的化合物的本申請聚合物1~本申請聚合物8中,均可得到霧度值低、沒有斑點且均勻的聚合物。另一方面,在比較聚合物1及比較聚合物3中,可得到霧度值高、在聚合物上產生白的線狀斑點且不均勻的聚合物。在比較聚合物2、比較聚合物4、比較聚合物5及比較聚合物6中在聚合物上產生若干白的線狀斑點。 (In the formula, Td is the diffusion transmittance, and Tt is the total light transmittance.) The haze measuring device (NHD2000 manufactured by Nippon Denshoku Industries Co., Ltd.) was used for the measurement. The measurement was performed at five places on the substrate, and the average was taken. In addition, if there is no spot or the like on the polymer and it is uniform throughout, it is recorded as ◎, and when a spot is found, it is recorded as Δ or × depending on the degree of the spot. Formulas (I-1), (I-3), (I-7), (I-8), and (I-28), Formula (I-30), Formula (I-48) and Formula (I-52) The compounds of the present application polymer 1 to the present application polymer 8 can all obtain low haze values No spots and uniform polymer. On the other hand, in Comparative Polymer 1 and Comparative Polymer 3, a polymer having a high haze value, white linear spots on the polymer, and unevenness was obtained. In Comparative Polymer 2, Comparative Polymer 4, Comparative Polymer 5, and Comparative Polymer 6, several white linear spots were generated on the polymer.

由此可知,本發明的化合物折射率各向異性均大,相對於比較化合物,保存穩定性高。另外,將含有本發明的化合物的聚合性液晶組成物進行聚合時,霧度值低,也沒有斑點,因此可知本發明的化合物具有高配向性。因而,在具有膽甾醇結構的光學膜等的用途中是有用的。 From this, it can be seen that the compounds of the present invention have large refractive index anisotropy and have high storage stability relative to the comparative compounds. In addition, when the polymerizable liquid crystal composition containing the compound of the present invention is polymerized, the haze value is low and there are no spots. Therefore, it is found that the compound of the present invention has high alignment. Therefore, it is useful for applications, such as an optical film which has a cholesteric structure.

Claims (11)

一種聚合性化合物,係由通式(I)所表示,(式中,P表示選自下述式(P-1)、(P-2)或式(P-11)表示的聚合性基的取代基;,S1表示碳原子數1~20的伸烷基、1個-CH2-或不相鄰的2個以上的-CH2-分別獨立地經-O-、-S-、-CO-、-COO-、-OCO-、-CO-S-、-S-CO-、-O-CO-O-、-CO-NH-、-NH-CO-取代的碳原子數1~20的伸烷基、或單鍵;X1分別獨立地表示-O-、-S-、-OCH2-、-CH2O-、-CO-、-COO-、-OCO-、-CO-S-、-S-CO-、-O-CO-O-、-CO-NH-、-NH-CO-、-SCH2-、-CH2S-、-CF2O-、-OCF2-、-CF2S-、-SCF2-、-CH2CH2-、-CH2CF2-、-CF2CH2-、-CF2CF2-、-CH=CH-COO-、-CH=CH-OCO-、-COO-CH=CH-、-OCO-CH=CH-、-COO-CH2CH2-、-OCO-CH2CH2-、-CH2CH2-COO-、-CH2CH2-OCO-、-COO-CH2-、-OCO-CH2-、-CH2-COO-、-CH2-OCO-、-CY1=CY2-、-C≡C-或單鍵,式中,Y1及Y2分別獨立地表示氫原子、碳原子數1~12的烷基、氟原子、氯原子或氰基;L1~L6分別獨立地表示氫原子、氟原子、氯原子、氰基、硝基、碳原子數1~7的烷基、碳原子數1~7的烷氧基或碳原子數1~7的烷醯基,存在於該烷基、烷氧基或烷醯基中的1個以上的氫原子可取代為氟原子或氯原子;M1~M4分別獨立地表示氫原子、氟原子、氯原子、氰基、硝基、碳原子數1~7的烷基、碳原子數1~7的烷氧基、碳原子數1~7的烷醯基或-X2-S2-P,式中,X2、S2及P分別表示與所述X1、S1及P相同含意,各自可為相同的基團也可為不同的基團,存在於該烷基、烷氧基或烷醯基中的1個以上的氫原子可以取代為氟原子或氯原子,不存在M1~M4全部同樣地為氫原子的情況;A1、A2及A3分別獨立地表示1,4-伸苯基、萘-2,6-二基、1,4-伸環己基、1,4-伸環己烯基、1,4-雙環[2.2.2]伸辛基、十氫萘-2,6-二基、1,2,3,4-四氫萘-2,6-二基、吡啶-2,6-二基、嘧啶-2,5-二基或1,3-二烷-2,5-二基,此等基團可未經取代,也可以經氟原子、氯原子、氰基、硝基、碳原子數1~7的烷基、碳原子數1~7的烷氧基或碳原子數1~7的烷醯基取代,此等烷基、烷氧基或烷醯基的1個以上的氫原子可以取代為氟原子或氯原子,A1及/或A2存在多個時此等可相同也可不同;Z1、Z2及Z4分別獨立地表示-OCH2-、-CH2O-、-COO-、-OCO-、-CO-S-、-S-CO-、-CO-NH-、-NH-CO-、-SCH2-、-CH2S-、-CF2O-、-OCF2-、-CF2S-、-SCF2-、-CH2CH2-、-CH2CF2-、-CF2CH2-、-CF2CF2-、-CH=CH-COO-、-CH=CH-OCO-、-COO-CH=CH-、-OCO-CH=CH-、-COO-CH2CH2-、-OCO-CH2CH2-、-CH2CH2-COO-、-CH2CH2-OCO-、-COO-CH2-、-OCO-CH2-、-CH2-COO-、-CH2-OCO-、-CY3=CY4-、-C≡C-或單鍵,式中,Y3及Y4分別獨立地表示氫原子、碳原子數1~12的烷基、氟原子、氯原子或氰基,Z1、Z2及Z4存在多個時此等可相同也可不同;Z3表示-OCH2-、-CH2O-、-COO-、-OCO-、-CO-S-、-S-CO-、-CO-NH-、-NH-CO-、-SCH2-、-CH2S-、-CF2O-、-OCF2-、-CF2S-、-SCF2-、-CH2CH2-、-CH2CF2-、-CF2CH2-、-CF2CF2-、-CH=CH-COO-、-CH=CH-OCO-、-COO-CH=CH-、-OCO-CH=CH-、-COO-CH2CH2-、-OCO-CH2CH2-、-CH2CH2-COO-、-CH2CH2-OCO-、-COO-CH2-、-OCO-CH2-、-CH2-COO-、-CH2-OCO-、-CY5=CY6-或單鍵,式中,Y5及Y6分別獨立地表示氫原子、碳原子數1~12的烷基、氟原子、氯原子或氰基;R表示-X3-S3-P,S1與S3不為單鍵;式中,X3、S3及P分別表示與所述X1、S1及P相同含意,各自可為相同的基團也可為不同的基團,存在於該烷基中的1個以上的氫原子可以取代為氟原子、氯原子、氰基,另外,該烷基中的1個-CH2-或不相鄰的2個以上的-CH2-可分別獨立地經-O-、-S-、-CO-、-COO-、-OCO-、-CO-S-、-S-CO-、-O-CO-O-、-CO-NH-、-NH-CO-、-CH=CH-、-CH=CF-、-CF=CH-或-C≡C-取代;m1及m2分別獨立地表示0或1,m1=0、m2=0時,A3表示萘-2,6-二基以外的基團)。A polymerizable compound represented by the general formula (I), (In the formula, P represents a substituent selected from a polymerizable group represented by the following formula (P-1), (P-2), or (P-11); , S 1 represents an alkylene group having 1 to 20 carbon atoms, one -CH 2- , or two or more non-adjacent -CH 2 -each independently through -O-, -S-, -CO-, -COO-, -OCO-, -CO-S-, -S-CO-, -O-CO-O-, -CO-NH-, -NH-CO- substituted carbon number 1-20 Group, or single bond; X 1 independently represents -O-, -S-, -OCH 2- , -CH 2 O-, -CO-, -COO-, -OCO-, -CO-S-,- S-CO-, -O-CO-O-, -CO-NH-, -NH-CO-, -SCH 2- , -CH 2 S-, -CF 2 O-, -OCF 2- , -CF 2 S-, -SCF 2- , -CH 2 CH 2- , -CH 2 CF 2- , -CF 2 CH 2- , -CF 2 CF 2- , -CH = CH-COO-, -CH = CH-OCO -, -COO-CH = CH-, -OCO-CH = CH-, -COO-CH 2 CH 2- , -OCO-CH 2 CH 2- , -CH 2 CH 2 -COO-, -CH 2 CH 2 -OCO-, -COO-CH 2- , -OCO-CH 2- , -CH 2 -COO-, -CH 2 -OCO-, -CY 1 = CY 2- , -C≡C- or single bond, formula Herein, Y 1 and Y 2 each independently represent a hydrogen atom, an alkyl group having 1 to 12 carbon atoms, a fluorine atom, a chlorine atom, or a cyano group; and L 1 to L 6 each independently represent a hydrogen atom, a fluorine atom, and a chlorine atom. , Cyano, nitro, alkyl having 1 to 7 carbon atoms, alkoxy having 1 to 7 carbon atoms or alkyl fluorenyl having 1 to 7 carbon atoms Present in the alkyl group, alkoxy group or acyl of one or more hydrogen atoms may be substituted with a fluorine atom or a chlorine atom; M 1 ~ M 4 each independently represent a hydrogen atom, a fluorine atom, a chlorine atom, a cyano group , Nitro, alkyl group having 1 to 7 carbon atoms, alkoxy group having 1 to 7 carbon atoms, alkylfluorenyl group having 1 to 7 carbon atoms or -X 2 -S 2 -P, where X 2 , S 2 and P each have the same meaning as the above-mentioned X 1 , S 1 and P, and each may be the same group or different groups, and the groups existing in the alkyl group, alkoxy group, or alkylfluorenyl group One or more hydrogen atoms may be substituted by fluorine atoms or chlorine atoms, and there is no case where all of M 1 to M 4 are hydrogen atoms; A 1 , A 2 and A 3 each independently represent 1,4-phenylene Naphthalene-2,6-diyl, 1,4-cyclohexyl, 1,4-cyclohexenyl, 1,4-bicyclo [2.2.2] octyl, decahydronaphthalene-2,6- Diyl, 1,2,3,4-tetrahydronaphthalene-2,6-diyl, pyridine-2,6-diyl, pyrimidine-2,5-diyl, or 1,3-diyl Alkane-2,5-diyl, these groups may be unsubstituted, or may be fluorine, chlorine, cyano, nitro, 1 to 7 carbon atoms, 1 to 7 carbon atoms Alkoxy or alkanoyl having 1 to 7 carbon atoms may be substituted, and one or more hydrogen atoms of such alkyl, alkoxy or alkanoyl may be substituted by fluorine or chlorine atoms, A 1 and / or A These may be the same or different when there are two or more; Z 1 , Z 2 and Z 4 each independently represent -OCH 2- , -CH 2 O-, -COO-, -OCO-, -CO-S-, -S-CO-, -CO-NH-, -NH-CO-, -SCH 2- , -CH 2 S-, -CF 2 O-, -OCF 2- , -CF 2 S-, -SCF 2- , -CH 2 CH 2- , -CH 2 CF 2- , -CF 2 CH 2- , -CF 2 CF 2- , -CH = CH-COO-, -CH = CH-OCO-, -COO-CH = CH -, - OCO-CH = CH -, - COO-CH 2 CH 2 -, - OCO-CH 2 CH 2 -, - CH 2 CH 2 -COO -, - CH 2 CH 2 -OCO -, - COO- CH 2- , -OCO-CH 2- , -CH 2 -COO-, -CH 2 -OCO-, -CY 3 = CY 4- , -C≡C- or single bond, where Y 3 and Y 4 Each independently represents a hydrogen atom, an alkyl group having 1 to 12 carbon atoms, a fluorine atom, a chlorine atom, or a cyano group. When there are a plurality of Z 1 , Z 2, and Z 4 , these may be the same or different; Z 3 represents- OCH 2- , -CH 2 O-, -COO-, -OCO-, -CO-S-, -S-CO-, -CO-NH-, -NH-CO-, -SCH 2- , -CH 2 S -, -CF 2 O-, -OCF 2- , -CF 2 S-, -SCF 2- , -CH 2 CH 2- , -CH 2 CF 2- , -CF 2 CH 2- , -CF 2 CF 2 -, -CH = CH-COO-, -CH = CH-OCO-, -COO-CH = CH-, -OCO-CH = CH-, -COO-CH 2 CH 2- , -OCO-CH 2 CH 2 -, -CH 2 CH 2 -COO-, -CH 2 CH 2 -OCO-, -COO-CH 2- , -OCO-CH 2- , -CH 2 -COO-, -CH 2 -OCO-, -CY 5 = CY 6 -or a single bond, where Y 5 and Y 6 each independently represent a hydrogen atom, an alkyl group having 1 to 12 carbon atoms, a fluorine atom, a chlorine atom, or a cyano group; R represents -X 3 -S 3 -P, S 1 and S 3 are not single bonds; in the formula, X 3 , S 3 and P respectively represent the same meaning as the X 1 , S 1 and P, and each may be the same group or different Group, one or more hydrogen atoms present in the alkyl group may be substituted with a fluorine atom, a chlorine atom, or a cyano group, and one -CH 2 -or two or more non-adjacent groups in the alkyl group may be substituted. -CH 2 -can be independently passed through -O-, -S-, -CO-, -COO-, -OCO-, -CO-S-, -S-CO-, -O-CO-O-, -CO-NH-, -NH-CO-, -CH = CH-, -CH = CF-, -CF = CH- or -C≡ C-substituted; m 1 and m 2 each independently represent 0 or 1, and when m 1 = 0 and m 2 = 0, A 3 represents a group other than naphthalene-2,6-diyl). 如申請專利範圍第1項之聚合性化合物,其中,在通式(I)中,M1~M4中之任一者選自氟原子、氯原子、氰基、硝基、碳原子數1~7的烷基、碳原子數1~7的烷氧基、碳原子數1~7的烷醯基、1個以上的氫原子取代為氟原子或氯原子之碳原子數1~7的烷基、1個以上的氫原子取代為氟原子或氯原子之碳原子數1~7的烷氧基、或1個以上的氫原子取代為氟原子或氯原子之碳原子數1~7的烷醯基;M1~M4中其餘的3個表示氫原子。For example, the polymerizable compound according to the first patent application range, in the general formula (I), any one of M 1 to M 4 is selected from a fluorine atom, a chlorine atom, a cyano group, a nitro group, and a carbon number of 1. ~ 7 alkyl groups, alkoxy groups having 1 to 7 carbon atoms, alkanoyl groups having 1 to 7 carbon atoms, and 1 to 7 carbon atoms having 1 to 7 carbon atoms substituted with fluorine or chlorine atoms Group, 1 to 7 carbon atoms having 1 to 7 carbon atoms substituted with fluorine atom or chlorine atom, or 1 to 7 carbon atoms having 1 to 7 hydrogen atom substituted with fluorine atom or chlorine atom Fluorenyl; the remaining three of M 1 to M 4 represent hydrogen atoms. 如申請專利範圍第1或2項之聚合性化合物,其中,在通式(I)中,L1~L6表示氫原子、氟原子或氯原子。For example, the polymerizable compound according to item 1 or 2 of the scope of patent application, wherein in the general formula (I), L 1 to L 6 represent a hydrogen atom, a fluorine atom, or a chlorine atom. 如申請專利範圍第1或2項之聚合性化合物,其中,在通式(I)中,Z1、Z2及Z4分別獨立地表示-COO-、-OCO-、-CH=CH-COO-、-CH=CH-OCO-、-COO-CH=CH-、-OCO-CH=CH-、-COO-CH2CH2-、-OCO-CH2CH2-、-CH2CH2-COO-、-CH2CH2-OCO-、-COO-CH2-、-OCO-CH2-、-CH2-COO-、-CH2-OCO-、-C≡C-或單鍵。For example, the polymerizable compound in the first or second scope of the patent application, wherein in the general formula (I), Z 1 , Z 2 and Z 4 each independently represent -COO-, -OCO-, -CH = CH-COO -, -CH = CH-OCO-, -COO-CH = CH-, -OCO-CH = CH-, -COO-CH 2 CH 2- , -OCO-CH 2 CH 2- , -CH 2 CH 2- COO-, -CH 2 CH 2 -OCO-, -COO-CH 2- , -OCO-CH 2- , -CH 2 -COO-, -CH 2 -OCO-, -C≡C-, or a single bond. 如申請專利範圍第1或2項之聚合性化合物,其中,在通式(I)中,Z3表示-COO-、-OCO-、-CH=CH-COO-、-CH=CH-OCO-、-COO-CH=CH-、-OCO-CH=CH-、-COO-CH2CH2-、-OCO-CH2CH2-、-CH2CH2-COO-、-CH2CH2-OCO-、-COO-CH2-、-OCO-CH2-、-CH2-COO-、-CH2-OCO-或單鍵。For example, the polymerizable compound according to item 1 or 2 of the scope of patent application, wherein, in the general formula (I), Z 3 represents -COO-, -OCO-, -CH = CH-COO-, -CH = CH-OCO- , -COO-CH = CH-, -OCO-CH = CH-, -COO-CH 2 CH 2- , -OCO-CH 2 CH 2- , -CH 2 CH 2 -COO-, -CH 2 CH 2- OCO-, -COO-CH 2- , -OCO-CH 2- , -CH 2 -COO-, -CH 2 -OCO-, or a single bond. 如申請專利範圍第1或2項之聚合性化合物,其中,在通式(I)中,Z2及Z3分別獨立地表示-COO-、-OCO-、-CH=CH-COO-、-CH=CH-OCO-、-COO-CH=CH-、-OCO-CH=CH-或單鍵。For example, in the polymerizable compound of the first or second patent application range, in the general formula (I), Z 2 and Z 3 each independently represent -COO-, -OCO-, -CH = CH-COO-,- CH = CH-OCO-, -COO-CH = CH-, -OCO-CH = CH- or single bond. 如申請專利範圍第1或2項之聚合性化合物,其中,在通式(I)中,M1表示氟原子、氯原子、氰基、甲基或甲氧基,M2~M4表示氫原子。For example, in the polymerizable compound of claim 1 or 2, in the general formula (I), M 1 represents a fluorine atom, a chlorine atom, a cyano group, a methyl group, or a methoxy group, and M 2 to M 4 represent hydrogen atom. 如申請專利範圍第1或2項之聚合性化合物,其中,在通式(I)中,m1表示0。For example, the polymerizable compound according to item 1 or 2 of the patent application range, wherein m 1 in the general formula (I) represents 0. 一種聚合性組成物,係含有如申請專利範圍第1至8中任一項之聚合性化合物。A polymerizable composition containing a polymerizable compound according to any one of claims 1 to 8. 一種聚合物,係藉由將如申請專利範圍第9項之聚合性組成物進行聚合而得到。A polymer is obtained by polymerizing a polymerizable composition such as the item 9 in the patent application. 一種光學各向異性體,係使用如申請專利範圍第10項之聚合物。An optically anisotropic body uses a polymer such as item 10 of the scope of patent application.
TW101109357A 2011-03-29 2012-03-19 Polymerizable compound, polymerizable composition, and optical anisotropy TWI622598B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2011072208 2011-03-29

Publications (2)

Publication Number Publication Date
TW201307407A TW201307407A (en) 2013-02-16
TWI622598B true TWI622598B (en) 2018-05-01

Family

ID=46987703

Family Applications (1)

Application Number Title Priority Date Filing Date
TW101109357A TWI622598B (en) 2011-03-29 2012-03-19 Polymerizable compound, polymerizable composition, and optical anisotropy

Country Status (4)

Country Link
JP (1) JP5962965B2 (en)
KR (1) KR101763667B1 (en)
CN (1) CN102731312B (en)
TW (1) TWI622598B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5834489B2 (en) * 2011-05-18 2015-12-24 Dic株式会社 Polymerizable naphthalene compound
JP5962949B2 (en) * 2011-11-28 2016-08-03 Dic株式会社 Polymerizable liquid crystal compound
JP5962992B2 (en) * 2012-11-22 2016-08-03 Dic株式会社 Compound with fluorinated naphthalene structure
JP6372060B2 (en) * 2013-08-20 2018-08-15 Dic株式会社 Polymerizable compound and optical anisotropic body
JP6323144B2 (en) * 2014-04-22 2018-05-16 Dic株式会社 Polymerizable compound and optical anisotropic body
DE102015008172A1 (en) * 2014-07-28 2016-01-28 Merck Patent Gmbh Liquid-crystalline media with homeotropic alignment
CN111548324A (en) * 2014-12-04 2020-08-18 Dic株式会社 Polymerizable compound, composition, polymer, optically anisotropic body, liquid crystal display element, and organic EL element
WO2016136533A1 (en) * 2015-02-24 2016-09-01 Dic株式会社 Polymerizable compound and optical isomer
JP6292462B2 (en) * 2015-10-23 2018-03-14 Dic株式会社 Polymerizable compound and optical anisotropic body
WO2020115936A1 (en) * 2018-12-06 2020-06-11 Dic株式会社 Liquid crystal composition and liquid crystal display element

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008088291A (en) * 2006-10-02 2008-04-17 Adeka Corp Polymerizable composition
JP2009029929A (en) * 2007-07-26 2009-02-12 Adeka Corp Polymerizable composition containing polymerizable liquid crystal compound and radical photopolymerization initiator
TW201011036A (en) * 2008-09-11 2010-03-16 Dainippon Ink & Chemicals Polymeric chiral compound

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1294954C (en) * 1986-12-26 1992-01-28 Masakatsu Nakatsuka Optically active naphthalene derivatives
JP2007119415A (en) * 2005-10-31 2007-05-17 Adeka Corp Polymerizable liquid crystal compound having condensed ring, and homo- and co-polymers of the polymerizable liquid crystal compound
JP5408841B2 (en) * 2006-12-29 2014-02-05 株式会社Adeka Polymerizable compound and polymerizable composition
JP5441311B2 (en) * 2007-02-09 2014-03-12 株式会社Adeka Polymerizable composition
KR101540139B1 (en) * 2008-01-11 2015-07-28 메르크 파텐트 게엠베하 Reactive mesogenic compounds and mixtures

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008088291A (en) * 2006-10-02 2008-04-17 Adeka Corp Polymerizable composition
JP2009029929A (en) * 2007-07-26 2009-02-12 Adeka Corp Polymerizable composition containing polymerizable liquid crystal compound and radical photopolymerization initiator
TW201011036A (en) * 2008-09-11 2010-03-16 Dainippon Ink & Chemicals Polymeric chiral compound

Also Published As

Publication number Publication date
JP2012214756A (en) 2012-11-08
KR101763667B1 (en) 2017-08-01
TW201307407A (en) 2013-02-16
CN102731312B (en) 2017-04-12
CN102731312A (en) 2012-10-17
JP5962965B2 (en) 2016-08-03
KR20120112049A (en) 2012-10-11

Similar Documents

Publication Publication Date Title
TWI622598B (en) Polymerizable compound, polymerizable composition, and optical anisotropy
CN108368070B (en) Polymerizable compound and optically anisotropic body
KR102624959B1 (en) Polymerizable compound, composition, polymer, optically anisotropic body, liquid crystal display device and organic el element
CN107108473B (en) Polymerizable compound and optically anisotropic body
USRE42221E1 (en) Polymerizable liquid crystal composition and polymer thereof
JP5376272B2 (en) Polymerizable compound having a lateral substituent in the terminal ring structure
JP5168976B2 (en) Biphenyl and terphenyl compounds and polymerizable liquid crystal compositions containing the compounds
JP5103981B2 (en) Polymerizable compound having 5, 6 and 7 rings, and polymerizable liquid crystal composition containing the compound
JP5464230B2 (en) Polymerizable liquid crystal composition and polymer thereof
KR101523330B1 (en) Polymerizable chiral compound
JP5505686B2 (en) Polymerizable biphenyl compound
JP5888544B2 (en) Polymerizable liquid crystal compound
JP5310548B2 (en) Polymerizable liquid crystal compound, liquid crystal composition and polymer
JP2008239569A (en) Polymerizable compound
JP6308415B2 (en) Polymerizable compound and liquid crystal composition using the same
KR101648041B1 (en) Polymerizable compound
KR101563574B1 (en) Polymerizable biphenyl compound
JP2010222280A (en) Polymerizable biphenyl compound
US20100264367A1 (en) Polymerizable liquid crystal compound, liquid crystal composition, and polymer
JP2014019654A (en) Polymerizable acetylene compound

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees